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Due to the drawbacks associated with traditionally used bone substitutes, such as 
autografts and allografts, the field of tissue engineering, regenerative medicine and biomaterials 
science has recently come to the forefront with new strategies for bone repair and de novo tissue 
formation. Current research has focused on employing bionanocomposites composed of 
polymers, such as poly(lactide) (PLA), and inorganic calcium phosphate ceramics, such as 
hydroxyapatite (HA). These hybrid materials benefit from combining biodegradability, 
biocompatibility, bioactivity, and other advantageous scaffold properties to better mimic biological 
and structural characteristics of native bone.  
With this in mind, the work presented in this dissertation focuses on the synthesis of well-
controlled PLA homopolymers, as well as amphiphilic block copolymers. This was achieved via 
the ring opening polymerization (ROP) of lactide using an organocatalyst and the successful 
combination of ROP of lactide and the reversible addition-fragmentation chain transfer (RAFT) 
polymerization of poly(ethylene glycol) ethyl ether methacrylate (PEGEEMA) using a novel 
heterofunctional initiator/chain transfer agent (inifer). Comprehensive kinetics studies also 
provided valuable insights into the factors influencing the synthesis of well-defined block 
copolymers. These polymers were then successfully processed into fibrous scaffolds using 
electrospinning techniques and the different parameters affecting fiber formation and morphology 
were investigated. In addition, the prepared scaffolds were evaluated in terms of overall 
hydrophilicity, in vitro performance, and biodegradation behavior. Furthermore, a hydrothermal 
synthesis approach was employed to produce well-defined HA nanoparticles with tunable sizes 
that can be used in biomimetic nanocomposite scaffolds. Lastly, the surface modification of the 
HA nanoparticles was investigated via a grafting-from approach using the ROP of lactide, as well 
as via the use of a poly(dopamine) coating. Overall, the results presented in this dissertation 
iv 
 
provide important mechanistic insights into the successful synthesis of well-controlled amphiphilic 
block copolymers and also contribute to developing facile methods to prepare biomimetic HA 
nanoparticles and biodegradable fiber scaffolds. The findings also further highlight the importance 
of polymer and nanoparticle-containing bionanocomposite scaffolds, which have the potential to 
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CHAPTER 1  
INTRODUCTION 
 
1.1 Introduction and Thesis Organization 
Since the first official meeting in the 1980s, the field of tissue engineering, regenerative 
medicine, and biomaterials science has emerged as a multidisciplinary endeavor to develop 
scaffold materials that remedy organ loss or tissue failure.1-3 Bone represents one of the most 
transplanted tissues, which has fueled research efforts to develop suitable materials for bone 
substitutes aside from autografts and allografts.4,5 Especially poly(lactide) (PLA), among other 
biodegradable polyesters, has been widely investigated due to its biocompatibility, eco-
friendliness, and processability. PLA has been successfully employed in biomedical applications, 
such as sutures, nanocarriers for drug delivery, bone fixation devices, and porous scaffolds.6,7 
With the development of so-called “organocatalysts” like 1,8-diazabicyclo[5.4.0]undec-7-ene 
(DBU), the preparation of PLA has in the past decade experienced a renaissance, allowing for 
the ring opening polymerization (ROP) of lactide without the use of traditional metal-based 
catalysts.8,9 Despite its benefits, the inherent hydrophobic nature of PLA-based materials has a 
detrimental effect on cell attachment and biodegradation. Researchers have therefore focused on 
addressing these shortcomings via the development of amphiphilic block copolymers by 
combining ROP with one of the living radical polymerization techniques, such as reversible 
addition-fragmentation chain transfer (RAFT) polymerization.10 
Another material that has been of considerable interest is hydroxyapatite (HA), which is a 
part of the calcium phosphate ceramics family. HA, or Ca10(OH)2(PO4)6, structurally and 
chemically resembles native bone matrix crystals and has therefore been an excellent candidate 
for bone tissue engineering applications.11,12 Several solid state, wet chemistry, as well as high 
temperature synthesis routes have been developed over the years to successfully prepare 
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hydroxyapatite nanoparticles (HANPs) that mimic the inorganic component of natural bone. HA 
materials are generally considered biocompatible, bioactive, and can provide structural support, 
but they are also brittle, which limits their processability.11,13 One approach to overcome this 
shortcoming that also concurrently makes use of the aforementioned benefits of HA lies in the 
preparation of hybrid or composite materials. Biocomposites comprised of HA and polymers such 
as PLA-based homopolymers and amphiphilic block copolymers are promising as they combine 
the advantageous properties of each materials and can aid in the preparation of biomaterial 
scaffolds that better mimic the biological and structural properties of bone. Due to bone itself being 
an organic-inorganic hybrid material, consisting of collagen fibrils and HA nanocrystals, 
composites containing polymer fibers and inorganic nanoparticles have been especially attractive 
for bone tissue engineering applications.14-16 
One of the prominent methods of preparing biomimetic fiber scaffolds is electrospinning 
(ES). ES is a relatively convenient and cost-effective method to produce micrometer or 
nanometer-sized fibers by charging and ejecting a polymer solution through a spinneret in the 
presence of a high voltage electric field. The many variables that govern the ES process, such as 
solution, processing and ambient parameters, make ES a versatile method that can be tuned to 
be applicable to a variety of polymers or nanoparticle-containing polymer composite materials.17-
19 For example, Khakestani et al.20 recently used ES to prepare a nanofibrous PLA scaffold 
containing nanosized HA as well as a herbal extract with anti-inflammatory and antibacterial 
properties. These nanocomposite scaffolds exhibited improved mechanical properties and 
showed promising results in vitro, promoting attachment, proliferation and osteogenic 
differentiation of mesenchymal stem cells, thus promoting biocomposite materials as suitable 
candidates for bone tissue engineering applications. 
While organic-inorganic hybrid materials based on PLA and HA have shown considerable 
potential as bone graft substitutes, some challenges still remain. Recent insights into the 
mechanism of DBU-catalyzed ROP of lactide have revealed different mechanistic pathways by 
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which the polymerization can proceed.21,22 If not controlled, the ROP of lactide using DBU can 
produce a mixture of cyclic and linear PLA, which is unfavorable given that the cyclic species 
cannot undergo subsequent chain extension to produce amphiphilic block copolymers. In 
addition, due to the wide variety of existing techniques to synthesize HANPs, only a few reliable 
methods exist to reproducibly prepare HANPs with well-defined sizes, morphology, stoichiometry, 
phase purity, and crystallinity. Due to their hydrophilic nature, HANPs also do not disperse 
particularly well in hydrophobic polymer matrices such as PLA, which results in poor interfacial 
adhesion between the polymer and the nanoparticles.23-25 This can lead to nanoparticle 
aggregation and mechanical failure at the nanoparticle-polymer interface. In order to overcome 
this issue, surface modification techniques have been employed. For example, the ROP of lactide 
has been used to graft PLA from the surface of HANPs, thus producing surface modified 
nanoparticles with enhanced adhesion affinity to the PLA matrix.26,27 However, a lack of 
exhaustive characterization as well as lack of mechanistic insights leaves the surface modification 
of HANPs presently not well understood. Lastly, the powerful yet complex nature of the ES 
technique allows fibrous scaffolds to be prepared from a variety of polymer and nanocomposite 
solutions, but the process to find optimized conditions for uniform and defect-free fiber formation 
can be time-consuming as no universal protocols exist. The biodegradation of the fibrous 
scaffolds also depends on various factors, which can make degradation studies a complex 
research endeavor and, without universal testing standards, can convolute the comparison of 
experimental results to existing literature data. 
Therefore, the overall goal of this dissertation is to synthesize well-controlled PLA-based 
homopolymers and amphiphilic block copolymers as well as well-defined nanosized HA, which 
can be readily processed via ES into uniform fiber scaffolds for bone tissue engineering 
applications. The relevant background highlighting the concepts and current research in the field 
of tissue engineering is presented in Chapter 2. The first section briefly discusses the importance 
and history of tissue engineering, regenerative medicine, and biomaterials science and then 
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covers typical characteristics of biodegradable scaffolds, and provides an overview of pertinent 
materials for scaffold preparation, with a focus on materials suitable for bone tissue engineering. 
The following section introduces biodegradable polyesters and then focuses in on the synthesis 
of PLA homopolymers as well as PLA-based amphiphilic block copolymers. Next, the properties, 
synthesis, and surface modification of HANPs is discussed. The background chapter then 
concludes with a review of ES and the parameters affecting fiber formation and morphology as 
well as a discussion of biodegradation processes. 
Chapter 3 focuses on the synthesis of well-controlled PLA homopolymers via ROP of 
lactide, as well as the preparation of well-defined amphiphilic block copolymers based on PLA 
and poly(poly(ethylene glycol) ethyl ether methacrylate) (PPEGEEMA), using a combination of 
ROP and RAFT polymerization. As previously mentioned, recent literature results have 
highlighted multiple pathways for the ROP of lactide in the presence of DBU. Therefore, detailed 
kinetics studies of the ROP are presented along with a discussion about the effect of monomer 
concentration, reaction time, and initiator-to-catalyst ratios on the ROP of lactide.  Furthermore, 
additional kinetics studies are discussed, examining the sterically demanding RAFT 
polymerization, in order to provide a better understanding of the synthesis of well-defined 
amphiphilic block copolymers. 
Chapter 4 centers on the use of ES methods to produce uniform fiber scaffolds prepared 
from the PLA-based homopolymers and block copolymers synthesized in Chapter 3. Some of the 
parameters affecting fiber formation and morphology, such as solution concentration, applied 
voltage, molecular weight, solution conductivity, and distance from the spinneret to the collector 
are analyzed. In addition, the overall processing conditions that are suitable for both the 
homopolymers as well as the amphiphilic block copolymers are presented. The results of a 
degradation study encompassing the prepared fiber scaffold under physiological and accelerated 
conditions are also discussed in detail. Lastly, a preliminary cell study highlighting the promising 
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in vitro performance of the PLA and PPEGEEMA-based amphiphilic block copolymers concludes 
the chapter. 
Detailed results of the successful synthesis of well-defined HANPs with biologically 
relevant sizes, as well as well-controlled morphologies and properties is presented in Chapter 5. 
Parameters such as reactant concentration, addition of sodium citrate, temperature, and reaction 
time - and their effect on the overall particle size - are also discussed. Furthermore, challenges 
associated with the surface modification of HANPs via the ROP of lactide are disclosed. 
Finally, Chapter 6 details the main conclusions of this dissertation and includes directions 
for future work. Appendices A, B, and C add supporting information and data for the main 
chapters. 
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2.1 Tissue Engineering, Regenerative Medicine and Biomaterial Science – Importance, 
Strategies, and Materials 
2.1.1 Importance and History 
Each year, millions of Americans suffer from tissue loss or organ failure caused by injury, 
disease or trauma. Furthermore, with the progressive aging of our population, age-related tissue 
degeneration has become an increasingly costly healthcare problem. Hundreds of thousands of 
procedures related to joint replacements, hip or knee repair, bone grafts or bone fixation, diabetic 
ulcers, and many other organ and tissue deficiencies are performed annually. Numbers for 
treatments of burns or dental diseases even extend into the millions.1-3 In addition, every year 
almost 17,000 kidney, 6,000 liver, and 3,000 heart transplants are performed in the U.S. alone. 
In 2017, the costs associated with just one of these procedures ranged from $400,000 – 
1,400,000.4 Although therapies, such as transplants, surgical reconstruction, and the use of 
biomedical devices, have had a tremendous impact on patients’ lives, they remain imperfect 
solutions. For example, organ donor shortages continue to be an issue. According to the United 
Network for Organ Sharing, almost 115,000 individuals (with 75,000 on an active waiting list) are 
currently in need of an organ transplant in the U.S., yet less than 12,000 donors are available.5 
Furthermore, surgical reconstructions are expensive and biomedical devices often suffer from 
long-term incompatibility and instability.2,3 
As an alternative, the field of tissue engineering has emerged, aiming to apply “the 
principles of engineering and the life sciences toward the development of biological substitutes 
that restore, maintain, or improve tissue function”.3 Following the first National Science 
Foundation meeting - which was held in the late 1980s in Keystone, Colorado – entitled “Tissue 
Engineering”, the term was first recorded in a publication named “Functional Organ Replacement: 
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The New Technology of Tissue Engineering”.6-8 While the idea of tissue replacement may be 
traced back as far as the 16th century, when Gasparo Tagliacozzi at the University of Bologna 
employed a forearm flap as a nose replacement, the field of tissue engineering, regenerative 
medicine and biomaterials science has since matured into a multidisciplinary endeavor, 
encompassing research from medicine, engineering, chemistry, material science, 
nanotechnology, biology, bio-information, and other disciplines.9 
 
 
Figure 2.1 Generations of biomaterials over the decades. 
 
The evolution of biomaterials used for tissue engineering and regenerative medicine has 
happened in stages (Figure 2.1).  First generation materials were mostly focused on being inert 
and evoking no response or only a minimal response from the host. Some of these early materials 
were industrially relevant, but not necessarily specifically designed for medical use. For example, 
pyrolytic carbon originally served as a coating material for nuclear fuel particles, but has been 
widely used to coat components of mechanical heart valves. The second generation includes 
bioresorbable materials or bioactive materials that elicit a controlled reaction. For instance, drug-
eluting stents have been used to diminish blood vessel closure after angioplasty. In addition, 
biodegradable sutures comprised of poly(glycolic acid) (PGA) have been clinically employed since 
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the 1960s. The third generation materials now focus mainly on stimulating and regenerating 
functional tissue. Biointeractive materials such as Dermagraft®, for example, consist of a 
bioresorbable scaffold, an extracellular matrix, and fibroblasts, which help restore the skin in 
patients who suffer from foot ulcers due to chronic diabetes.1,10,11 Overall, the evolution and 
development of biomaterials is an ongoing process, and common strategies and materials used 
in tissue engineering applications are discussed in the following section. 
2.1.2 Strategies and Materials for Tissue Engineering Scaffolds 
Tissue engineering strategies can typically be divided into three components: a scaffold, 
cells, and bioactive factors (Figure 2.2). The scaffold represents the main part and it serves as a 
temporary support system as well as a template for tissue growth and reconstruction. In addition, 
scaffolds can also be seeded with stem cells or differentiated cells to further help with tissue 
regeneration. Bioactive factors, such as growth factors, integrin-binding ligands, and nucleic acids 
can also be incorporated into the scaffold to promote cell attachment, migration, and proliferation.9 
 
 
Figure 2.2 The triad of tissue engineering, encompassing scaffolds, cells, and bioactive agents. 
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Ideally, biomimetic scaffolds used in tissue engineering, regenerative medicine, and 
biomaterials science should be designed to exhibit several characteristics. First, scaffolds must 
be biocompatible and should not elicit an immune response that may diminish the healing process 
or cause rejection by the body. Furthermore, scaffolds are meant to serve as temporary templates 
for tissue regeneration and are not intended as permanent implants. As such, scaffolds need to 
be biodegradable and should degrade without producing significantly cytotoxic, inflammatory, or 
immunogenic by-products. In addition, the architecture of the scaffolds plays an important role. 
Scaffolds should exhibit an interconnected pore system that allows for cell infiltration and also 
supports the transport of nutrients and waste products in and out of the construct. Last, but not 
least, the surface chemistry and topography of the scaffold should promote cell interaction.9,12 
 
Table 2.1 Overview of materials used for tissue engineering and biomaterial science applications. 
 
 
Another important aspect of the tissue engineering paradigm is the choice of material from 
which the scaffold is to be fabricated. Typically, three groups of materials – metals, ceramics, and 
polymers – have been employed. An overview of different materials, examples for each class, as 
well as advantages and disadvantages are listed in Table 2.1. Permanent metal implants based 
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on stainless steel, titanium and titanium alloys, as well as cobalt-chromium alloys have been 
widely used for biomaterials applications for decades. Due to their excellent mechanical 
properties, metals are especially suitable for load-bearing applications such as hip implants, but 
there are also limitations associated with metal-based biomaterials. Device complications 
associated with the adverse interaction of the metal and the surrounding tissue, as well as 
corrosion-related metal ion release often require expensive and invasive revision surgeries and 
have limited the long-term use of permanent metal implants.13,14 Ceramic materials such as 
aluminum oxide, calcium phosphate, and bioactive glass have been employed as artificial femoral 
heads or acetabular liners, bone graft substitutes, and bone void fillers. While ceramics generally 
exhibit high compressive strength, their overall mechanical properties depend on the 
manufacturing process and inherent porosity of the material. Furthermore, due to their hard and 
brittle nature as well as poor solubility, they also possess limited biodegradability and 
processability.14-16 Lastly, polymer materials have been of great interest, as they span a wide 
range from natural to synthetic polymers. The use of natural polymers, such as collagen, gelatin,  
alginate, chitosan, starch, silk fibroin, and fibrin, has been explored due to their degradability, low 
cost, and availability.14,17-20 Collagen has been an especially attractive biomaterial candidate, as 
it represents the major protein component of the extracellular matrix (ECM) and provides support 
to connective tissues in the body. However, natural polymers also suffer from drawbacks like 
batch to batch variability, difficult purification, and limited processability.19,21 Polyesters, 
polyurethanes, polyanhydrides, polyphosphazenes, and other synthetic polymers have also been 
researched.14,17,18,20,22,23 Synthetic polymers generally offer superior homogeneity in terms of 
chemical composition, are often more easily purified and processed, and can be functionalized 
and tailored to different properties.21,23 However, not all synthetic polymers involve low-cost 
syntheses, possess adequate mechanical properties, or degrade into non-immunogenic 
degradation products. It is also important to note, that although polymer-based biomaterials have 
been quite promising for tissue engineering applications, each class of polymers comes with its 
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own set of advantages and disadvantages. Therefore, the potential of a material for tissue 
engineering applications depends on what type of tissue is to be repaired or restored.24 With this 
in mind, materials design and engineering has been an ongoing and active area of tissue 
engineering and biomaterials research, continually aiming to develop materials that better mimic 
the functional and mechanical properties of the target tissue. 
One of the areas of tissue engineering that has received considerable interest involves 
the development of new materials for bone repair and bone loss, because bone represents one 
of the most transplanted tissues.25 Although many fractures and bone defects can heal 
spontaneously, bone regeneration can be impaired by traumatic injuries, cancer, congenital 
anomalies and pathological diseases, such as Paget’s disease, osteoporosis, and 
osteoarthritis.25-27 Over 2 million orthopedic procedures are performed annually, resulting in a high 
demand for bone grafts and bone substitutes.28 Presently, autograft and allografts represent the 
most frequently employed treatment options for bone defects and bone loss. Autografts involve 
autologous tissue transfer, in which segments or pieces of bone are transplanted from one site 
within the patient to another. Since autografts originate from within the same patient, the native 
bone tissue can be readily incorporated at the implant site and severe adverse immune responses 
are rare. However, autografts are suffer from donor site morbidity, which manifests itself through 
infection, necrosis and post-operative pain at the harvest site. Furthermore, the availability of 
autograft bone tissue is limited, especially in pediatric and elderly patients. Alternatively, 
allografts, which employ bone fragments obtained from donors or cadavers, have been used. 
Although, the cost related to harvesting, processing, sterilizing, and storing donor bone tissue, as 
well as the potential for disease transmission and tissue rejection has limited the application of 
allografts.29-31  
Due to the significance of bone tissue engineering and the drawbacks associated with 
autografts and allografts, the development of suitable bone graft substitutes has been of 
considerable interest and is the focus of this dissertation. One of the most promising strategies 
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for bone repair and bone tissue engineering has been the use of composite materials.27,32-36 Native 
bone itself consists of Type I collagen and hydroxyapatite (HA) nanocrystals, thus making up an 
organic-inorganic hybrid composite.37 The hybrid nature of the native bone matrix has therefore 
inspired the use of hybrid or nanocomposite materials, consisting of an organic component 
(polymer) and an inorganic component (nanoparticles). While other nanoparticles or 
microparticles, such as silica-based nanoparticles, metal oxides, and also carbon nanotubes, 
have been considered for nanocomposite applications, HA stands out as the material of choice 
due to its close resemblance to the native bone matrix and its ability to be incorporated into the 
newly formed bone.32,35 In terms of the polymer matrix, natural polymers or synthetic polymers 
may be used as biomaterials. For example, biocomposites based on collagen and HA have been 
considered for bone tissue engineering applications. These types of scaffolds have shown good 
biocompatibility with osteoblast precursor cells and have resulted in aiding cell adhesion, 
proliferation, and differentiation. However, limited cell penetration into the scaffold has been 
observed. In addition, natural polymers, such as collagen, were also found to lack the appropriate 
mechanical strength needed for bone tissue engineering applications and displayed a variable 
degradation profile, because their degradation behavior is dependent on enzymatic 
pathways.21,34,38,39 Alternatively, synthetic polymers have been considered for bone tissue 
engineering applications and have garnered increased interest due to their ability to be 
functionalized and tailored to different properties. One synthetic polymer class in particular, 
namely synthetic poly(α-hydroxy acids) or polyesters, has been widely researched due its 
excellent biocompatibility and tunable degradation properties. Scaffolds based on polyesters and 
HA have therefore been investigated for bone tissue engineering applications and have been 
found to be promising in terms of biocompatibility, bioactive behavior, and tunable degradation 
profile, which is dependent on hydrolytic processes as opposed to enzymatic and oxidative 
pathways.17,21,34,39,40 Considering the advantageous properties associated with HA and polyesters, 
the work presented in this thesis focuses on these materials and the following sections discuss 
15 
 
the properties, synthesis and modification of polyester-based polymers, as well as HA 
nanoparticles. 
2.2 Biodegradable Polyesters – Properties and Synthesis of Homopolymers and Block 
Copolymers 
2.2.1 Properties of Polyesters 
As previously mentioned, biodegradable polyesters have been of great interest for 
biomedical and tissue engineering applications, such as bone tissue engineering. Three 
candidates (shown in Figure 2.3), namely polylactide (PLA), polyglycolide (PGA), and poly(ε-
caprolactone) (PCL), have been researched the most, due to their synthetic versatility, diverse 
properties, and long-standing history of regulatory compliance. PGA represents the simplest 
linear aliphatic polyester and it is highly crystalline, has a high melting point (225 – 230 °C), and 
a low solubility in organic solvents. PGA was one of the first biodegradable polymers to be 
commercially used for medical applications, such as Dexon™ sutures. PGA has also been 
employed in bone fixation devices like Biofix™ bone pins due to its high Young’s modulus (E = 
12.8 GPa, compared to E = 10 – 15 GPa for trabecular bone and E = 19 – 21 GPa for cortical 
bone).41 PGA scaffolds and constructs, however, generally degrade over a period of weeks after 
implantation, thus losing their mechanical properties rather rapidly. The fast degradation in 








PCL is a semi-crystalline linear aliphatic polyester and possesses more favorable 
processing temperatures (melting point range = 59 - 60 °C, glass transition temperature = -60 °C) 
as well as improved solubility in organic solvents. Nonetheless, PCL exhibits comparatively poor 
mechanical properties (E = 0.4 GPa) and slow degradation times (~2 years), which have partially 
restricted the use of PCL as a biomaterial. PCL is however still investigated in copolymer, blend, 
or composite materials for long-term drug delivery sutures, nerve regeneration, oral surgery, and 
wound dressings.21,42,43 Lastly, PLA has been of great interest due to its biocompatibility, low 
immunogenicity, and reasonable mechanical properties (E = 4.8 GPa), which can be further 
enhanced via the addition of HA in the form of a nanocomposite. PLA can be produced from 
renewable resources and is recyclable and compostable. Furthermore, PLA is FDA-approved for 
direct contact with biological fluids.21,44-46 The chirality of the lactide or lactic acid monomer, which 
exists as the S (L) and R (D) isomer, gives rise to different polymer configurations: the 
stereoregular polymers L-PLA (or PLLA) and D-PLA (or PDLA), the racemic polymer D,L-PLA (or 
PDLLA), as well as meso-PLA, which can be synthesized from a third lactide isomer, namely RS 
(DL) lactide. PLLA and PDLA are semicrystalline polymers, but PLLA is more frequently used, 
because its hydrolysis yields L-lactic acid, which is the naturally occurring isomer of lactic acid. 
Racemic or meso-PLA is amorphous and is generally more often employed in drug delivery 
applications, but has also found limited applications in blends to tune the mechanical and 
degradation properties of biomaterials.21,42,43 With these properties in mind, the work presented in 
this dissertation focuses on the synthesis and properties of PLLA (Chapters 3 and 4). 
2.2.2 Synthesis of PLA Homopolymers 
In general PLA can be synthesized via two different routes: the polycondensation of lactic 
acid or the ring opening polymerization (ROP) of lactide. Although the direct polycondensation 
method was the first approach to produce PLA by heating lactic acid under vacuum while 
removing water, it generally produces oligomers or low molecular weight PLA, largely due to 
depolymerization of PLA caused by high temperature and insufficient water removal.47-49 An 
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alternative method involves the ROP of the cyclic diester lactide, which has been extensively 
studied and has been the preferred route to prepare well-defined PLA with different molecular 
weights. Traditionally, the ROP of lactide has been mediated by metal-based catalysts in the 
presence of an initiator (typically an alcohol) and the polymerization follows a coordination-
insertion mechanism.50-56 Tin(II) 2-ethylhexanoate (stannous octoate) has been the most widely 
used metal catalyst and has routinely been employed to produce PLA of varying molecular 
weights.57-61 However, there are some drawbacks associated with the use of metal catalysts. In 
general, relatively high reactions temperatures and long reaction times are required. Furthermore, 
the complete removal of the metal catalyst from the polymer can sometimes not be guaranteed, 
which is a concern if these polymers are to be employed in biomedical and tissue engineering 
applications. 
These disadvantages prompted a search for alternative catalysts for the ROP of lactide 
and other cyclic lactones.  In 2001, Nederberg et al.62 were the first to report a novel metal-free 
catalyst system, thus introducing a new synthetic strategy utilizing so-called organocatalysts for 
the ROP of lactide. Strongly basic amines such as 4-dimethylaminopyridine (DMAP) and 
pyrrolidinopyridine were the first class of organocatalysts to be reported, although a variety of 
other metal-free catalysts, such as N-heterocyclic carbenes (NHCs), acid catalysts, bifunctional 
thiourea-amine catalysts, as well as guanidine and amidine catalysts, has emerged since.63-67  
Especially one of the amidine “superbases”, namely 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), 
has been of considerable interest due to its commercial availability, low cost, and high catalytic 
activity. Lohmeijer et al.68 were the first to publish the successful ROP of lactide using DBU and 
it was initially reported that DBU activates the alcohol initiator, via hydrogen bonding, for the 
nucleophilic attack of the lactide monomer. However, subsequent studies by Brown et al.69 and 
Sherck et al.70 have provided evidence that DBU is able to directly participate in the polymerization 
via a zwitterionic mechanism (Scheme 2.1). Brown et al.69 reported that in the absence of an 
alcohol initiator, DBU can serve as the nucleophile and an attack on the lactide monomer 
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generates an equilibrium of two species: a neutral tricycle (dormant species T1) and an amidinium 
zwitterion (active species Z1). Upon addition of lactide monomer to the alkoxide end, the zwitterion 
undergoes chain growth (Zn) and ultimately generates cyclic PLA, as the alkoxide end can attack 
the amidinium end of the polymer chain. In addition, the deprotonation of Z1 can generate a ketene 
aminal species (KA), which can also undergo chain growth, producing ketene aminal end-capped 
PLA. Due to the ability of ketene aminal species to acylate alcohols, the resulting linear PLA 
chains can again cyclize and also participate in transesterification, if methanol is used during the 
workup of the polymerization. Sherck et al.70 further investigated this zwitterionic mechanism and 
indicated that the ratio of initiator to DBU played a role whether or not the polymerization followed 
the activated-alcohol pathway (AAP) or the nucleophilic-attack pathway (NAP). The authors 
reported that by using excess alcohol initiator, the ROP of lactide is initiated by the DBU-activated 
alcohol initiator (following the AAP), whereas excess DBU causes the polymerization to undergo 
the zwitterionic mechanism (following the NAP). 
 
 




These recent publications have highlighted that understanding these two pathways is of 
great importance for the successful synthesis of well-controlled PLA homopolymers, since only 
the AAP produces linear PLA chains with well-defined end groups, whereas the NAP can result 
in a mixture of cyclic and linear chains. Cyclic chain architectures and thus loss of end groups can 
be disadvantageous, especially if the polymer is to be tailored to specific properties or is to further 
undergo post-polymerization modification or function as a part of a block copolymer. Despite 
these new mechanistic insights, most recent literature aiming to produce PLA-based polymers for 
tissue engineering applications does not consider the AAP and NAP pathways, which has inspired 
the work presented in Chapter 3, which focuses on examining the synthetic, mechanistic, and 
kinetics aspects of PLA-based homopolymers as well as block copolymers. 
2.2.3 Synthesis of PLA-Based Amphiphilic Block Copolymers 
Despite its advantageous properties, PLA also suffers from drawbacks. Firstly, PLA is a 
hydrophobic material, with a static water contact angle of 80°. Its hydrophobic nature results in a 
short residence and circulation time for PLA-based nanocarrier and drug delivery systems. 
Furthermore, it generally induces a low cell affinity and affects the degradation time and in vivo 
lifetime of tissue engineering scaffolds. Secondly, PLA also possesses a limited potential for 
biofunctionalization, which makes its surface and bulk modification a challenging task.44,71 While 
strategies like click chemistry, surface hydrolysis, and plasma treatment have been considered, 
such methods can be expensive and can compromise the mechanical integrity of the scaffold.72-
75 Another approach makes use of PLA-based block copolymers, in order to allow for additional 
properties, such as improved hydrophilicity and the potential for functionalization, to be 
incorporated. Block copolymer architectures are generally preferred over statistical copolymers, 
because a wider variety of monomers can serve as the second block and because the properties 
of each block can be readily tuned and manipulated. Statistical copolymers of PLA are limited to 
a few functional lactide monomers or other lactones and often also involve complicated and costly 
conjugation or click chemistry methodologies. Any functionalization achieved with statistical 
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copolymers is also random and does not offer a means to reliably and reproducibly tune or 
manipulate certain properties or functionalities.73,75,76 
Among PLA-based block copolymers, amphiphilic block copolymers, consisting of a 
hydrophobic PLA block as well as a hydrophilic biopolymer block, have been a prominent area of 
research due to their ability to serve as drug delivery vehicles, tissue engineering scaffolds, 
sutures and implants for bone fixation.71 The simplest route to produce amphiphilic block 
copolymers involves using polyethylene glycol (PEG) as the initiator for the ROP of lactide, thus 
generating linear PEG-b-PLA block copolymers.77,78 While this method offers the ease of using 
commercially available PEG, it is limited by the range of molecular weights available and also 
does not offer a facile way to further functionalize the polymer with bioactive agents. In order to 
synthesize more complex polymer architectures or allow for biofunctionalization, a combination 
of ROP and one of the living radical polymerization techniques, such as reversible addition-
fragmentation chain transfer (RAFT) polymerization, has been shown to be one of the best 
methods.79 RAFT polymerization has arguably been one of the most versatile living radical 
polymerization techniques due to its tolerance to a variety of functional moieties and relatively 
facile reaction conditions, and will be the focus of this dissertation. In addition, both ROP and 
RAFT polymerization are considered controlled polymerization techniques, in which the molecular 
weight of the polymer increases linearly with conversion. This allows for the synthesis of polymers 
with an average degree of polymerization (DP) that is predeterminable and facilitates the 
preparation of well-defined block copolymers with tunable properties by adjusting the DP of each 
block within the block copolymer.79-81 
The general mechanism for RAFT polymerization is shown in Scheme 2.2. The 
decomposition of a conventional radical initiator results in the formation of an initiator derived 
radical (I•), which reacts with monomer to form a oligomeric propagating radical (Pn•).Under ideal 
conditions, Pn• then reacts with a so-called “chain-transfer agent” or “RAFT agent” (1) to give an 
intermediate radical (3), which fragments to yield an oligomeric RAFT agent (2) and a RAFT 
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agent-derived radical (R•), which reinitiates the polymerization. The pre-equilibrium ends once 1 
has been fully consumed and all R• have reacted with monomer to form oligomeric propagating 
radicals (Pm•). In a well-controlled RAFT polymerization, the pre-equilibrium is completed early on 
in the polymerization and is followed by the main equilibrium, in which the active propagating 
radicals (Pm• and Pn•) and the dormant oligomeric RAFT agent (2) quickly exchange. This allows 
for the equal probability of all polymer chains to initiate at approximately the same time and grow 
at the same rate, which results in the synthesis of polymers with defined molecular weights and 
narrow molecular weight distributions.80 
 
 
Scheme 2.2 Mechanism of RAFT polymerization. 
 
In order to successfully combine ROP and RAFT polymerization, which are 
mechanistically different, two different approaches can be used. The first approach involves using 
a generic small molecule alcohol initiator to synthesize the PLA block, which is then modified via 
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post-polymerization functionalized to incorporate the thiocarbonythio moiety-containing chain 
transfer agent needed for the RAFT polymerization of the second block. For example, Barz et 
al.82,83 prepared a PLA homopolymer via the ROP of lactide using neopentyl alcohol. The PLA 
homopolymer was then modified via Steglich transesterification of the hydroxyl end groups of the 
polymer chains and the carboxylic acid end group of a dithiobenzoate chain transfer agent. The 
chain transfer agent-containing PLA homopolymer was then chain extended via RAFT 
polymerization to yield an amphiphilic block copolymer (see Scheme 2.3). However, this approach 
suffers from drawbacks, which primarily centers on the observation that the post-polymerization 
modification is not always successful for 100% of the polymer chains, leaving a mixture of 
modified and unmodified PLA. Barz et al.82,83 reported a total degree of end group functionalization 
of approximately 69-75%. Without further purification to completely remove the unmodified PLA 
(which may be difficult to achieve), the following RAFT polymerization does not produce well-
defined amphiphilic block copolymers, but results in a mixture of block copolymers and 
homopolymers, which is unfavorable. 
 
 
Scheme 2.3 Synthesis of PLA-based amphiphilic block copolymers using a post-polymerization 




The second approach makes use of a heterofunctional initiator/chain transfer agent 
molecule that can mediate both ROP and RAFT polymerization. This so-called “inifer” must bear 
a hydroxyl group to initiate the ROP of lactide, but must also contain a thiocarbonylthio group that 
can mediate the RAFT polymerization. This method was successfully demonstrated by Kang et 
al.,84 who synthesized a series of block copolymers based on the ROP of lactide, caprolactone, 
valertolactone, or trimethylene carbonate, as well as the RAFT polymerization of styrene, 
(meth)acrylate or acrylamide monomers. Inspired by the results, this technique has been 
extended to prepare amphiphilic block copolymers via the use of an inifer and the combination of 
the ROP or lactide and the RAFT polymerization of different bio-monomers, such as 
oligo(ethylene glycol) methacrylate (OEGMA), 2-(dimethylamino)ethyl methacrylate, glycerol 
monomethacrylate, 2-(methacryloyloxy)ethyl phosphorylcholine, acrylic acid, and N-(2-
hydroxypropyl) methacrylamide.85-89 An example, illustrating the successful use of a hydroxyl- and 
trithiocarbonate-containing inifer to synthesize amphiphilic block copolymers based on PLA and 
poly(OEGMA), is shown in Scheme 2.4.87 In addition, there are presently several RAFT agents 
that can be modified to serve as inifers, as well as even some OH-functional RAFT agents are 
commercially available, which generally makes this route to synthesize well-defined amphiphilic 
block copolymers via ROP and RAFT a more elegant and practical synthetic effort.79 The 
preparation of the particular inifer used in this dissertation was modeled after the aforementioned 
literature examples, and the details regarding the design and the synthesis of the inifer are 
discussed in Chapter 3. 
As previously discussed, RAFT polymerization is an effective and versatile technique that 
is compatible with a variety of different vinyl monomers. Among other previously mentioned bio-
monomers, OEGMA has been of great interest for applications in the biomedical field.90-93 As non-
linear analogs to PEG, poly(OEGMA) represents a “brush architecture”, composed of a carbon-
carbon backbone and multiple oligo(ethylene glycol) side chains. Poly(OEGMA) is hydrophilic, 
biocompatible, and exhibits a thermoresponsive behavior similar to poly(N-isopropylacrylamide), 
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which has made it an attractive material for drug delivery as well as tissue engineering 
applications. For example, Saeed et al.87 used ROP and RAFT polymerization to synthesize a 
poly(lactic acid-co-glycolic acid)-block-poly(poly(ethylene glycol) methyl ether methacrylate) 
(PLGA-b-PEGMA) block copolymer, which showed potential for applications in micellar drug 
delivery (Scheme 2.4). However, this study used the traditional tin(II) 2-ethylhexanoate to catalyze 
the ROP of lactide and glycolide and does not include any information regarding the kinetics of 
either the ROP or the subsequent RAFT polymerization.  
 
 
Scheme 2.4 Synthesis of PLGA-b-PEGMA amphiphilic block copolymers using ROP and RAFT 
polymerization. Used with permission from reference 87. 
 
Themistou et al.86 and Viswanathan et al.85 also synthesized PLA-b-POEGMA block 
copolymers, with the intention of using them for tissue engineering applications. The authors 
employed the organocatalyst DMAP, but also did not present any kinetics studies regarding either 
block. The amphiphilic block copolymer prepared in this study was then blended with high 
molecular weight PLA (300 000 g/mol) to produce polymer fibers, in which the core was composed 
of PLA and the PLA-b-POEGMA block copolymer was presented on the surface, forming the 
shell. The resulting fiber scaffolds exhibited improved hydrophilicity as opposed to the PLA 
homopolymer, but did not degrade significantly over the course of one month. In addition, the cell 
attachment studies showed no cells were observed on the fibers using the block copolymer, 
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unless they were further functionalized with the cell adhesive peptide RGD. These results may 
have been caused by using block copolymer ratios, in which the POEGMA block dominates the 
overall block copolymer. Similar to PEG, POEGMA possesses antifouling properties that can 
suppress the adsorption of proteins and, thus, diminish cell adhesion.94 These results highlight 
that amphiphilic block copolymers show great potential for biomedical and tissue engineering 
applications, yet there is a need to investigate materials like PLA-b-POEGMA in terms of the 
kinetics of each block in order to allow for the design and synthesis of well-defined block 
copolymers with tunable properties. Again, without a clear understanding of the synthetic, 
mechanistic, and kinetics aspects of preparing amphiphilic block copolymers such as PLA-b-
POEGMA, material properties such as overall hydrophilicity, degradation behavior, and in vitro 
and in vivo behavior cannot be tuned and manipulated. Inspired by this, Chapter 3 of this 
dissertation focuses on evaluating the synthesis of well-designed and well-controlled PLA-b-
POEGMA polymers for tissue engineering applications. 
Following the discussion of PLA-based homopolymers and block copolymers, the next 
section centers on the inorganic component of bone-inspired bionanocomposites and aims its 
attention at the properties, synthesis, and surface modification of nanoscale HA. 
2.3 Hydroxyapatite Nanoparticles – Synthesis and Surface Modification 
2.3.1 Properties and Synthesis of Nanoscale Hydroxyapatite 
As previously discussed, HA has been an attractive candidate for bone repair and bone 
tissue engineering due to its similarity to the mineral part of bone. As shown in Figure 2.4, bone 
consists of collagen and nanosized HA and therefore represents a hybrid or nanocomposite 
material.95 HA is part of the calcium phosphate ceramics family, which also includes other calcium 
phosphate phases, such as tricalcium phosphate, dicalcium phosphate, and tetracalcium 
phosphate. However, only tricalcium phosphate and HA exhibit an adequate degradation and 
resorption behavior, as the rate of degradation of the other phases is faster than the rate of tissue 
remodeling and regeneration. In addition, tricalcium phosphate is more often used as additive to 
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HA-based scaffolds and biomaterials than a standalone ceramic, because its increased solubility 
can help tune the biodegradation of HA.96-98 With this in mind, the focus of this dissertation is to 
consider the properties and synthesis of HA. 
In general, HA materials are considered bioactive and biocompatible, and gradually 
degrade and are slowly resorbed during bone remodeling and restoration processes.30,99,100 In 
addition, bone graft substitutes and bone tissue engineering materials based on HA exhibit 
osteoconductive behavior, meaning that they are able to promote the attachment of osteoblasts 
or osteoprogenitor cells. HA materials may also be considered osteoinductive, thus aiding in the 
differentiation of mesenchymal stem cells to osteoblasts, although some studies have suggested 
that the osteoinductive behavior may be linked to the microstructure of the material and may not 
be a property inherent to HA. Scaffolds and biomaterials based on HA don’t show the ability to 
induce de novo bone formation (osteogenicity), but can exhibit osteogenic behavior if seeded with 
cells prior to being introduced into the body.101-103 Lastly, HA-based bone graft substitutes can 
provide initial structural support, but their mechanical properties may vary depending on their 
porosity. HA ceramics are generally brittle materials, which limits their processability and again 
highlights the benefits of employing an organic-inorganic hybrid scaffold or construct.26,32,100 
 
 




Considering the preparation of HA for bone tissue engineering applications, various 
methods yielding nano- and micro-structures - ranging from irregular shapes to nanorods, 
nanosheets, flowers, porous microspheres, and rod bundles and clusters - have been 
reported.95,104,105 However, in order to mimic native bone, which typically contains small HA 
nanocrystals that are 40 - 60 nm long and 20 - 25 nm wide and have a stoichiometric ratio of Ca/P 
= 1.50 - 1.67, a synthesis technique that can successfully control the stoichiometry, size, and 
morphology of the particles is crucial.106 Although a variety of techniques - including dry methods 
(solid state), wet methods (precipitation, sol-gel, hydrothermal, emulsion), and high temperature 
methods (combustion, pyrolysis) – have been researched, three methods have been most 
commonly employed.95,104,105 First, precipitation methods are generally easy to conduct and allow 
for some control over the stoichiometry of the nanoparticles by adjusting the calcium and 
phosphate reagent concentrations, but the resulting hydroxyapatite nanoparticles (HANPs) often 
exhibit variable phase purity and size distribution, diverse morphologies, and low crystallinity. 
Next, sol-gel techniques have proven advantageous due to molecular-level mixing of the 
reactants, thus improving the chemical homogeneity of the product. However, long aging times 
and high calcination temperatures are needed and the phase purity, crystallinity, and 
morphologies of the HANPs produced by sol-gel methods still vary. Lastly, hydrothermal methods, 
involving the reaction of chemicals in an aqueous solution at elevated temperature and pressure, 
has been of great interest. Hydrothermal methods currently represent the most commonly 
employed synthesis technique to produce nanosized HA and will be the focus of this dissertation. 
One of the benefits of using hydrothermal methods is that the resulting HANPs exhibit good 
stoichiometry as well as high phase purity and crystallinity.95,104,105 Furthermore, additives such 
as surfactants and small molecules can be used to tune the size and morphology of the HANPs. 
The use of small molecule additive sodium citrate has been particularly popular, as it is 
biocompatible. Citrate ions also form complexes with calcium ions, thus reducing the binding rate 
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between calcium and phosphate ions and slowing down the nucleation and subsequent crystal 
growth of the HANPs.107-109 
 
 
Figure 2.5 Effect of the molar ratio of sodium citrate to calcium precursor: A) 0, B) 1/30, C) 1/15, 
D) 2/15, E) 4/15, F) 1/3, G) 2/3, and H) 4/3. Used with permission from reference 108. 
 
Over the past few years, Jin et al. have researched the effect of the citrate concentration 
as well as temperature on the size of HANPs.107,108 The authors investigated the effect of the 
molar ratio of sodium citrate to calcium precursor and found that the aspect ratio of the resulting 
HANPs increased as the molar ratio was increased (Figure 2.5). This can be attributed to the 
adsorption of citrate ions to the surface of the growing nanoparticles. The citrate ions preferentially 
adsorb to the crystal facets perpendicular to the anisotropic growth direction, thus resulting in 
nanorods. With an increase in the molar ratio of sodium citrate to the calcium precursor, the 
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adsorption density of citrate ions is increased, thus resulting in longer HA nanorods with 
increasing aspect ratios. In addition, higher molar ratios also enhanced the colloidal stability of 
the nanoparticles due to increasing electrostatic repulsion from the surface-adsorbed citrate ions.  
In addition, Jin et al.107 examined the effect of temperature and reported that increase in 
hydrothermal temperature resulted in larger particle sizes and higher crystallinity. However, the 
HANPs synthesized in these studies were generally larger than 100 nm (with sizes up to 1 μm), 
which do not fall in the size range mimicking biological HA. In addition, the experiments also only 
yielded very small amounts of HANRs (tenths of milligrams). 
Zhang et al.109 also investigated the synthesis of HA using a hydrothermal approach. The 
authors again employed sodium citrate, but also evaluated changes in pH of the initial reactant 
mixtures, ranging from pH 4 to pH 9. When working in a neutral or basic reaction environment, 
the resulting structures were dominated by isotropic or weakly anisotropic growth, giving short 
nanoparticles or nanorods. This was attributed to the strong adsorption probability of hydroxide 
ions to the HA nuclei. Conversely, when acidic conditions were used, in which the concentration 
of hydroxide ions was low, the probability of adsorption of hydroxide ions to the HA nuclei was 
limited and resulted in strongly anisotropy growth. The authors also additionally employed the 
cationic surfactant cetyl trimethylammonium bromide (CTAB) and found that it led to further self-
assembly and the formation of multiform morphologies, such as microspheres, microflowers, and 
microsheets. While the exact mechanism for the formation of these hierarchical superstructures 
is not yet explained, the authors hypothesized that the surface assembly may be associated with 
the electrostatic interactions of hydroxide ions and ammonium ions present in the reaction 
mixture. While this work presented valuable insights into the effect of solution pH on particle 
growth and allowed for the preparation of interesting multiform morphologies, only very basic 
reaction conditions (pH = 9) were able to produce HA nanoparticles with biologically relevant 
sizes. The results were also prone to be affected by the composition and purity of CTAB, as ionic 
impurities can cause ion substitutions and thus a change in the crystal structure and lattice 
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parameters of HA, which may not make CTAB a favorable candidate for the synthesis of well 
controlled HANPs. Overall, these literature examples highlight the potential of hydrothermal 
synthesis, especially in conjunction with sodium citrate, but also indicate that more research 
regarding the size control of HA is needed to reliably produce HANPs that mimic HA nanocrystals 
present in the native bone matrix. Inspired by these results and the need to better understand the 
synthesis of biologically relevant HANPs, Chapter 5 of this dissertation aims to further evaluate 
the hydrothermal synthesis of nanoscale HA. 
Following the discussion of the synthesis of HANPs, another aspect to consider is how 
these nanoparticles interact with a polymer matrix once combined to form nanocomposite 
materials, which is presented in the subsequent section. 
2.3.2 Surface Modification of HA for Composite / Hybrid Scaffolds 
As discussed earlier, composite or hybrid materials constructed from polymers such as 
PLA and inorganic nanoparticles like HANPs have been a promising strategy in the field of bone 
tissue engineering due to their ability to combine the advantages of both materials.32-34 While the 
polymer functions as a biodegradable matrix that serves as a temporary template for tissue 
regeneration, the HA component allows for osteoconductive behavior and provides mechanical 
reinforcement. Several reports of porous PLA- and HA-based hybrid scaffolds, which were 
prepared either via thermally induced phase separation (TIPS) or electrospinning (ES), have 
highlighted the enhanced osteoinductive, osteoconductive behavior as well as improved 
degradation and mechanical properties of these biomaterials.110-115 Despite these benefits, 
nanocomposites are also associated with drawbacks due to the incompatibility of the inorganic 
nanoparticles with the polymer matrix. HA is hydrophilic and has a low affinity towards 
hydrophobic polyesters such as PLA as well as many of the organic solvents that are used during 
scaffold preparation, which causes the particles to poorly disperse and aggregate, thus creating 
composites with uneven distributions and properties. For example, Figure 2.6 shows the poor 
mixing of HANPs and PLA in a hybrid fiber scaffold due to matrix incompatibility. Overall, 
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inadequate mixing in nanocomposites is a concern, as it can lead to mechanical failure at the 
polymer-nanoparticle interface, as well as inconsistent performances in vivo.110,111,113,116 
 
 
Figure 2.6 TEM micrographs of A) PLA fibers, B) HANPs, C) PLA fibers with 5 wt% HANPs, and 
D) PLA fibers with 15 wt% HANPs. Used with permission from reference 113. 
 
In order to improve integration of the HANPs into the PLA matrix, different approaches, 
such as using surfactants or fillers, amphiphilic block copolymers, as well as polymer-grafted 
nanoparticles, have been studied.104,110,111,116-118 PLA grafted HANPs (PLA-g-HANPs) have 
garnered considerable research interest, because the polymer-modified nanoparticle surface 
promises to result in enhanced interfacial adhesion between the polymer matrix and the particles. 
Some of the most well-known and cited work by Hong et al.119,120 and Zhang et al.121 reports the 
preparation of PLA grafted HA for nanocomposite applications. This was achieved via the ROP 
of lactide using the hydroxyl groups present on the surface of the nanoparticles as the initiator. A 
cartoon representation like the one shown in Scheme 2.5 was presented, however no mechanism 
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or kinetics studies of the polymerization have been published. Overall, the authors reported better 
particle dispersion, slightly improved mechanical properties and slightly enhanced cell 
attachment, yet the results remain confusing and unclear. Proof of the surface grafting was 
presented using thermogravimetric analysis (TGA), Fourier transform infrared (FTIR) 
spectroscopy, transmission electron microscopy (TEM), and solid state nuclear magnetic 
resonance (NMR) data. TGA curves show a 6% weight loss and FTIR results reveal an ester 
carbonyl stretch, which is indicative of polymer being present in the sample but does not confirm 
covalent attachment to the surface of the particles. Furthermore, TEM images do not show 
apparent surface coating and while a 31P NMR spectrum depicts a small shift, no detailed 
discussion was offered by the authors. Even though this research has promising implications for 
the preparation of improved nanocomposites, the mechanism of the grafting polymerization as 
well as successful characterization of the surface modified nanoparticles need to be further 
investigated. Chapter 5 of this dissertation focuses on elucidating these results further by 
employing more thorough characterization methods, as well as employing insights into the crystal 
structure and surface chemistry of HA. 
 
 
Scheme 2.5 Synthesis of PLA-g-HANPs via the ROP of lactide from the surface of HANPs. 
 
Another potential approach for the surface modification of HANPs involves the use of 
polydopamine (PDA). Lee et al.122 first reported the oxidative polymerization of dopamine to 
produce multifunctional coatings with surface-adherent properties similar to those found in 
mussels. PDA has since received considerable interest as a surface modification agent for drug 
delivery and other biomedical applications as well as battery, catalysis, and water treatment 
related applications.123-125 PDA coatings have also recently been employed to modify magnetic 
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nanoparticles in order to provide the appropriate surface chemistry, including hydroxyl or amine 
moieties, to initiate the ROP of lactide.126 But again, more exhaustive characterization techniques 
other than FTIR and TEM analysis, need to be employed to investigate the successful surface-
initiated ROP. this research, including determining the exact structure of PDA (the currently 
accepted structure of the catechol / amine / quinone / indole heteropolymer known as PDA is 
presented in Figure 2.8) as well as finding the optimal conditions to synthesize uniform PDA 
coatings on nanoparticles, is still ongoing.127-131 In addition, PDA coatings do not represent a 
covalent surface attachment, which may not make this a practical route in terms of surface 
modification, since the coating is removable.  
 
 
Figure 2.7 Structure of polydopamine (PDA). Used with permission from reference 128. 
 
Following the discussion of the properties and synthesis methods of PLA and HANPs, the 
subsequent sections review the preparation of fiber-based scaffolds, as well as examine the 
factors affecting the degradation of biomaterials scaffolds. 
2.4 Scaffold Fabrication and Degradation 
2.4.1 Electrospinning and Other Scaffolds Preparation Methods 
As mentioned earlier, tissue engineering scaffolds are porous structures with a high 
surface-to-volume ratio that allow for cell attachment and cell infiltration and that serve as 
temporary constructs until new tissue is formed. Essentially, biomaterials scaffolds aspire to mimic 
the body’s extracellular matrix (ECM) in terms of promoting cell growth, migration, and 
differentiation as well as proving adequate mechanical support. In general, the ECM consists of 
fibrous structural and adhesive proteins (such as collagen), specialized proteins (growth factors), 
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and an interfibrillary matrix (water, solutes, proteoglycans). The exact composition varies from 
tissue to tissue, but especially the fibrillary structure of collagen has served as the inspiration for 
fiber-based tissue engineering scaffolds.132-134 Among other scaffold fabrication techniques, 
including melt spinning, extrusion, phase separation, self-assembly, and 3D printing, 
electospinning (ES) represents one of the most prominent techniques. ES is a relatively 
convenient and cost-effective as well as versatile method that can be applied to a range of natural 
and synthetic polymers. It also has the potential to produce more complex scaffold architectures 
and fiber morphologies. Recent research examples have showcased electrospun scaffolds with 




Figure 2.8 Illustration of a simple electrospinning (ES) setup. Used with permission from reference 
145. 
 
The process of ES was first patented in 1934 by Anton Formhals and has emerged as an 
efficient method to produce polymer fibers with diameters ranging from a few hundred nanometers 
to several micrometers.144  A typical electrospinning setup (Figure 2.8) consists of three important 
components, namely a high voltage power supply, a needle or spinneret that is connected to the 
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power supply, and a grounded collector. When a polymer solution, with the help of a syringe 
pump, is pushed through the spinneret, charges are injected into the polymer solution. Because 
of the electrostatic force created by the repulsion of similar charges in the polymer solution as 
well as the attractive force between the oppositely charged polymer solution and the collector, a 
tensile force is exerted and elongates the pendant drop at the end of the needle. When a point is 
reached at which the charge repulsion overcomes the surface tension of the solution, the droplet 
transforms into what is called the “Taylor cone”. A fiber jet emitted from the apex of the cone is 
then accelerated towards and is collected on a grounded collector.145-147 
Although the ES setup is simple, the ES process itself is affected by a number of variables, 
such as the viscosity of the sample, polymer type and molecular weight, solution conductivity, 
voltage, flow, rate, distance from the spinneret to the collector, collector type and geometry, 
ambient temperature, and humidity. The solution viscosity (as controlled by changing the polymer 
concentration) is one of the most important factors in determining whether or not fibers are formed, 
because only when the critical entanglement concentration is reached, can fibers instead of 
droplets be maintained. Overall, an increased solution viscosity results in increased fiber 
diameters and reduced bead formation.137,141,146,147 However, the optimal viscosity or solution 
concentration needed to form uniform fibers changes with the type and the molecular weight of 
the polymer that is used as well as with the solvent system. For example, Casasola et al.148,149 
and Shenoy et al.150 have investigated the chain entanglement of high molecular weight PLA 
(approximately 100 000 g/mol and 700 000 g/mol) in a few different solvent, yet no universal 
model to successfully predict the appropriate chain entanglement concentration for a given 
polymer / solvent system has yet been presented. Next, the solution conductivity can be controlled 
by the choice of solvent (and its associated dielectric constant), as well the addition of salts or 
utilization of a conductive polymer. In general, solvents with higher dielectric constants require a 
lower applied voltage for fiber formation and the overall diameter of the fibers is decreased as the 
fiber jet is subjected to a greater tensile force in the presence of an electric field. Furthermore, the 
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applied voltage plays an important role in fiber formation, because insufficient electric field 
strength can cause the formation of the fiber jet to fail and also lead to beading defects. Other 
variables also have an impact on fiber morphology. The applied flow rate and spinneret-to-
collector distance affect how well fibers dry before reaching the collector. An increased flow rate 
can result in flattened and fused fibers and also create beading defects. The greater distance 
from the spinneret to the collector allows for more solvent evaporation as well as prolonged 
exposure of the fiber jet to the electric field, which can cause a decrease in fiber diameter. 
Elevated temperatures and humidity may also affect the fiber morphology and can create porous 
fibers. Lastly, fibers can be collected on stationary metal collectors, rotating drum collectors, wire 
meshes and other architectures, thus allowing for random, aligned, or otherwise structured fiber 
scaffold to be prepared.137,141,146,147 
Overall, ES is a powerful method to produce biomaterials fiber scaffolds, but given the 
number of processing parameters, the technique is equally complex and highly tunable. The 
tunability allows for the fabrication of scaffold from a wide variety of polymers and nanocomposite 
systems, but the lack of systematic research or universal models for defect-free fiber formation 
can make ES experiments a somewhat time-consuming trial-and-error approach. In addition, as 
mentioned in the previous section, the preparation of well-defined polymer and nanoparticle 
hybrid scaffolds can be especially challenging due to the poor mixing and matrix incompatibility 
of nanocomposite systems. To complicate matters, many current literature reports also do not 
justify the parameters and conditions that are used for the ES process, which makes the design 
and comparison of suitable processing variables challenging. Chapter 4 of this dissertation 
therefore presents a detailed evaluation of the most common processing parameters - such as 
solution concentration, voltage, solvent choice, flow rate, and distance - in order to provide a 
better understanding of these variables on the preparation of well-defined fiber scaffolds including 
PLA-based homopolymers and block copolymers. 
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2.4.2 Scaffold Degradation 
Last, but not least, the subject of scaffold degradation represents a complex topic. 
Typically, scaffold degradation proceeds via a series of cleavage events that lead to polymer 
chain scission, and ultimately a decrease in molecular weight (due to the formation of oligomers 
and monomers) and the loss of mechanical stability of the scaffold material. While there are other 
mechanisms, such as thermal degradation, mechanical degradation, photodegradation, microbial 
or enzymatic degradation, by which polymer materials can undergo chain scission, the most 
relevant method for biomaterial scaffolds involves hydrolytic processes.151 Hydrolytic degradation 
can divided into two modes, namely bulk degradation and surface erosion (Figure 2.9). 
 
 
 Figure 2.9 Illustration of surface erosion versus bulk degradation. Used with permission from 
reference 21. 
 
Considering the time it takes for water to diffuse into a polymer (TD), as well as the time 
required for hydrolysis of the polymer chains to occur (TH), the two degradation modes can be 
described as follows. If TD is higher than TH, the polymer scaffold becomes saturated by the 
degradation media, which results in non-linear mass loss over time. In addition, degradation 
products that exhibit reduced molecular mobility or diffusivity in the bulk may accumulate, thus 
leading to catalytic autoacceleration events that further exacerbate the non-linear mass loss. 
Surface erosion, on the other hand is represented by a higher TH than TD, which is characterized 
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by a linear mass loss over time. Since degradation products can freely diffuse away from the 
scaffold surface, autocatalytic effects are not observed in surface erosion.21,152,153 
Polyesters such as PLA predominantly degrade via bulk degradation and hydroxyl groups 
and carboxylic acid groups formed during the cleavage of the ester bonds in the polymer 
backbone, generally lead to autoacceleration. While a myriad of parameters (as seen in Table 
2.2) can influence the degradation of biomaterial scaffolds, one of the main factors affecting the 
degradation of PLA is hydrophilicity and the transport of water.154 The rate of degradation is 
determined by the accessibility of water to the ester bonds, which explains the slow degradation 
rate of PLA. For example, compared to PGA, PLA degrades more slowly due to the presence of 
hydrophobic methyl side groups that sterically hinder the attack of water on the ester bonds.21,44  
Table 2.2 Factors influencing the degradation of polymer scaffolds. 
 
While the degradation behavior of PLA and other polyester homopolymers has been 
investigated, there has been a general lack in terms of literature reporting on the hydrolytic 
breakdown of amphiphilic block copolymers or complex constructs such as multicomponent 
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fiber scaffold that had been prepared via the blending of a low molecular weight PLA-b-POEGMA 
sample with a high molecular weight PLA sample. The resulting scaffolds consisted of core-shell 
type fibers, which presented the hydrophilic POEGMA block on the surface of the fibers. The 
samples were studied for one month under physiological conditions, and the results suggested 
that the amphiphilic core-shell fibers didn’t undergo significant degradation, but lost more mass 
over the course of the study compared to a hydrophobic PLA scaffold. The additional mass loss 
was attributed to the cleavage of the entire hydrophilic block, but the results were only justified by 
comparing the amount of mass lost to the hydrophilic content that was calculated for the fibers. 
Because the numbers matched, the conclusion was made that it signified the loss of the 
hydrophilic block making up the corona of the core-shell constructs. No further characterization, 
was provided to support this theory. If the entirety of the hydrophilic block had been lost, contact 
angle measurements, for example, could have shown a switch from the initial hydrophilic behavior 
of the core-shell fibers to a hydrophobic behavior as the corona was lost, thus perhaps providing 
more proof for the cleavage theory.  
 
 
Figure 2.10 Proposed structure of electrospun PEG-b-PLA fibers with increasing PEG content. 




Granted the previously mentioned literature example deals with a more complex fiber 
architecture, yet publications investigating the degradation of “simple” amphiphilic block 
copolymer examples also do not exist. This may be due to the fact that the phase separation 
behavior of amphiphilic block copolymers within electrospun fibers ,and thus the structural 
aspects of even simple fiber block copolymer scaffolds are not well understood. Buttaro et al.155 
offer the most insight into the proposed structure of electrospun PEG-b-PLA fibers. A cartoon 
showing a change in phase separation behavior as the PEG content of the block copolymer is 
increased is shown in Figure 2.10. At low PEG content, the block copolymer phase separated, so 
that the PLA forms the bulk phase and PEG is presented on the surface. As the PEG content is 
increased, a new phase of PEG is also formed within the fiber, leaving less PEG available to 
present itself on the surface. The authors tentatively confirmed this via wetting studies and 
swelling comparisons, but more research needs to be conducted to truly investigate the phase 
separation and structural aspects of amphiphilic block copolymer fibers. Once a better 
understanding of the structure and architecture of amphiphilic block copolymer is found, 
predictions could be made as to how the presence of a hydrophilic block affects the wettability 
and transport of water, accessibility of hydrolysable ester bonds and thus the overall degradation 
behavior.  
One last aspect of degradation is associated with the parameters and conditions that are 
used. In terms of testing parameters, the in vitro degradation of PLA-based scaffolds is generally 
simulated and monitored under physiological conditions, using phosphate-buffered saline (PBS) 
with a pH of 7.4 and a temperature of 37 °C. While these conditions provide valuable insights as 
to the degradation behavior and rate in vivo, they do not completely mimic the environment and 
factors the scaffolds are exposed to under actual in vivo conditions. In vitro degradation 
simulations are typically advised to follow the testing parameters outlined for surgical implants 
(ASTM F1635), which include standards such as a) a solution-to-sample mass ratio of 30:1 or 
greater to provide sufficient buffer capacity, b) the use of a sealable container to prevent 
41 
 
evaporation of the medium, c) a minimum number of three specimens per time point, d) packaging 
and sterilization of the samples consistent with the final device, and e) the removal of dried and 
weighed specimens for a mass loss study. However these standards are not often successfully 
implemented, especially due to the often long degradation time of polyesters such as PLA. 
Alternatively, accelerated conditions using basic or acidic media may be employed to provide 
valuable insights on the degradation rates and mechanisms of polymer scaffolds.151 In addition, 
there is a lack of official testing parameters and conditions for amphiphilic block copolymers as 
well as nanocomposite-type scaffolds. 
Overall, the degradation behavior of polymers such as PLA as well as PLA-based 
amphiphilic block copolymers is a complex research effort and is affected by a large number of 
variables. Woodard et al.151 only recently published a paper calling for improved standards and 
evaluation methods in order to accurately investigate the processes involved in the 
biodegradation of PLA and PLA-based block copolymers. Such testing standards would allow 
researchers to more effortlessly compare new data to existing literature results and draw more 
meaningful conclusions. In addition, as the field of tissue engineering and biomaterials science is 
ever growing and expanding, more complex scaffold systems such as block copolymers as well 
as nanocomposite materials would also greatly benefit from the development of new testing 
standards. 
2.5 Conclusions 
To summarize, tissue engineering scaffolds based on polymers and nanocomposites have 
been of great interest, yet several challenges prevail. Recent insights into the DBU-catalyzed 
ROP of lactide have prompted a need for kinetics studies and further mechanistic investigation of 
the synthesis of PLA homopolymers. Understanding the mechanism and kinetics is crucial in 
terms of preparing polymers with well-controlled molecular weights, architectures, end groups, 
and properties. Kinetics experiments offer crucial information regarding the presence or absence 
of termination events, chain transfer, and other side reactions. In addition, controlled 
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polymerizations offer the ability to predetermine the DP, since molecular weight increases linearly 
with conversion. Without this control, the synthesis of polymers with specific molecular weights is 
not feasible. The ability to control the DP and to synthesize polymers with high end-group fidelity 
and well-defined architectures is equally important when preparing dual-functional or 
multifunctional systems, such as amphiphilic block copolymers, that are supposed to contain 
different blocks with well-controlled properties. Again, only with a clear understanding of the 
synthetic and kinetics aspects of the polymerization can the inherent materials properties and 
thus other related properties, such as degradation behavior and in vitro behavior, be tuned and 
manipulated. Furthermore, not only the synthesis of polymers benefits from a better mechanistic 
understanding. Despite the existence of a wide variety of synthesis methods to prepare inorganic 
nanoparticles like HANPs, the systematic and reliable preparation of particles with biologically 
relevant sizes, morphology, stoichiometry, phase purity, and crystallinity still presents a challenge. 
In addition, the surface modification of HANPs that aims at improving the interfacial adhesion 
between the nanoparticles and the polymer matrix within a nanocomposite is currently not well 
understood. Grafting methods may be greatly beneficial in order to tune the surface chemistry 
and properties of nanoparticles, but without a thorough understanding of the mechanism, as well 
as exhaustive characterization, they cannot be successfully realized. Lastly, the preparation of 
fiber scaffolds as well as the degradation behavior of thus produced polymer scaffolds containing 
PLA homopolymers and block copolymers or PLA-based nanocomposites is a complex research 
endeavor, which would greatly benefit from improved and unified preparation and processing 
parameters, as well as testing standards and evaluation methods. With this in mind, this 
dissertation focuses on the synthesis of well-defined PLA homopolymers as well as amphiphilic 
block copolymers by evaluating the underlying kinetics and mechanism of ROP and RAFT 
polymerization. Furthermore, the preparation and surface modification of HANPs is investigated 
in order to provide better insights into the synthesis of biomimetic and surface-functionalized HA. 
Next, this work systematically examines the effects of important electrospinning parameters on 
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the fiber formation and morphology in electrospun PLA homopolymers and amphiphilic block 
copolymer scaffolds. Finally, this dissertation presents important details regarding the 
degradation behavior of amphiphilic block copolymer scaffolds, and also reports on a preliminary 
in vitro study conducted using these scaffolds. 
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3.1 Abstract 
Amphiphilic block copolymers were synthesized via a heterofunctional initiator/chain 
transfer agent (“inifer”) that successfully initiated the ring opening polymerization (ROP) of L-
lactide (LLA) and subsequently mediated the reversible addition-fragmentation chain transfer 
(RAFT) polymerization of poly(ethylene glycol) ethyl ether methacrylate (PEGEEMA). The 
formation of each polymer block was confirmed using 1H nuclear magnetic resonance 
spectroscopy as well as gel permeation chromatography and comprehensive kinetics studies 
provided valuable insights into the factors influencing the synthesis of well-defined block 
copolymers. The effect of monomer concentration, reaction time, and molar ratios of inifer-to-
catalyst on the ROP of LLA are discussed, as well as the ability to produce poly(lactide) blocks of 
different molecular weights. The synthesis of hydrophilic PPEGEEMA blocks was also monitored 
via kinetics to provide a better understanding of the role the chain transfer agent plays in 
facilitating the sterically demanding RAFT polymerization of PEGEEMA. 
3.2 Introduction 
As a part of the family of biodegradable polyesters, poly(lactide) (PLA) has received 
noticeable attention in the areas of drug delivery, tissue engineering, as well as bionanocomposite 
and biomaterials science.1-7 PLA is a biocompatible, FDA-approved bioplastic that exhibits low 
                                               
1 Thesis advisor. 
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immunogenicity and reasonable mechanical properties.8-10 Furthermore, PLA is industrially 
derived from renewable resources and CO2 emissions related to commercial production are lower 
for PLA compared to other fossil fuel-based commodity polymers.11 
Aliphatic polyesters, such as PLA, are however inherently hydrophobic, which results in 
shortened in vivo residence and circulation times in applications in which PLA-based nanocarriers 
are used for intracellular drug delivery.1 In addition, its hydrophobic nature diminishes the ability 
for cell attachment and causes long degradation times for tissue engineering scaffolds.9,12,13 PLA-
based materials also possess a limited potential for attachment of bioactive factors, although 
some strategies that use functional lactide monomers or initiators have been successfully 
utilized.14-19 
The most common approach to address these challenges is to synthesize PLA-based 
block copolymers.1,2,20,21 While simple block copolymer structures can be realized by using 
poly(ethylene glycol) (PEG) as the initiator in the ring opening polymerization (ROP) of lactide, 
22,23 the synthesis of more complex block copolymer architectures requires the combination of 
ROP and one of the living radical polymerization (LRP) techniques, namely reversible addition-
fragmentation chain transfer (RAFT) polymerization, atom transfer radical polymerization (ATRP), 
and nitroxide-mediated polymerization (NMP). A recent review by Yildirim et al.21 thoroughly 
discusses the renaissance of ROP and LRP-based methods to produce linear and star-shaped 
PLA-based block copolymers, as well as more elaborate macromolecular architectures. 
Considering the ROP of lactide, a wide variety of polymerization conditions has been 
studied. Traditionally, metal alkoxide catalysts such as stannous octoate (SnOct2) have been 
used, but such catalysts generally require relatively high reaction temperatures and long reaction 
times. 24-28 In addition, the complete removal of the metal catalyst cannot always be guaranteed, 
which leads to concerns if the polymers are to be used for biomedical applications. An alternative 
route involves the use of so-called “organocatalysts”, of which the first, 4-dimethylaminopyridine 
(DMAP), was introduced in 2001 by Nederberg et al.29 Since then, a wide variety of classes of 
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organocatalysts such as N-heterocyclic carbenes (NHCs), acid catalysts like diphenyl phosphate 
(DPP), bifunctional thiourea-amine systems, as well as guanidines and amidines have 
emerged.30-34 While NHCs represent the most extensively studied family of organocatalysts, the 
guanidine and amidine superbases such as 1,5,7-triazabicyclo[4.4.0]dec-5-ene (TBD), 7-methyl-
1,5,7-triazabicyclo[4.4.0]dec-5-ene (MTBD), and 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU) have 
also been of considerable interest. The mechanism of DBU-catalyzed ROP of lactide in particular 
has been intensively investigated in recent years. Initially, it was reported that DBU serves as a 
catalysts via hydrogen-bonding to the initiator (typically an alcohol), thus activating it for 
nucleophilic attack.35 Subsequently, the possibility for a zwitterionic ROP (ZROP) mechanism was 
revealed, in which DBU can act as the nucleophile and can mediate the polymerization of lactide 
in the absence of an added alcohol initiator.36 Sherck et al.37 further examined the two different 
mechanistic routes which have been termed the activated-alcohol pathway (AAP) and the 
nucleophilic-attack pathway (NAP). Following the AAP, the ROP of lactide in the presence of an 
alcohol initiator and DBU produces linear PLA chains with well-controlled end groups, which is 
important if the PLA homopolymer is to further participate in the formation of well-defined block 
copolymers. Conversely, in the absence of an added initiator, DBU can mediate the ROP of lactide 
via the NAP, which generates a mixture of linear and cyclic PLA chains. The mixture of chain 
architectures and loss of end groups is unfavorable as it would significantly reduce the number of 
block copolymer chains produced and result in a combination of homopolymer and block 
copolymer structures. Thus, understanding the AAP and NAP is crucial in terms of synthesizing 
well-controlled PLA-based homopolymers and block copolymers. 
In light of this work, we report the synthesis of well-defined PLA-based amphiphilic block 
copolymers (ABCs) via the use of a dual-functional initiator/chain transfer agent (“inifer”) that 
contains a hydroxyl group to initiate the ROP of L-lactide (LLA), but also bears a thiocarbonylthio 
moiety to subsequently facilitate the RAFT polymerization of a hydrophilic monomer, namely 
poly(ethylene glycol) ethyl ether methacrylate (PEGEEMA). The previously mentioned ROP 
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studies by Brown et al. and Sherck et al. only include generic small molecule initiators such as 
benzyl alcohol or macroinitiators such as PEG.36,37 Furthermore, literature reports are inconsistent 
in terms of the monomer concentrations that were used (1.7 – 0.6 M) as well as the overall 
polymerization time (10 – 60 min).35-38 We thus seek to expand on these previous studies and 
investigate the kinetics of the ROP of lactide using our dual-functional inifer. In addition, we 
describe the effects of using different monomer concentrations, tuning the ratio of initiator-to-
catalyst concentrations, as well as the ability to produce different molecular weight PLLA 
homopolymers by adjusting the ratios of monomer to initiator concentrations. Lastly, we report on 
the ability of the PLLA-based homopolymers containing a thiocarbonylthio end group to serve as 
the macro-chain transfer agents (macro-CTAs) in the RAFT polymerization of PEGEEMA, thus 
producing ABCs with potential applications in biomedicine and tissue engineering. 
3.3 Experimental 
The following sections list the materials used in this chapter and describe the relevant 
synthesis and characterization methods. 
3.3.1 Materials 
1-Dodecanethiol (≥98%), tetrabutylammonium bromide (ReagentPlus, 99%), 
dichloromethane (anhydrous, ≥99.8%), silica gel (High Purity Grade, pore size 60 Å, 200 – 425 
mesh particle size), phosphorus pentoxide (P2O5, with moisture indicator), DBU (puriss., ≥99.0%), 
calcium hydride (CaH2, reagent grade, ≥90%), neopentyl alcohol (NPA, 99%), molecular sieves 
(4Å beads, 8-12 mesh), benzoic acid (ACS reagent grade, 99.5%), PEGEEMA (average Mn ~ 246 
g/mol, inhibited with 100 ppm MEHQ), 2,2’-azobisisobutyronitrile (AIBN, 98%), chloroform-D 
(CDCl3, 99.8 atom% D) were purchased from Sigma-Aldrich. Acetone (ChromAR), ethylene glycol 
(AR), tetrahydrofuran (THF, AR) were Macron Fine Chemicals brand and were purchased from 
VWR. Potassium hydroxide (KOH, Certified ACS Grade, pellets), carbon disulfide (Certified ACS 
Grade), chloroform (Certified ACS Grade), hexanes (Certified ACS Grade), ethyl acetate 
(Certified ACS Grade), toluene (Certified ACS Grade), ethyl ether (anhydrous, Certified ACS 
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Grade) were purchased from Fisher Scientific. Hydrochloric acid (HCl, ACS Grade) and 
tetrahydrofuran (THF, OmniSolv, stabilized) was purchased from EMD Millipore. Isopropyl alcohol 
(Reagent ACS Grade, 99%) and methanol (Reagent ACS Grade) were purchased from Pharmco-
Aaper.  DMAP (99%), N, N’-dicyclohexylcarbodiimide (DCC, 99%) and aluminum oxide (alumina, 
basic, for chromatography) were purchased from Acros Organics. Nanopure water was obtained 
from a Barnstead Nanopure water purification system. LLA (Purasorb L) was purchased from 
Purac Corbion and recrystallized three times from toluene, dried in a vacuum oven for 24 h, and 
then stored in a vacuum desiccator over P2O5 prior to use. DBU was freshly distilled from CaH2 
prior to use. Dry chloroform for all ROP experiments was obtained from a commercial solvent 
purification system (LC Technology Solutions, Inc.) and stored over activated molecular sieves 
and under argon prior to use. For the ROP experiments, all glassware, stir bars, ground-glass 
syringes and needles were oven-dried for at least 24 h and glassware was further flame-dried 
upon assembly. PEGEEMA was passed through a column of basic aluminum oxide to remove 
the inhibitor. AIBN was purified by double recrystallization from methanol. THF for all RAFT 
experiments was obtained from a commercial solvent purification system (Innovative Technology, 
Inc.). Schlenk flasks, stir bars, and ground-glass syringes used for all RAFT experiments were 
oven-dried for at least 24 h. All other chemicals were used as received. 
3.3.2 Instrumentation and Characterization 
1H and 13C nuclear magnetic resonance (NMR) spectra were recorded using CDCl3 at 
room temperature on a JEOL ECA 500 (500 MHz) spectrometer and data obtained was 
processed using MestReNova software. Attenuated total reflectance Fourier transform infrared 
spectroscopy (ATR-FTIR) was performed using a Thermo Scientific Nicolet iS50 spectrometer 
and processed using OMNIC software. Electron impact mass spectrometry (EI-MS) was 
conducted using a JEOL JMS-700T mass spectrometer. Molecular weights and molecular weight 
distributions were determined using gel permeation chromatography (GPC) and were conducted 
on a Viscotek GPCmax instrument, equipped with a triple detection system consisting of a 
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Viscotek 270 dual detector (differential viscometer detector and laser light scattering detector: 
RALS = 90° and LALS = 7°) in conjunction with a Viscotek 3580 refractive index detector. An 
Agilent Technologies PLgel 5μm mixed D and a PLgel 5μm mixed C column were used in series 
and THF (stabilized; 35 °C) was used as the eluent at a flow rate of 1 mL/min. GPC data was 
processed using OmniSEC software. The following refractive index increment values (dn/dc) were 
used: 0.049 mL/g (PLA), 0.057 mL/g (PLA-b-PPEGEEMA). 
3.3.3 Synthesis of S-1-Dodecyl-S’-(α,α’-Dimethyl-α’’-Acetic Acid) Trithiocarbonate 
S-1-Dodecyl-S’-(α,α’-Dimethyl-α’’-Acetic Acid) Trithiocarbonate (DATC) was synthesized 
using a procedure adapted from literature.39 In short, 30.3 g (0.150 mol) dodecanethiol, 1.92 g 
(6.00 mmol) tetrabutylammonium bromide and 150 mL acetone were added to a 1 L beaker 
equipped with a stir bar. A KOH solution (7.50 g dissolved in 7.50 mL nanopure water) was added 
dropwise to the solution. Carbon disulfide (7.80 mL, 0.129 mol) was then added drop-by-drop and 
the resulting orange-red solution was stirred for 30 min prior to the addition of 15.0 ml chloroform. 
After cooling the reaction mixture in an ice bath for 15 min, a KOH solution (36.0 g in 30.0 mL 
nanopure water) was added under vigorous stirring at 0 °C. The reaction mixture was 
subsequently covered and stirred at room temperature for 12 h. Nanopure water (180 mL) was 
then added and the reaction mixture was acidified using concentrated HCl and stirred for an 
additional 15 min. The solid product was separated out by filtration and dissolved in hot isopropyl 
alcohol (1 L). Upon cooling, S,S’-bis(1-dodecyl) trithiocarbonate crystallized out and was removed 
via filtration. Finally, isopropyl alcohol was removed using a rotary evaporator and the resulting 
orange oil was recrystallized twice from hexanes, yielding a bright yellow solid, which was dried 
in a vacuum oven for 12 h. 
Yield: 32%. M.p.: 62 - 63 °C (literature 62-62 °C). 1H NMR (500 MHz, CDCl3, δ, ppm): 0.88 
(t, 3H, -SCH2CH2(CH2)9CH3), 1.20-1.44 (m, 18H, -SCH2CH2(CH2)9CH3), 1.67 (quintet, 2H, -
SCH2CH2(CH2)9CH3), 1.73 (s, 6H, (CH3)2C<), 3.28 (t, 2H, -SCH2CH2(CH2)9CH3). 13C NMR (500 
MHz, CDCl3, δ, ppm): 14.28 (-SCH2CH2(CH2)9CH3), 22.85 (-SCH2CH2(CH2)8CH2CH3), 25.36 
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(CH3)2C<), 27.95, 29.12, 29.26, 29.50, 29.60, 29.71, 29.78, 29.79, 32.07 (-
SCH2CH2(CH2)8CH2CH3), 37.22 (-SCH2CH2(CH2)8CH2CH3), 55.64 (CH3)2C<), 178.31 (-COOH), 
220.96 (-SC(=S)S-). IR (ATR-FTIR, cm-1): 3300 – 2500 (OH stretching vibration carboxylic acid), 
1702 (C=O stretching vibration carboxylic acid), 1064 (C=S stretching vibration thiocarbonyl). EI-
MS (m/z):364.0 [M]+. 
3.3.4 Synthesis of Hydroxyl Functionalized DATC (DATCOH) 
13.0 g (0.0357 mol) DATC were dissolved in 50.0 mL anhydrous dichloromethane. 2.20 
mL (0.0392 mol) ethylene glycol and 0.436 g (3.57 mmol) DMAP were then added and the solution 
was cooled to 0 °C in an ice bath. Following the addition of 7.36 g (0.0357 mol) DCC, the reaction 
mixture was stirred for 12 h. The reaction was filtered to remove dicyclohexylurea and then 
concentrated using a rotary evaporator. The crude DATCOH was purified by column 
chromatography (silica gel, ethyl acetate : hexanes 2 : 3). After complete removal of the solvents 
using a rotary evaporator, a yellow viscous liquid was obtained that crystallized into yellow waxy 
crystals in the freezer. 
Yield: 45%. M.p.: 31 - 32 °C. 1H NMR (500 MHz, CDCl3, δ, ppm): 0.88 (t, 3H, -
SCH2CH2(CH2)9CH3), 1.20-1.44 (m, 18H, -SCH2CH2(CH2)9CH3), 1.65 (quintet, 2H, -
SCH2CH2(CH2)9CH3), 1.71 (s, 6H, (CH3)2C<), 2.00 (broad, -OH), 3.27 (t, 2H, -
SCH2CH2(CH2)9CH3), 3.80 (t, 2H, -OCH2CH2OH), 4.25 (t, 2H, -OCH2CH2OH. 13C NMR (500 MHz, 
CDCl3, δ, ppm): 14.27 (-SCH2CH2(CH2)9CH3), 22.83 (-SCH2CH2(CH2)8CH2CH3), 25.53 
(CH3)2C<), 27.96, 29.07, 29.22, 29.48, 29.57, 29.68, 29.75, 29.76, 32.05 (-
SCH2CH2(CH2)8CH2CH3), 37.23 (-SCH2CH2(CH2)8CH2CH3), 56.10 (CH3)2C<), 61.14 (-
OCH2CH2OH), 67.89 (-OCH2CH2OH), 173.41 (-COO-), 222.52 (-SC(=S)S-). IR (ATR-FTIR, cm-
1): 3283 (OH stretching vibration alcohol), 1728 (C=O stretching vibration ester), 1057 (C=S 
stretching vibration thiocarbonyl). EI-MS (m/z):408.2 [M]+. 
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3.3.5 General Synthesis of PLLA Homopolymers via ROP 
LLA was weighed into a flame-dried Schlenk flask equipped with a stir bar and dried under 
a vacuum (Schlenk line) for at least 12 h. The flask was backfilled with argon prior to the addition 
of dry chloroform. Once LLA had dissolved, DATCOH or NPA was added as a solution in dry 
chloroform using a dry syringe. Subsequently, DBU was added as a solution in dry chloroform 
using a dry syringe. The polymerization was allowed to stir at room temperature and was 
quenched after a specified time via the addition of a concentrated benzoic acid solution in dry 
chloroform (1-2 times the molar equivalence of the initiator or DBU, depending on which amount 
was greater). The polymer was then precipitated twice into cold methanol (for the dilute 
conditions, the reaction mixture was concentrated via rotary evaporation prior to precipitation), 
washed with more methanol, and collected by centrifugation. Finally, the polymer was dried in a 
vacuum oven for 12 h. Typical conditions for the kinetic studies were as follows: LLA (0.500 g, 
3.47 x 10-3 mol), DATCOH (0.0142 g, 3.47 x 10-5 mol), DBU (5.28 mg, 5.20 μL, 3.47 x 10-5 mol), 
chloroform (2.1 mL) (Table 3.1, DATCOH, entries R1 – R9); LLA (0.500 g, 3.47 x 10-3 mol), NPA 
(3.05 mg, 3.47 x 10-5 mol), DBU (5.28 mg, 5.20 μL, 3.47 x 10-5 mol), chloroform (2.1 mL) (Table 
3.1, NPA, entries R1 – R9); LLA (0.500 g, 3.47 x 10-3 mol), DATCOH (0.0142 g, 3.47 x 10-5 mol), 
DBU (5.28 mg, 5.20 μL, 3.47 x 10-5 mol), chloroform (5.1 mL) (Table A.1, DATCOH, entries R1 – 
R5); LLA (0.500 g, 3.47 x 10-3 mol), NPA (3.05 mg, 3.47 x 10-5 mol), DBU (5.28 mg, 5.20 μL, 3.47 
x 10-5 mol), chloroform (5.1 mL) (Table A.1, NPA, entries R1 – R5). Typical conditions for the 
experiments using different inifer-to-catalyst ratios were as follows: LLA (0.500 g, 3.47 x 10-3 mol), 
DATCOH (0.0142 g, 3.47 x 10-5 mol), DBU (2.64 mg, 2.59 μL, 1.73 x 10-5 mol), chloroform (2.1 
mL) (Table 3.2, entry R1); LLA (0.500 g, 3.47 x 10-3 mol), DATCOH (0.0142 g, 3.47 x 10-5 mol), 
DBU (10.6 mg, 10.4 μL, 6.94 x 10-5 mol), chloroform (2.1 mL) (Table 3.2, entry R2); LLA (0.500 
g, 3.47 x 10-3 mol), DATCOH (0.0142 g, 3.47 x 10-5 mol), DBU (1.06 mg, 1.04 μL, 6.94 x 10-6 mol), 
chloroform (2.1 mL) (Table 3.2, entry R3); LLA (0.500 g, 3.47 x 10-3 mol), DATCOH (0.0142 g, 
3.47 x 10-5 mol), DBU (26.4 mg, 25.9 μL, 1.74 x 10-4 mol), chloroform (2.1 mL) (Table 3.2, entry 
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R4); LLA (0.500 g, 3.47 x 10-3 mol), DBU (5.28 mg, 5.20 μL, 3.47 x 10-5 mol), chloroform (2.1 mL) 
(Table 3.2, entry R5); LLA (0.500 g, 3.47 x 10-3 mol), DATCOH (0.0142 g, 3.47 x 10-5 mol), 
chloroform (2.1 mL) (Table 3.2, entry R6). Typical conditions for the experiments using different 
monomer-to-inifer ratios were as follows: LLA (2.00 g, 0.0139 mol), DATCOH (0.1134 g, 2.78 x 
10-4 mol), DBU (0.0422 g, 0.0415 mL, 2.78 x 10-4 mol), chloroform (8.4 mL) (Table 3.2, entry R7); 
LLA (2.00 g, 0.0139 mol), DATCOH (0.0567 g, 1.39 x 10-4 mol), DBU (0.0211 g, 0.0208 mL, 1.39 
x 10-4 mol), chloroform (8.4 mL) (Table 3.2, entry R8); LLA (2.00 g, 0.0139 mol), DATCOH (0.0284 
g, 6.94 x 10-5 mol), DBU (0.0106 g, 0.0104 mL, 6.94 x 10-5 mol), chloroform (8.4 mL) (Table 3.2, 
entry R9); LLA (0.50 g, 3.47 x 10-3 mol), DATCOH (4.73 mg, 1.16 x 10-5 mol), DBU (1.76 mg, 1.73 
μL, 1.16 x 10-5 mol), chloroform (2.1 mL) (Table 3.2, entry R10); LLA (2.00 g, 0.0139 mol), 
DATCOH (0.0142 g, 3.47 x 10-5 mol), DBU (5.28 mg,  5.20 μL, 3.47 x 10-5 mol), chloroform (8.4 
mL) (Table 3.2, entry R11). 
3.3.6 General Synthesis of ABCs via RAFT Polymerization 
The macro-RAFT agent (PLLA-DATCOH) was added to a Schlenk flask equipped with a 
stir bar. Anhydrous THF was added and upon dissolution of PLLA-DATCOH, the solution was 
purged with argon in an ice bath for 15 min. PEGEEMA was then injected via syringe, followed 
by the addition of AIBN in THF via syringe. The reaction mixture was further degassed using at 
least three freeze-pump-thaw cycles and the Schlenk flask was then immersed into an oil bath 
and the reaction mixture was stirred for 24 h at 70 °C. Samples were withdrawn from the flask 
using a purged syringe at specific times and were precipitated twice into cold ethyl ether, washed 
with more ethyl ether, and collected by centrifugation. Finally, the polymer samples were dried in 
a vacuum oven for 12 h. Typical conditions were as follows (Table 3.3): PEGEEMA (1.00 g, 0.98 
mL, 4.07 x 10-3 mol), PLLA-DATCOH (8.13 x 10-5 mol which corresponds to 0.60 g of PLLA50-
DATCOH, 1.18 g of PLLA100-DATCOH, and 1.97 g of PLLA200-DATCOH), AIBN (3 mg, 1.63 x 10-
5 mol), and THF (10 mL). 
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3.4 Results and Discussion 
As previously mentioned, a combination of ROP and LRP techniques can be employed to 
create block copolymer structures based on PLA. Amphiphilic block copolymers (ABCs) are of 
particular interest, as they can be used as micellar nanocarriers for drug delivery and for improving 
the overall hydrophilicity of biodegradable scaffolds for tissue engineering applications. Whereas 
degradable polyesters such as PLA serve as the hydrophobic block, a variety of polymers can 
function as the hydrophilic block. For example, 2-hydroxyethyl methacrylate, 2-
methacryloyloxyethyl phosphorylcholine, 2-(dimethylamino)ethyl methacrylate and other 
hydrophilic methacrylates and acrylates, as well as acrylamides such as N-(2-hydroxypropyl) 
methacrylamide and N-isopropylacrylamide (NIPAM) have been used.38,40-48 Similarly, 
macromonomers such as oligo(ethylene glycol) methacrylate (OEGMA) have been 
studied.42,43,49,50 As non-linear PEG-analogs, poly(OEGMA)-based materials show high 
biocompatibility, and due to their thermoresponsive behavior have emerged as alternatives to 
poly(NIPAM). A few research groups have reported the synthesis of ABCs based on PLA and 
poly(OEGMA).  Saeed et al.49 combined ROP and RAFT polymerization to produce poly(lactic 
acid-co-glycolic acid) and poly(OEGMA) block copolymers that showed potential as micellar drug 
carrier systems. In addition, Themistou et al.42 and Viswanathan et al.43 reported the synthesis of 
PLA-b-POEGMA block copolymers via a one-pot approach in which the ROP and RAFT 
polymerization were carried out simultaneously. These studies, however, focused on tin- or 
DMAP-catalyzed ROP and no details regarding the polymerization kinetics were presented. In 
order to generate well-defined block copolymers that can be used for biomedical applications, an 
understanding of the kinetics of each block is crucial. Expanding on this work, as well as 
considering the latest insights in DBU-catalyzed ROP of lactide and the attractive properties of 
amphiphilic block copolymers, we herein explore the synthesis of poly(L-lactide)-block-
poly(poly(ethylene glycol)ethyl ether methacrylate) (PLLA-b-PPEGEEMA) block copolymers and 
examine the polymerization kinetics of each block. 
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3.4.1 Kinetics Study of the Formation of PLLA Homopolymers via ROP 
In order to initiate the ROP of lactide and subsequently mediate the RAFT polymerization 
of PEGEEMA (Scheme 3.1), the heterofunctional inifer DATCOH was successfully synthesized. 
Trithiocarbonates have been widely used as CTAs for the RAFT polymerization of a range of vinyl 
monomers and DATC was thus chosen as a suitable candidate.39,51,52 DATC was modified with 
ethylene glycol using Steglich transesterification conditions53 to yield a hydroxyl-functionalized 
version of DATC (DATCOH) that can serve as a nucleophilic initiator for the ROP of LLA via the 
alcohol, as well as the CTA for the RAFT polymerization via the trithiocarbonate. The chemical 




Scheme 3.1 ROP of LLA using A) NPA or B) DATCOH as the initiator or inifer. C) shows the 
subsequent RAFT polymerization of PEGEEMA to produce ABCs. 
 
To determine the effectiveness of the DATCOH inifer to produce well-defined PLLA 
homopolymers with a predeterminable degree of polymerization (DP) and narrow molecular 
weight distributions, kinetic studies were conducted. The ROP of LLA using DATCOH and 
catalytic amounts of DBU was monitored over time and the results were compared to kinetic data 
obtained by employing the generic alcohol initiator NPA. As previously mentioned, the reaction 
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times and initial monomer concentrations vary throughout literature,35-38 thus two complete sets 
of kinetics experiments, one using a higher monomer concentration ([LLA]0 = 1.7 M) and one 
using a lower monomer concentration ([LLA]0 = 0.7 M), were conducted. All experiments were 
carried out in an air-free environment at room temperature, and used equimolar amounts of 
DATCOH (or NPA) and DBU. A target DP of 100 was chosen, because it was comparable to the 
studies conducted by Brown et al. and Sherck et al.36,37 
 
Table 3.1 Experimental results for the ROP of LLA (1.7 M) using DATCOH or NPA and DBU. 














DATCOH        
R1 0.25 13 2 280 3 150 3 800 4 110 1.08 
R2 0.50 33 5 170 5 310 4 950 5 370 1.08 
R3 1 46 7 040 7 900 6 780 7 400 1.09 
R4 2 68 10 210 10 640 8 380 9 080 1.08 
R5 5 82 12 230 11 940 10 050 10 830 1.08 
R6 10 87 12 950 14 100 10 600 11 460 1.08 
R7 15 91 13 530 14 250 10 520 11 630 1.11 
R8 30 93 13 810 14 820 10 680 11 900 1.11 
R9 60 96 14 250 14 250 9 810 11 130 1.13 
NPA        
R1 0.25 9 1 390 2 680 N/Af N/A N/A 
R2 0.5 22 3 260 3 690 2 520 2 730 1.08 
R3 1 44 6 430 7 150 4 790 5 250 1.10 
R4 2 62 9 020 9 310 6 420 6 960 1.08 
R5 5 83 12 050 12 480 8 570 9 300 1.09 
R6 10 87 12 630 13 350 8 940 9 820 1.10 
R7 15 90 13 060 13 350 9 260 10 030 1.08 
R8 30 92 13 350 13 490 9 150 10 250 1.12 
R9 60 94 13 640 13 490 8 860 10 310 1.16 
 
a Polymerization conditions: [LLA]0 : [ROH]0 : [DBU]0 = 100:1:1, [LLA]0 = 1.7 M, RT, CHCl3. 
b Conversion was calculated using gravimetric methods. 
c Theoretical molecular weight was calculated based on the determined conversion, using the 
following equation: Mn (theoret.) = [LLA]0 / [ROH]0 x Conversion x MLLA + MROH, where MLLA and 
MROH are the molecular weights of LLA monomer and alcohol inifer or initiator, and [LLA]0 and 
[ROH]0 are the initial concentrations of LLA and inifer or initiator. 
d Calculated by end group analysis using 1H NMR. 
e Determined by GPC. Polydispersity index (PDI) was calculated using the following equation: 
PDI = Mw / Mn. 





Table 3.1 summarizes the findings for the polymerizations of LLA using the higher 
monomer concentration conditions and indicates that the DATCOH inifer performs well compared 
to a generic alcohol initiator such as NPA, with both reaching conversions of 90 percent within 15 
minutes. The semilogarithmic plots (Figure 3.1) of monomer conversion versus time for both the 
DATCOH and NPA initiated ROPs show a linear relationship until at high conversions higher than 
90 percent a plateau is reached. This demonstrates a controlled polymerization with a constant 
concentration of the active species for the majority of the polymerization, but suggests that as 
monomer is depleted at high conversions transesterification reactions occur. As esters are 
susceptible to attacks via a nucleophile, the process of transesterification competes with the 
process of the ROP. Typically, ring opening and enchainment of monomer occurs more rapidly 
than transesterification, but as the concentration of monomer decreases with increasing 
conversion, the probability of attack on the esters present in the polymer backbone increases and 
transesterification events become apparent. Transesterification can lead to branching and thus 
increased molecular weights and a broadening of the overall molecular weight distribution. 
Transesterification is common with superbase catalysts that exhibit strong nucleophilicity, such 
as TBD or DBU, and is generally mitigated by monitoring the polymerization kinetics and 
quenching the polymerization before reaching too high conversions.32 Furthermore, the rate 
constant was derived from the linear portion of the slope of the semilogarithmic plots (Figure A.2, 
Appendix A) and was determined to be 34 s-1M-1 for DATCOH and 30 s-1M-1 for NPA, which also 
confirms a fast rate of propagation, with a propagation rate constant (kp) value comparable to 
NHC-mediated ZROPs (49 s-1M-1).54 
Another important aspect of kinetics experiments is to examine the relationship between 
the number average molecular weight (Mn) and conversion (Figure 3.1). The plots reveal a linear 
increase of Mn with conversion, which is consistent with a controlled polymerization containing a 
constant number of polymer chains. The theoretical molecular weights were calculated based on 
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conversions determined from gravimetrical methods by weighing the overall reaction mixture and 
dried polymer samples. 
 
 
Figure 3.1 Semilogarithmic plots (left) for the ROP of LLA (1.7 M) using A) DATCOH or B) NPA 
in the presence of DBU, as well as the evolution of number average molecular weight (Mn) and 
PDI as a function of conversion (right). 
 
Molecular weights were also determined via 1H NMR end group analysis, comparing the 
peak integrations of the methyl protons of DATCOH (0.88 ppm) or NPA (0.93 ppm) to the methine 
protons (5.16 ppm) of the LLA repeat unit. Representative 1H NMR spectra of PLLA 
homopolymers synthesized using DATCOH or NPA are shown in Figures A.3 and A.4 (Appendix 
68 
 
A). Theoretical and NMR molecular weights were generally in good agreement, indicating that the 
majority of the polymer chains were successfully initiated by DATCOH or NPA. Mn values were 
also established using gel permeation chromatography (GPC). The values thus obtained were 
lower than the theoretical values or the ones determined by NMR spectroscopy, which can be 
attributed to challenges associated with determining molecular weights for PLA via GPC in 
general. The signal intensity of liquid chromatography detectors, such as refractive index and light 
scattering detectors in a GPC system, depends on the concentration, molar mass, but also 
sample related constants such as the refractive index increment (dn/dc value). High dn/dc values 
indicate a higher signal intensity and therefor higher accuracy and precision in terms of molecular 
weight determination. The refractive index increment (dn/dc) of PLA in THF is low (0.042 – 0.049 
mL/g)55,56 compared to other polymers, for example polystyrene in THF (0.185 mL/g), which can 
make an accurate absolute molecular weight measurement more difficult. Themistou et al.42 also 
observed this phenomenon when characterizing PLA-based homopolymers and block 
copolymers and reported discrepancies between molecular weight values determined by GPC as 
opposed to NMR spectroscopy. Other approaches, such as solvent enhanced light scattering, 
can be employed to improve the signal intensity, but determining optimal conditions can be a time 
consuming and costly process. At present, the use of a combination of methods such as GPC, 
NMR spectroscopy, and gravimetric methods still represent the most practical way to characterize 
polymer samples. 
While the Mn values may not match closely, they still prove useful as they support a linear 
increase of Mn with conversion, until at high conversion when propagation ceases. The PDI values 
also remain low until an increase is observed at conversions above 90 percent, where a slight 
increase in the values is observed (Figure 3.1). This increase in the molecular weight distribution 
can be observed in the GPC chromatograms (Figure 3.2), which initially were monomodal and 
had a narrow distribution, but show an evolution of a higher molecular weight peak at high 
conversions, indicating transesterification events. As previously mentioned, transesterification 
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can lead to branching and a sudden increase in molecular weight, as well as a broadening of the 
molecular weight distribution, as evidenced by the higher molecular weight peak in the GPC 
chromatograms as well as the increased PDI values at conversions above 90 percent. 
 
 
Figure 3.2 GPC chromatograms for the kinetics study of the ROP of LLA (1.7 M) using A) 
DATCOH and B) NPA in the presence of DBU. 
 
The experiments conducted at the lower monomer concentrations paint a similar picture 
to the higher monomer concentration (Table A.1, Appendix A). The semilogarithmic plots (Figure 
A.5, Appendix A) for both the DATCOH and NPA initiated kinetics experiments present a linear 
relationship at first and reach a plateau as higher conversions are reached. The calculated rate 
constants (Figure A.6, Appendix A; 28 s-1M-1 for DATCOH and 31 s-1M-1 for NPA) were 
comparable to the ones calculated for the more concentrated conditions. Again, a linear 
correlation can be found between Mn and conversion, and PDI values remain relatively low until 
a small increase is observed at conversions above 85 percent. Transesterification was not as 
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pronounced under the more dilute conditions, which can also be seen in a less noticeable higher 
molecular weight peak in the GPC chromatograms (Figure A.7, Appendix A), because slightly 
lower conversions (84 – 89 percent as compared to the previous 94 – 96 percent) were reached. 
In general, there was more variation in terms of conversion between the DATCOH and NPA data 
sets, as well as variation regarding the PDI values for the NPA kinetics for the more dilute reaction 
conditions. This could be attributed to the workup, as the purification method is slightly more 
complicated for the dilute conditions. Prior to the precipitation into methanol, the samples had to 
be concentrated via rotary evaporation, and the extra time may have contributed to 
polymerizations not being quenched at exactly the predetermined time. 
3.4.2 The Effect of Inifer-to-Catalyst Ratio on the ROP of Lactide 
Next, we investigated the effect of using different molar ratios of DATCOH inifer to DBU 
catalyst concentrations. Since Brown et al.36 first reported an amidine-mediated ZROP 
mechanism, it has been known that in the absence of an alcohol initiator, DBU can initiate and 
participate in the polymerization of lactide. DBU can act as a nucleophile and attack the carbonyl 
carbon of the lactide monomer, likely generating an equilibrium of two species: a neutral tricycle 
(dormant species) and an acylated amidinium zwitterion (active species). From here, two possible 
mechanistic pathways have been considered. Following the first route, the zwitterion could 
undergo chain growth by adding monomer to the alkoxide end. Ultimately, the alkoxide chain end 
of the now polymeric zwitterion can attack the acyl amidinium end, resulting in a cyclic polymer. 
On the other hand, the original zwitterion can be deprotonated to yield a ketene aminal. This 
species again can undergo chain growth, resulting in ketene aminal end-capped PLA chains. 
Subsequently, these linear polymer chains can again cyclize as ketene aminals can acylate 
alcohols. Furthermore, esterification with methanol (from the workup) is also a possibility. As 
previously mentioned, the formation of cyclic species or a mixture of cyclic and linear species can 
be detrimental if the PLA homopolymer is to be further functionalized or to participate in the 
polymerization of another monomer to synthesize a block copolymer, because a loss of end 
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groups reduces the number of block copolymer chains produced and ultimately results in a 
combination of homopolymer and block copolymer structures. 
Sherck et al.37 subsequently proposed that under conditions using excess alcohol initiator, 
DBU activates the alcohol toward nucleophilic attack and thus follows the AAP. Alternatively, 
when excess DBU is used, it can undergo the mechanistic routes described above and follow 
what the authors coined the NAP. The authors also reported experimental results conducted using 
a generic initiator as a proof of concept to confirm this, showing that only well-defined 
homopolymers and narrowly distributed and monomodal GPC traces were achieved when an 
excess of alcohol initiator was used. This work for the first time highlighted the necessity to 
understand how the ratio of initiator to catalyst can govern the likelihood of the polymerization 
following the AAP or NAP. 
Therefore, to further expand on these recent insights, a series of polymerizations were 
conducted using different ratios of initial DATCOH to DBU concentrations and the results are 
compiled in Table 3.2 (entries 1-6). A control experiment, containing only DATCOH and no DBU, 
yielded no polymer, confirming that without the catalyst H-bonding to the initiator and thus 
activation, the polymerization does not occur. When using excess DATCOH (2:1, 5:1), the 
polymerizations reached high conversions, with experimental molecular weights close to the 
targeted value. In addition, the GPC traces (Figure 3.3) were narrow and unimodal (with a small 
transesterification peak) and PDI values were low. This indicates that the polymerizations 
predominantly followed the AAP mechanism. When using an excess of DBU, on the other hand, 
the NAP mechanism came into play. A ratio of initiator to DBU of 1:2 still resulted in high 
conversion and only a slight broadening of the PDI due to transesterification events becoming 
more prevalent, but a large excess of DBU (a ratio of 1:5) caused a significant increase in the PDI 
value. These results are in agreement with Sherck et al.37, indicating that the NAP, and especially 
the ketene aminal-based mechanistic route, is becoming more attainable, thus resulting in a 
broadening of the GPC traces and higher PDI values due to the presence of different polymer 
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species obtained via the combination of AAP and NAP related mechanistic processes. Lastly, an 
experiment using only DBU produced a high molecular weight - most likely predominantly cyclic 
– polymer with a relatively high PDI, which concurs with the earlier work by Brown et al.36 
 
Table 3.2 Experimental results for the ROP of LLA using different molar ratios of DATCOH to 
DBU (entries 1-6) or using different molar ratios of LLA to DATCOH (entries 7-11). 
    Theoret. NMR GPC 











         
1 100 : 1 2 : 1 91 13 530 13 810 11 700 12 700 1.09 
2 100 : 1 1 : 2 92 13 670 15 980 11 630 12 660 1.09 
3 100 : 1 5 : 1 90 13 380 14 970 11 750 12 560 1.07 
4 100 : 1 1 : 5 87 12 950 13 960 7 140 10 220 1.43 
5 100 : 1 1 : 0 0 no polymer 
6 100 : 0 0 : 1 76 10 950 n.d.f 36 840 43 520 1.18 
         
7 50 : 1 1 : 1 96 7 330 8 340 7 410 8 280 1.12 
8 100 : 1 1 : 1 98 14 530 13 960 12 310 13 490 1.10 
9 200 : 1 1 : 1 83 24 190 22 320 18 320 19 180 1.05 
10 300 : 1 1 : 1 72 31 690 30 960 17 770 18 560 1.05 
11 400 : 1 1 : 1 40 23 470 26 500 17 000 17 880 1.05 
 
a Polymerization conditions: I (initiator) = DATCOH, [LLA] = 1.7 M, 15 min, RT, CHCl3 
b Conversion was calculated using gravimetric methods. 
c Theoretical molecular weight was calculated based on the determined conversion, using the 
following equation: Mn (theoret.) = [M]0 / [I]0 x Conversion x MMonomer + MInitiator, where MMonomer and 
MInitiator are the molecular weights of monomer and inifer, and [M]0 and [I]0 are the initial 
concentrations of monomer and inifer. 
d Calculated by end group analysis using 1H NMR. 
e Determined by GPC. Polydispersity index (PDI) was calculated using the equation PDI = Mw / 
Mn. 
f Not determined (due to no discernable end groups). 
 
 
3.4.3 Preparation of PLLA Homopolymers with Different Molecular Weights 
The possibility of targeting DPs other than 100 and to produce a series of PLAs with 
different molecular weights was also examined. Since our kinetics plots indicated that Mn is a 
linear function of conversion, the DP should be predeterminable by changing the initial monomer 
to initiator concentration. Table 3.2 (entries 7-11) summarizes the results. DPs of 50 and 100 
(using monomer to initiator concentrations of 50:1 and 100:1) are readily achieved and Mn values 
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determined experimentally closely match the targeted values. The PDI values are relatively low 
and the GPC chromatograms (Figure 3.3) only show a very small high molecular weight peak. 
Starting with a DP of 200 (using a monomer to initiator ratio of 200:1), however, the conversion 
was notably lower and decreased even further for the experiments targeting a DP of 300 and 400 
(using monomer to initiator concentrations of 300:1 and 400:1). In each case, the GPC traces had 
a narrow molecular weight distribution and the PDI values were very low, suggesting that 
propagation had ceased, but not necessarily due to premature termination of the polymer chains. 
 
 
Figure 3.3 GPC chromatograms for A) the experiments using different molar ratios of DATCOH 
to DBU and for B) the experiments using different molar ratios of LLA to DATCOH. 
 
Sherck et al.37 observed similar results when the authors conducted three independent 
experiments under the same conditions, trying to achieve the same molecular weight. However, 
a variation in terms of conversion (ranging from 66 – 91 percent) was observed from batch to 
batch, which was attributed to catalyst poisoning due to acid contamination. Commercial lactide 
74 
 
monomer contains free lactic acid and even though the monomer is purified prior to 
polymerization, it can be challenging to completely remove the acid. Sherck et al.37 devised a 
possible mechanism in which the superbase catalyst is deactivated and consumed by the acid 
present and DBU does no longer provide activation of the propagating chain end. The authors 
noted that the addition of extra DBU after the point of cessation in the polymerization, resulted in 
a decrease in monomer concentration, suggesting the polymer chains were able to continue to 
grow and were not irreversibly terminated. 
Taking the amount of free acid into account, it makes sense that the DBU deactivation 
phenomenon becomes more pronounces for polymerizations targeting a higher DP. The 
certificate of analysis of the lactide monomer obtained from Purac lists a free acid content of 1 
mequiv / kg of lactide, which translates to 10-6 mol of acid per gram of monomer. In our reactions, 
this would be equivalent to an acid concentration of 10-4 M. For DPs of 50 and 100, the catalyst 
concentration is on the order of 10-2 M, but decreases to 10-3 M for the higher DPs, as the amount 
of catalyst used was fixed at 1 mol percent relative to the amount of monomer used. As the ratio 
the initial monomer-to-catalyst concentration increases for DPs from 50 to 400, the likelihood of 
catalyst poisoning by free acid contamination increases as well, thus resulting in continually 
lowered conversions. At present, a few reports successfully synthesizing PLA with high molecular 
weights using DBU have been presented, but rigorous purification of the lactide monomer was 
generally required.19,35 
3.4.4 Kinetics Study of the Formation of ABCs via RAFT Polymerization 
Finally, in order to investigate the ability of the PLA homopolymer bearing a 
thiocarbonylthio end group to serve as the macro-CTA in the RAFT polymerization of PEGEEMA, 
a series of amphiphilic PLLA-b-PPEGEEMA block copolymers was synthesized. PEGEEMA was 
polymerized in the presence of AIBN in THF at 70 °C and three different molecular weight PLLA 
homopolymer macro-CTAs – PLLA50-DATCOH, PLLA100-DATCOH, and PLLA200-DATCHOH – 
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were employed. Again, it is important to evaluate the kinetics and the results of our kinetic studies 
are summarized in Table 3.3. 
 
Table 3.3 Experimental results for the RAFT polymerization of PEGEEMA using different PLLA-
DATCOH macro-RAFT agents. 














PLLA50-DATCOH        
1 3 3 7 630 11 290 9 750 21 530 2.21 
2 6 18 9 500 13 010 12 180 28 100 2.31 
3 12 29 10 950 14 730 15 290 33 200 2.17 
4 18 40 12 260 14 980 15 530 34 770 2.24 
5 24 51 13 560 14 730 14 010 30 770 2.20 
PLLA100-DATCOH        
1 3 3 15 030 16 910 13 560 21 640 1.60 
2 6 16 16 500 18 390 18 570 32 640 1.76 
3 12 27 17 980 20 350 19 300 32 490 1.68 
4 18 43 19 950 21 830 20 700 34 750 1.68 
5 24 53 21 180 21 580 21 110 35 170 1.67 
PLLA200-DATCOH        
1 3 4 24 680 25 270 18 860 24 640 1.31 
2 6 17 26 160 27 480 21 910 30 640 1.40 
3 12 29 27 880 29 450 23 700 33 590 1.42 
4 18 37 28 860 30 430 23 350 33 190 1.42 
5 24 51 30 340 30 680 24 750 34 510 1.39 
 
a Polymerization conditions: [PEGEEMA] : [PLLA-DATCOH] = 50:1, [PLLA-DATCOH] : [AIBN] = 
5:1, THF, 70°C. 
b Conversion was calculated using gravimetric methods. 
c Theoretical molecular weight was calculated based on the determined conversion, using the 
following equation: Mn (theoret.) = [M]0 / [RAFT]0 x Conversion x MMonomer + MRAFT, where MMonomer 
and MRAFT are the molecular weights of monomer and RAFT agent, and [M]0 and [I]0 are the initial 
concentrations of monomer and RAFT agent. 
d Calculated by end group analysis using 1H NMR. 




The semilogarithmic plots of monomer conversion versus time (Figure 3.4) shows a linear 
correlation, indicating a constant concentration of active species. The three different macro-RAFT 
agents also seem to perform similarly, reaching comparable conversions, as indicated by the 
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identical slope. In addition, the kinetic plots of Mn versus conversion depicts a linear increase in 
molecular weights as conversion increases.  
 
 
Figure 3.4 A) Semilogarithmic plot for the RAFT polymerization of PEGEEMA using different 
molecular weight PLLA-DATCOH macro-CTAs (PLLA50-DATCOH is shown in red, PLLA100-
DATCOH is shown in blue, and PLLA200-DATCOH is shown in green). Also shown is the evolution 
of B) number average molecular weight (Mn) and C) PDI as a function of conversion. 
 
Molecular weight values were established via three methods. Again, theoretical molecular 
weights were determined gravimetrically and compared to values obtained by 1H NMR and GPC 
analysis. As end groups were not readily discernable, NMR molecular weights were calculated 
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by comparing the methine proton (5.16 ppm) of the already characterized PLA block to the 
PEGEEMA block methylene protons (4.08 ppm) next to the ester moiety. A representative 1H 
NMR spectrum is again presented in Figure A.8 (Appendix A). Furthermore, molecular weights 
and PDI values were determined by GPC. The values are generally in good agreement, with some 
variation stemming from the different approaches to calculate Mn. 
 
 
Figure 3.5 GPC chromatograms for the RAFT polymerization of PEGEEMA using A) PLLA50-
DATCOH, B) PLLA100-DATCOH, and C) PLLA200-DATCOH. 
 
GPC analysis also provided more insights. The GPC chromatograms (Figure 3.5) for the 
kinetics experiments show a bimodal distribution for the RAFT polymerization mediated by 
PLLA50-DATCOH. This was also reflected in high PDI values throughout the polymerization. The 
distributions become more narrowly distributed for PLLA100-DATCOH and PLLA200-DATCOH, 
resulting in lower PDI values. Comparative PDI values have been seen in the literature for PLA-
b-POEGMA, but no kinetics results with corresponding GPC chromatograms were reported. For 
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RAFT polymerizations of bulky monomers, such as PEGEEMA, using a macro-CTA, which 
contains a bulky R group, steric considerations become important. During the pre-equilibrium, the 
RAFT agent derived radical, (R•) must be a good or better leaving group compared to the 
propagating radical (Pn•). With PEGEEMA containing a relatively long side chain and the polymer 
adopting a ‘brush-like’ conformation, the Pn• is in competition with the R• as a leaving group from 
the intermediate radical. As the R group of the RAFT agent becomes bulkier, as the molecular 
weight of the PLA block increases, the equilibrium is favored to fragment the R• from the 
intermediate radical and not to revert to give Pn•. Steric congestion may also further affect the 
main equilibrium, not providing an equal opportunity for all chains to grow, therefore resulting in 
broad PDIs. With this in mind, it makes sense that PLLA200-DATCOH exercised the best control 
over the RAFT polymerization of PEGEEMA. 
3.5 Conclusions 
We synthesized a new heterofunctional inifer, DATCOH, which was shown to successfully 
initiate the ROP of LLA and subsequently mediate the RAFT polymerization of PEGEEMA. 
DATCOH proved to perform as well as a generic alcohol initiator. In addition, comprehensive 
kinetics studies showed the ROP exhibited first order kinetics for the majority of the 
polymerization, until high conversions were reached. Although the more dilute conditions resulted 
in less transesterification events, the overall results were more varied and the thus the more 
concentrated conditions were preferred. Experiments using different molar ratios of inifer-to-
catalyst demonstrated that excess inifer or initiator can help the polymerization follow the AAP. 
Additionally, PLA homopolymers of different molecular weights were synthesized, although more 
strenuous monomer purification may be required to attain high molecular weight polymers. Finally, 
the kinetics of the RAFT polymerization of PEGEEMA using different molecular weight PLLA-
DATCOH macro-CTAs were monitored. The results suggested that the polymerization was mostly 
well-controlled, but that the bulkier higher molecular weight CTAs were able to better mediate the 
reaction. Understanding the reaction conditions and kinetics of these functional systems overall 
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helps create ABCs with better designed and controlled properties and architectures, which can 
be employed in the biomedical field. 
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PREPARATION OF BIODEGRABLE FIBER SCAFFOLDS BASED ON AMPHIPHILIC BLOCK 




Electrospinning techniques were successfully used to prepare well-defined fiber scaffolds 
from poly(L-lactide) (PLLA) homopolymers, as well as two amphiphilic block copolymers (PEG-b-
PLLA and PLLA-b-PPEGEEMA) based on PLLA and poly(ethylene glycol) (PEG) and PLLA and 
poly(poly(ethylene glycol) ethyl ether methacrylate) (PPEGEEMA). Important processing 
parameters - such as the solution concentration, voltage, solvent choice, distance, and flow rate 
- were investigated in terms of their effect on fiber formation and morphology. Contact angle 
measurements were then performed to evaluate the wetting behavior of the amphiphilic PEG-b-
PLLA and PLLA-b-PPEGEEMA block copolymer scaffolds compared to the hydrophobic PLLA 
homopolymer scaffolds. In order to gain important insights into the degradation behavior, the 
polymer fiber scaffolds were also subjected to physiological conditions as well as accelerated 
conditions for two weeks. Lastly, a preliminary cell study provided a better understanding of the 
behavior of the different polymer scaffolds in an in vitro environment. 
4.2 Introduction 
Millions of patients suffering from organ failure or tissue loss due to injury, disease, or 
trauma have become a costly healthcare problem worldwide.1 These tissue and organ 
deficiencies are generally treated via organ transplantation, surgical reconstruction, or the use of 
mechanical devices and have improved countless lives. While the significance and impact of 
these strategies has been monumental, they are associated with limitations such as organ donor 
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shortages, expensive surgical procedures, and device incompatibility or instability in the long 
term.2,3 
The main approach to overcome these challenges has been found in the field of tissue 
engineering, regenerative medicine, and biomaterials science. Since its inception, tissue 
engineering has aimed to devise “biological substitutes that restore, maintain, or improve tissue 
function”.4 Encompassing engineering, chemistry, biology, physics, medicine, and other fields of 
science, tissue engineering has led to the development of a wide variety of materials, ranging 
from metals, ceramics and bioactive glasses, to natural and synthetic polymers.5-9 Traditionally, 
biostable materials such as metal implants have been prominent in tissue engineering and 
regenerative medicine. However, device complications related to the interaction of the metal and 
the surrounding tissue and metal ion release due to corrosion, require costly and invasive revision 
surgeries and have limited the long-term use of these implants.10 
As an alternative to permanent implants, biodegradable polymer scaffold materials have 
received a lot of interest.8,9,11-15 A range of natural polymers, including collagen, gelatin, fibrin, silk 
fibroin, chitosan, alginate, and hyaluronic acid, have been employed as biomaterials due to their 
biocompatibility, low cost and ease of access. In addition, synthetic polymers have been used as 
they provide improved homogeneity in terms of chemical composition, as well as easier 
processability and purification.16,17 Furthermore, the hydrolytic degradation of synthetic polymers 
can be more easily tuned as opposed to the degradation profile of natural polymers, which 
generally follows enzymatic or oxidative pathways that depend on in vivo enzyme and 
macrophage levels.18 Synthetic polymers also stand out due to their ability to be functionalized 
and to be tailored to different properties.19 Within the class of synthetic polymers, aliphatic 
polyesters, such as poly(lactide) (PLA), poly(glycolide) (PGA), and poly(caprolactone) (PCL), 
have been the most widely researched polymers for tissue engineering and biomedical 
applications.13,18,20 PLA especially has gained considerable attention as it is biocompatible, FDA-
approved, eco-friendly, biodegradable, and possesses relatively good physical and mechanical 
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properties.21-24 PLA-based commercial products include fixation devices (BioScrew® XtraLok®, 
LactoSorb®), sutures (Vicryl™, PolySorb™), skin grafts (Dermagraft®), and materials for nerve 
regeneration (Neurolac®). Despite the previously mentioned benefits, PLA suffers from 
drawbacks that limit its use as biomaterials scaffolds. Most importantly, polyesters such as PLA 
are intrinsically hydrophobic. This affects cell attachment and makes these polymers poor 
substrates for cell adhesion, proliferation, differentiation, and new tissue formation. In addition, 
degradation rates are generally slow, taking months or even years to fully hydrolyze PLA to lactic 
acid.24,25 
Ways to combine or impart new properties into a polymer material generally include 
copolymerization techniques or the use of polymer blends. Poly(ethylene glycol) (PEG) has been 
an attractive candidate for biomaterials blends and copolymers, as its hydrophilic nature helps 
increase the overall hydrophilicity of the material and also aids with biocompatibility. Both, block 
copolymers of PEG and PLA (PEG-b-PLA) and blends of PLA with PEG as well as PEG-b-PLA 
block copolymers have been researched.26-36 For example, Lins et al.34 recently fabricated 
biodegradable fiber scaffolds using blends of either PEG and PLA homopolymers or a PLA-b-
PEG-b-PLA triblock and PLA homopolymers. Simple PEG and PLA homopolymer blends resulted 
in fiber scaffolds with non-uniform fibers, as PEG and PLA exhibit limited miscibility due to their 
different solubility parameters and surface energies, which causes phase separation in the blend. 
Conversely, blends of PLA and PLA-b-PEG-b-PLA produced more homogenous fibers, as 
miscibility is improved via interaction of the PLA segments of the homopolymer and the triblock 
copolymer. The overall hydrophilicity of the scaffolds increased using either type of blend, but 
neither outperformed the PLA control scaffold in terms of cell attachment. This is the result of the 
hydrophilic fiber surface actually suppressing the adsorption of proteins, thus diminishing cell 
adhesion. PEG and its non-linear analog poly(oligo (ethylene glycol) methacrylate), 
poly(OEGMA), have been known to resist protein adsorption and have been used in the past for 
anti-fouling coatings.37,38 Another study that showed similar results was reported by Viswanathan 
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et al.39 The authors blended PLA with the amphiphilic block copolymer PLA-b-POEGMA to 
produce fiber scaffolds with improved hydrophilicity. Again, the blend scaffolds exhibited anti-
adhesion properties and only proved to be suitable cell substrates after further modification with 
cell-adhesive peptide RGD. Conversely, another study by Evrova et al.40 reported blends of 
poly(lactic-co-glycolic acid) (PLGA) and PEG which resulted in more hydrophilic scaffolds that 
successfully supported cell adhesion and proliferation. The challenge in comparing and 
interpreting literature results such as these lies in the similarity, yet dissimilarity of the studies. 
While the goal to improve the properties (e.g. hydrophilicity, cell attachment, degradation 
behavior, mechanical properties et cetera) of PLA-based scaffolds by incorporating PEG additives 
represents the underlying goal, the majority of the studies employ commercial PLA or PEG 
polymers of varying molecular weights and compositions, use different ratios of polymers in the 
blends as well as different cell lines, which makes comparison challenging. However, it is 
apparent from the literature that scaffold parameters such as hydrophilicity need to be carefully 
tuned in order to achieve overall improved properties such as cell interaction and attachment and 
that the ability to tune material properties is a key factor in producing well-defined biomaterials 
scaffolds. 
As previously discussed, blends offer a facile way to tune material properties, but they are 
limited by polymer miscibility and compatibility. In addition, simple block copolymers such as PEG-
b-PLA can improve interactions between the different phases in the blend, but these block 
copolymers are generally prepared via ring opening polymerization (ROP) of lactide using 
commercially produced mono- or bifunctional PEG as the initiator which limits the range of 
molecular weights available, and thus the tunability. PEG-b-PLA block copolymers also do not 
offer an easy way to further functionalize the polymer. The synthesis of amphiphilic block 
copolymers such as PLA-b-POEGMA requires the combination of ROP and one of the living 
radical polymerization techniques, such as reversible addition-fragmentation chain transfer 
(RAFT) polymerization, but it allows for the preparation of well-defined block copolymers with 
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tunable properties. As ROP and RAFT polymerization are considered to be controlled 
polymerization techniques, in which the molecular weight increases linearly with conversion, the 
degree of polymerization (DP) becomes predeterminable and the properties of the polymer can 
be adjusted by controlling the DP of each block within the block copolymer. Using RAFT 
polymerization also opens up the possibility to copolymerize OEGMA with another vinyl monomer 
to add additional functionalization to the block copolymer material. 
With this in mind, we seek to use amphiphilic block copolymers that can be tailored to 
improve the hydrophilicity and cell attachment of a biodegradable scaffold without the need for 
blends or complicated functionalization. We herein report the synthesis of poly(L-lactide)-block-
poly(poly(ethylene glycol) ethyl ether methacrylate) (PLLA-b-PPEGEEMA) fiber scaffolds via 
electrospinning and compare their wetting behavior, degradation profile, and in vitro behavior to 
corresponding PLLA as well as PEG-b-PLLA scaffolds. 
4.3 Experimental 
The following sections list the materials used in this chapter and describe the relevant 
synthesis and characterization methods. 
4.3.1 Materials 
Poly(ethylene glycol) mono-methyl ether (mPEG, 5000 g/mol) was purchased from 
PolySciences. Phosphorus pentoxide (P2O5, with moisture indicator), 1,8-
diazabycyclo[5.4.0]undec-7-ene (DBU, puriss., ≥99.0%), calcium hydride (CaH2, reagent grade, 
≥90%), molecular sieves (4Å beads, 8-12 mesh), benzoic acid (ACS reagent grade, 99.5%), 
dimethyl sulfoxide (DMSO, anhydrous, ≥99.9%), and glutaraldehyde were purchased from Sigma-
Aldrich. Chloroform (CHCl3, Certified ACS Grade), toluene (Certified ACS Grade), sodium 
chloride (Certified ACS Grade), sodium phosphate (dibasic, anhydrous), potassium phosphate 
(monobasic, Certified ACS Grade), Gibco™ PBS, and Gibco™ Anti - Anti were purchased from 
Fisher Scientific. Sodium hydroxide (NaOH, ACS Grade, pellets) and potassium chloride (ACS 
Grade) were Macron Fine Chemicals brand and were purchased from VWR. Tetrahydrofuran 
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(THF, OmniSolv, stabilized) and hydrochloric acid (HCl, ACS Grade) were purchased from EMD 
Millipore. Isopropyl alcohol (Reagent ACS Grade, 99%) was purchased from Pharmco-Aaper. 
Nanopure water was obtained from a Barnstead Nanopure water purification system. L-lactide 
(LLA, Purasorb L) was purchased from Purac Corbion and was recrystallized three times from 
toluene, dried in a vacuum oven for 24 h, and then stored in a vacuum desiccator over P2O5 prior 
to use. DBU was freshly distilled from CaH2 prior to use. mPEG was dried by azeotropic distillation 
in toluene prior to use. Dry chloroform for the synthesis of PEG-b-PLLA was obtained from a 
commercial solvent purification system (LC Technology Solutions, Inc.) and stored over activated 
molecular sieves and under argon prior to use. For the PEG-b-PLLA synthesis, all glassware, stir 
bars, ground-glass syringes and needles were oven-dried for at least 24 h and glassware was 
further flame-dried upon assembly. All other chemicals used for the synthesis of PLLA 
homopolymers and PLLA-b-PPEGEEMA block copolymers are listed in Chapter 3. Unless 
otherwise indicated, all chemicals were used as received. All supplies (tubing, connections, 
microscope slides, syringes and needles) for the electrospinning experiments were purchased 
from ChromTech, Inc., VICI-Jour, Fisher Scientific and McMaster-Carr. 
4.3.2 Instrumentation and Characterization 
Molecular weights and molecular weight distributions were determined using gel 
permeation chromatography (GPC) and were conducted on a Viscotek GPCmax instrument, 
equipped with a triple detection system consisting of a Viscotek 270 dual detector (differential 
viscometer detector and laser light scattering detector: RALS = 90° and LALS = 7°) in conjunction 
with a Viscotek 3580 refractive index detector. An Agilent Technologies PLgel 5μm mixed D and 
a PLgel 5μm mixed C column were used in series and THF (stabilized; 35 °C) was used as the 
eluent at a flow rate of 1 mL/min. GPC data was processed using OmniSEC software. The 
following refractive index increment value (dn/dc) was used: 0.049 mL/g (PEG-b-PLLA). PLLA 
fibers produced in the initial electrospinning experiments were characterized using an Olympus 
IX71 inverted microscope using a 40x objective (unless otherwise indicated). PLLA as well as 
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PEG-b-PLLA and PLLA-b-PPEGEEMA fiber mats used in the degradation study or in vitro study 
were examined using a FEI Quanta 600i scanning electron microscope (SEM). Samples were 
mounted onto samples holders and coated with gold using a sputter coater prior to imaging. 
ImageJ software was used to determine average fiber diameters (initial electrospinning 
experiments: 50 fibers; degradation and in vitro study: 100 fibers). Samples for the degradation 
study were freeze-dried using a Labconco FreeZone 6 benchtop lyophilizer. The initial and final 
masses of the fiber squares used in the degradation study were determined using a Mettler MT5 
microbalance. A Lab-Line Imperial II Incubator was used to simulate in vitro conditions (37 °C) for 
the degradation study. pH measurements were taken on a Fisher Scientific Accumet AE150 pH 
meter. All contact angle measurements were performed using a Ramé-Hart Model 200-00 
Standard Goniometer, using 10 μL drops of nanopure water and data was processed using 
DropImage software. Fiber mat thicknesses were measured using a Fowler digital micrometer. 
An Evos inverse microscope and an Olympus confocal microscope were used throughout the 
course of the cell studies. 
4.3.3 Polymer Synthesis 
LLA and mPEG were weighed into a flame-dried Schlenk flask equipped with a stir bar 
and dried under a vacuum (Schlenk line) for at least 12 h. The flask was backfilled with argon 
prior to the addition of dry chloroform. Once LLA and mPEG had dissolved, DBU was added using 
a dry syringe. The polymerization was allowed to stir at room temperature and was quenched 
after 15 min via the addition of a benzoic acid solution in dry chloroform (1-2 times the molar 
equivalence of DBU). The polymer was then precipitated twice into cold isopropyl alcohol, washed 
with more isopropyl alcohol, and collected by centrifugation. Finally, the polymer was dried in a 
vacuum oven for 12 h. Typical conditions for the PEG-b-PLLA block copolymers (Table 4.3, 
entries 3 and 4) were as follows: LLA (5.00 g, 0.0347 mol), mPEG (0.867 g, 1.73 x 10-4 mol), DBU 
(0.0264 g, 0.0259 mL, 1.73 x 10-4 mol), chloroform (21 mL). LLA (10.0 g, 0.0694 mol), mPEG 
(1.73 g, 3.47 x 10-4 mol), DBU (0.0528 g, 0.0519 mL, 3.47 x 10-4 mol), chloroform (42 mL). PLLA 
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homopolymer and PLLA-b-PPEGEEMA block copolymer synthesis was described in Chapter 3. 
Typical conditions for the PLLA homopolymers (Table 4.1, entries 1 and 2; Table 4.3, entries 1 
and 2) were as follows: LLA (2.00 g, 0.0139 mol), DATCOH (0.0567 g, 1.39 x 10-4 mol), DBU 
(0.0211 g, 0.0208 mL, 1.39 x 10-4 mol), chloroform (8.4 mL). LLA (2.00 g, 0.0139 mol), DATCOH 
(0.0284 g, 6.94 x 10-5 mol), DBU (0.0106 g, 0.0104 mL, 6.94 x 10-5 mol), chloroform (8.4 mL). LLA 
(15.0 g, 0.104 mol), DATCOH (0.213 g, 5.20 x 10-4 mol), DBU (0.0792 g, 0.0778 mL, 5.20 x 10-4 
mol), chloroform (63 mL). LLA (10.0 g, 0.0694 mol), NPA (0.0306 g, 3.47 x 10-4 mol), DBU (0.0528 
g, 0.0519 mL, 3.47 x 10-4 mol), chloroform (42 mL).Typical conditions for the PLLA-b-PPEGEEMA 
block copolymers (Table 4.3, entries 5 and 6) were as follows: PEGEEMA (2.00 g, 1.96 mL, 8.13 
x 10-3 mol), PLA-DATCOH (3.04 g, 1.08 x 10-4 mol), AIBN (3.6 mg, 2.17 x 10-5 mol), and THF (20 
mL). PEGEEMA (2.00 g, 1.96 mL, 8.13 x 10-3 mol), PLLA-DATCOH (2.95 g, 1.08 x 10-4 mol), 
AIBN (3.6 mg, 2.17 x 10-5 mol), and THF (20 mL). 
4.3.4 Electrospinning 
PLLA-based homopolymers and block copolymers were dissolved in either a mixture of 
CHCl3 and DMSO (9:1) or CHCl3. The resulting polymer solution was then pumped through 
perfluoroalkoxy (PFA) tubing at a constant flow rate, using a KDS 100 syringe pump (KD 
Scientific). A Spellman CZE 1000R power supply was used as the voltage source and was 
connected to a 22 gauge needle housed inside a custom made fiberglass box (32 x 32 x 46 cm). 
Fibers were collected on aluminum foil (experiments creating fiber mats) or glass microscope 
slides (preliminary electrospinning experiments) mounted on top of a 10 x 10 cm lab jack which 
was connected to ground. The specific electrospinning parameters for each experiment are 
summarized in Tables 4.2 and 4.4. 
4.3.5 Degradation Study 
The electrospun polymer fiber mats were cut into squares (1 x 1 cm) for the degradation 
study. The initial contact angle of the samples was measured and the squares were then freeze-
dried for two days. The initial mass of each sample was determined using an analytical 
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microbalance and the squares were then placed in centrifuge tubes containing 5 mL of either 
phosphate buffered saline (PBS, pH 7.4), aqueous NaOH solution (pH 12.0), or aqueous HCl 
solution (pH 2.0). The tubes were placed in an incubator (37 °C) and triplicate samples for each 
kind of polymer were removed at specific time intervals. For the experiment at elevated 
temperature (HCl, pH 2.0, 60 °C), the centrifuge tubes were placed in a temperature-controlled 
oil bath. After removal from the centrifuge tubes, the samples were rinsed thoroughly with 
nanopure water and freeze-dried for two days. The dry squares were then weighed again to 
determine the mass loss over time. Photos of the fiber mat squares were taken and the 
morphology of the samples was further examined using SEM. In addition, the pH of the solutions 
was also monitored and recorded over the course of the degradation study. The contact angle of 
the samples was measured again at the final time interval (14 days). 
4.3.6 Preliminary In Vitro Study 
Samples of each electrospun fiber mat were hydrated in PBS for 1 h. After sterilization in 
anti-anti for 2 h, the samples were immersed in PBS for another hour. Duplicates of each sample 
were placed in a 96-well plate and 103 GFP-Cu110 cells were then added to each well and the 
samples were cultured for 1 week. The samples were fixed in glutaraldehyde and imaged using 
fluorescence microscopy, confocal fluorescence microscopy, and SEM. 
4.4 Results and Discussion 
4.4.1 Preparation of Fiber Scaffolds Using Electrospinning 
Scaffolds used in tissue engineering and regenerative medicine serve as temporary 
templates and ideally should be designed to exhibit the following characteristics: they should a) 
be biocompatible and biodegradable, b) be highly porous materials to allow cell infiltration, c) have 
an interconnected pore system that allows for nutrients and waste products to be transported in 
and out of the scaffold, and d) have a surface chemistry that promotes cell interaction.1,10,41 In 
essence, biomimetic scaffolds aim to mimic the function of the body’s extracellular matrix (ECM). 
The native ECM not only provides physical support, but also manages cell behavior in terms of 
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cell growth, migration, differentiation et cetera. The main structural protein of the ECM – collagen 
– can form fibrils and fibers and provides a substrate, in which adhered cells can interact and 
signal each other.42,43 The fibrillar structure of collagen has thus inspired the development of nano- 
and microfibrous tissue engineering scaffolds. While there are other techniques such as self-
assembly, thermally-induced phase separation, melt spinning, extrusion, and 3D printing to 
produce porous scaffolds, electrospinning (ES) has emerged as a popular and prominent method 
to fabricate biomimetic fiber scaffolds. ES is a versatile technique that can be applied to a variety 
of different natural and synthetic polymers and it provides a relatively convenient and cost-
effective way to create fiber scaffolds in the lab.44-52 
 
 
Figure 4.1 Schematic illustration of the ES process and ES setup used in this study. 
 
In principle, ES works by applying a high voltage to a needle through which a polymer 
solution is pushed by a syringe pump. A drop of the polymer solution at the end of the needle then 
experiences the electrostatic repulsion between the surface charges and the Coulombic force 
exerted by the external electric field and it is elongated into what is termed the “Taylor cone”. 
Once the charge repulsion overcomes the surface tension, a fiber jet is emitted from the apex of 
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the Taylor cone and then accelerated toward and collected on a grounded collector.53 Our own 
setup including a syringe pump, power supply, spinneret (needle), and collector is shown in Figure 
4.1. 
While ES is an inexpensive and convenient method to produce fiber scaffolds, the process 
can be affected by a number of parameters such as solution properties (viscosity, polymer 
molecular weight, conductivity, voltage), controlled variables (flow rate, distance between needle 
and collector, collector type and geometry), as well as ambient properties (temperature, 
humidity).50,54,55 Because these parameters can have a significant effect on fiber formation and 
fiber morphology, we first investigated how some of the main parameters influence the ES 
process using PLLA homopolymers, before moving on to PEG-b-PLLA and PLLA-b-PPEGEEMA 
block copolymers. 
Initially, we evaluated the following solution properties: solubility parameters, solvent 
properties, and solution concentration. First, it is important to consider the interactions between 
the solvent and the polymer in order to choose an appropriate solvent system. These interactions 
can be examined by determining the Flory-Huggins Interaction parameter (χ) which can be 
defined as shown in equation 4.1, where δs and δp are the Hildebrand solubility parameter of the 
solvent and the polymer, Ms is the molecular weight of the solvent, R is the universal gas constant, 
T is the temperature, ρs is the density of the solvent, and the value 0.34 represents a lattice 
parameter.56 
 χ = (δs- δp)2 MsRTρs  + 0.34 4.1 
Generally, χ values smaller than 0.5 indicate favorable interactions between polymer 
chains and solvent, whereas values greater than 0.5 indicate unfavorable interactions.56 A variety 
of different solvents and solvent mixtures (including CHCl3, CHCl3/DMF, CHCl3/methanol, 
CHCl3/ethanol, CHCl3/DMSO, DMF/acetone, acetone, DCM, DMF/acetone, DMF, and 
hexafluoroisopropanol)28,34,35,39,40,57-60 have been reported in the literature for the ES process of 
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PLA homopolymers and block copolymers, which can make choosing an appropriate solvent 
challenging, as many publications do not offer their reasoning for choosing a particular solvent 
system. CHCl3, acetone, and mixtures of CHCl3/DMF and CHCl3/DMSO as well as acetone/DMF 
appear to be the most prevalent, so it was decided to focus our initial experimental design on 
those four solvents. The χ parameter for the interaction of PLA and each solvent was calculated 
and values are listed in Table B.2 (Appendix B). Values lower than 0.5 were obtained for acetone 
and chloroform, indicating good polymer – solvent interactions, whereas values higher than 0.5 
were calculated for DMSO and DMF, suggesting poor interactions. While χ parameters offer a 
means to gauge polymer chain and solvent interactions, the Flory-Huggins model does not 
consider secondary forces or interactions and should only be applied to non-polar molecules. 
Alternatively, Hansen developed a model, in which the total solubility parameter can be divided 
into dispersive (nonpolar) (δD), polar (δP), and hydrogen bonding interactions (δH), which are 
known as the Hansen solubility parameters (HSPs).61,62 When plotted in 3D, the HSPs can be 
used to provide a solubility sphere with a radius R for a given polymer in 3D solubility space. The 
distance of any solvent form the center of the solubility sphere of the polymer can be calculated 
using the following equation: 
 d2 = 4 (δD,p-δD,s)2+ (δP,p- δP,s)2+ (δH,p- δH,s)2  4.2 
This distance can then be compared to the radius of the solubility sphere, using d / R, 
which is also known as the relative energy difference (RED). The RED values for PLA and a 
number of solvents has been reported by Agrawal et al.63, and are listed in Table B.3 (Appendix 
B). Generally, if the RED value is lower than 1, the liquid used is considered to be a solvent for 
the polymer of interest, whereas a value higher than 1 constitutes a non-solvent. All four solvents 
of interest in this study showed values lower than 1 and were thus considered suitable. 
The above calculations raise the question, if all four solvents are appropriate in terms of 
solubility parameters, why would a mixture of two solvents be of interest as opposed to simply 
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employing one solvent? This can be illustrated by considering the volatility as well as the dielectric 
constant of a particular solvent. Acetone and CHCl3 have low boiling points compared to DMF 
and DMSO, which makes them useful solvents for ES, because the solvent easily evaporates as 
the jet travels towards the collector, yielding defect-free fibers. Higher boiling point solvents can 
be successfully employed if very slow flow rates are used for the ES process.35 The use of 
solvents like DMF and DMSO can however be beneficial due their high dielectric constant. Adding 
one of these solvents to another solvent can increase the solution conductivity, thus helping 
stabilize the charged jet and facilitating uniform fiber formation.55,60 With this in mind, solvent 
mixtures of either acetone or CHCl3 and DMF or DMSO presented themselves as promising 
choices. Ultimately, a solvent system based on CHCl3 and either DMF or DMSO was chosen, 
because more literature was available for this system and chloroform could be easily obtained 
from a solvent purifier in the lab. Preliminary experiments trying to spin a PLLA homopolymer and 
PEG-b-PLLA block copolymer from a 3:1 CHCl3 / DMF mixture were conducted, but the results 
were inconsistent and uniform fibers were not achieved due to the slow evaporation of DMF in 
the solvent mixture, even when other ES parameters were adjusted. Alternatively, Tomaszewski 
et al.57 had reported conditions for spinning PLA homopolymers of different molecular weights 
from a 9:1 CHCl3 / DMSO solvent mixture, which proved to be successful in initial ES tests and 
was adopted as the solvent system of choice in this study. 
Another important parameter to consider is the polymer solution concentration, because 
polymer chain entanglement and, thus, fiber formation can only be achieved if the concentration 
is sufficiently high.54,60 A few publications have examined the minimum polymer concentration and 
viscosities required to successfully spin defect-free PLA fibers.60,64,65 It has been reported that in 
dilute conditions (concentrations less that the critical overlap concentration, C*), fibers are not 
formed as chain entanglements are essentially absent and the formation of beads or droplets is 
observed. In the semi-dilute unentangled regime (concentrations in between C* and the 
entanglement concentration, Ce), fibers as well as beads are formed. At concentrations higher 
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than Ce (approximately 2 – 2.5 times Ce; semi-dilute entangled regime), only uniform and defect-
free fibers are present. While rheological measurements offer a way to determine viscosities and 
thus C* and Ce values, it is a time-consuming process to calculate values as they differ for different 
polymers, different molecular weights, and different solvent systems. As previously mentioned, 
after reviewing solution parameters and properties and conducting preliminary ES tests, we 
decided to adopt conditions from Tomaszewski et al.57 who spun a range of different molecular 
weight (23 000 g/mol to 132 000 g/mol) PLA homopolymers. 
 
Table 4.1 Experimental results for the PLLA homopolymers used in the ES study. 












1 100 : 1 : 1 78 11 650 8 850 9 570 1.08 
2 200 : 1 : 1 80 23 610 16 520 17 570 1.06 
a Polymerization conditions: I (inifer) = DATCOH, [LLA] = 1.7 M, 15 min, RT, CHCl3 
b Conversion was calculated using gravimetric methods. 
c Theoretical molecular weight was calculated based on the determined conversion, using the 
following equation: Mn (theoret.) = [M]0 / [I]0 x Conversion x MMonomer + MInitiator, where MMonomer and 
MInitiator are the molecular weights of monomer and inifer, and [M]0 and [I]0 are the initial 
concentrations of monomer and inifer. 
e Determined by GPC. Polydispersity index (PDI) was calculated using the equation PDI = Mw / 
Mn. 
 
PLLA homopolymer samples used for investigating important parameters - such as the 
effect of solution concentration, voltage, molecular weight, conductivity, distance, and flow rate -  
were prepared via DBU-catalyzed ROP of LLA as discussed in Chapter 3. The theoretical 
molecular weight and GPC molecular weight values are summarized in Table 4.1. In this study, 
we targeted lower molecular weight PLLA homopolymers, because higher molecular weight 
samples are associated with prolonged degradation times, and not much literature exists on 
spinning low molecular weight PLLA. PLLA12k (Table 4.1, entry 1) was the first sample to be spun. 
Since Tomaszewski et al.57 used a 14 wt% polymer concentration to successfully spin a 22 000 
g/mol PLA homopolymer, an initial concentration of 20 wt% was selected for our PLA12k sample 
(Table 4.1, entry 1). The overall conditions for all ES experiments are summarized in Table 4.2. 
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1 11 650 20 15 20 1 CHCl3 : DMSO 
2 11 650 25 15 20 1 CHCl3 : DMSO 
3 11 650 25 20 20 1 CHCl3 : DMSO 
4 23 610 20 20 20 1 CHCl3 : DMSO 
5 23 610 20 20 20 1 CHCl3 
6 23 610 20 20 5 1 CHCl3 : DMSO 
7 23 610 20 20 10 1 CHCl3 : DMSO 
8 23 610 20 20 15 1 CHCl3 : DMSO 
9 23 610 20 20 20 1 CHCl3 : DMSO 
10 23 610 20 20 20 0.5 CHCl3 : DMSO 
11 23 610 20 20 20 1 CHCl3 : DMSO 
23 23 610 20 20 20 2 CHCl3 : DMSO 
 
Constant conditions: A 22 gauge needle was used for all experiments and fibers were collected 
on microscope slides mounted on top of a 10 x 10 cm lab jack covered in aluminum foil. 
 
The results showed fiber formation, but also beading, which indicates that the 
concentration profile lies in the semi-dilute unentangled regime, in between C* and Ce. Increasing 
the concentration by 5% resulted in more uniform fibers, as the semi-dilute entangled regime was 
reached (Figure 4.2). The sample still includes a few bead defects, but no other parameters had 
been adjusted at this point. 
 
 
Figure 4.2 Effect of polymer concentration, A) 20 wt% and B) 25 wt%, on fiber formation. 
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When the voltage was increased from 20 to 25 kV, the beading defects disappeared 
(Figure 4.3 A and B). The applied voltage plays an important role, because non-optimized electric 
field strengths can result in an unstable and deformed Taylor cone and fiber jet (Figure 4.3 C), 
which leads to bead formation. Hence, the voltage needs to be chosen such that the Taylor cone 
is formed at the tip of the pendant drop exiting the capillary (needle). If the voltage is too high, the 
Taylor cone can be formed at the tip of the capillary or even within the capillary, which is 
associated with increased beading.54,55 
 
 
Figure 4.3 Effect of voltage, A) 15 kV and B) 20 kV, on fiber formation. An example of a deformed 








Because these initial experiments proved successful, we then applied these parameters 
to a higher molecular weight sample, PLLA23k (Table 4.1, entry 2), which was also spun into well-
defined fibers (Figure 4.4). The solution concentration required to form fibers was lower (20 wt%) 
for PLLA23k, as the higher molecular weight increases the viscosity of the solution and chain 
overlap and entanglement occur at a lower overall concentration. 
As previously discussed, an increased solution conductivity can help stabilize the charged 
fiber jet and decrease bead formation. The solution conductivity, however, also affects the fiber 
diameter. This can be seen in Figure 4.5, which shows a comparison of the PLLA23k sample, spun 
from 9:1 CHCl3/DMSO, or just CHCl3. An average fiber diameter was calculated for both samples 
and found to be 1.4 μm and 3.6 μm, respectively. The sample spun from 9:1 CHCl3/DMSO 
exhibited smaller diameter fibers, as the added DMSO increases the overall solution conductivity, 
and as a result the fiber jet is subjected to a greater tensile force in the presence of the electric 
field.50,54 Although both solvents produced well-defined fibers, continued work utilized the 
CHCl3/DMSO mixture, because an increased fiber diameter diminishes the spacing in between 
the fibers, thus lowering the porosity of the scaffold, which in turn may affect cell infiltration. 
 
  




Figure 4.6 Effect of distance, A) 5 cm, B) 10 cm, C) 15 cm, and D) 20 cm, on fiber morphology. 
 
Lastly, the effect of the distance of the spinneret (needle) to the collector, as well as the 
effect of the flow rate were examined (Figure 4.6). In terms of distance, it was observed that both 
a 15 cm and 20 cm distance produced uniform and defect-free fibers.  At distances of 5 or 10 cm, 
fused fiber networks or heterogeneous fibers were collected, as the fibers had insufficient time to 
dry before reaching the collector, thus indicating that a minimum distance of 15 cm was required 
to produce well-defined fibers. 
Choosing an appropriate flow rate is related to the solvent volatility. As our solvent system 
mostly consists of CHCl3, relatively fast flow rates could be employed (Figure 4.7). In general, 
flow rates faster than 0.5 mL/h produced more uniform fibers, although it has been reported that 
high flow rates can result in defects and beading, due to insufficient solvent evaporation prior to 
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fiber collection on the collector.54,55 However, characterization of the fiber mats in this study 




Figure 4.7 Effect of flow rate A) 0.5 mL/h, B) 1 mL/h, and C) 2 mL/h on fiber morphology. 
 
After examining the effect of various ES parameters and establishing suitable conditions 
for spinning uniform PLLA homopolymer fibers, these conditions were used to produce well-
defined PLLA, PEG-b-PLLA, and PLLA-b-PPEGEEMA fiber mats. While limited lower molecular 
weight PLA-based block copolymers have been investigated for drug delivery applications, the 
ES literature examples generally focuses on the use of high molecular weight PLA homopolymers 
and block copolymers (100 – 300 000 g/mol) due to their commercial availability.34,35,39,40,60,66,67 
The degradation profile of these materials, however, tends to be slow (months to even years) and 
as previously discussed, these scaffolds have exhibited varying degrees of cell interaction and 
attachment, despite improved overall hydrophilicity. As such, this study focused on using lower 
molecular weights PLLA-based homopolymers and block copolymer, whose successful synthesis 
was reported in Chapter 3. Results from the previous chapter indicated that PLLA200 exercised 
the best control over the RAFT polymerization of PEGEEMA, thus PLLAs with a DP of 
approximately 200 (molecular weight of about 25 000 g/mol) were targeted. This was successfully 
accomplished and the molecular weights of the PLLA homopolymer samples synthesized for this 
study are listed in Table 4.3 (entries 1 and 2). 
103 
 
Table 4.3 Summary of experimental results for PLLA-based homopolymers and block copolymers 
used in the degradation study and preliminary in vitro study 
Entry Sample 











1 PLLA (DATCOH) 26 930 24 570 26 100 1.06 0 0 
2 PLLA (NPA) 27 760 24 400 26 350 1.08 0 0 
3 PEG-b-PLLA 31 520 19 450 20 720 1.07 113 16 
4 PEG-b-PLLA 31 810 26 020 28 220 1.08 113 16 
5 PLLA-b-PPEGEEMA 35 830 33 020 53 740 1.63 105 13 
6 PLLA-b-PPEGEEMA 36 450 29 690 47 330 1.59 102 12 
 
a Polymerization conditions: For the ROP: I  = DATCOH or NPA, [LLA] : [I] : [DBU] = 200:1:1, 
[LLA] = 1.7 M, 15 min, RT, CHCl3. For the RAFT polymerization: [PEGEEMA] : [PLLA-DATCOH] 
= 75:1, [PLLA-DATCOH] : [AIBN] = 5:1, THF, 70°C, 18 h. 
b Theoretical molecular weight was calculated using the following equation: For the ROP: Mn 
(theoret.) = [M]0 / [I]0 x Conversion x MMonomer + MInitiator, where MMonomer and MInitiator are the 
molecular weights of monomer and inifer or initiator, and [M]0 and [I]0 are the initial concentrations 
of monomer and inifer or initiator. For the RAFT polymerization: Mn (theoret.) = [M]0 / [RAFT]0 x 
Conversion x MMonomer + MRAFT, where MMonomer and MRAFT are the molecular weights of monomer 
and RAFT agent, and [M]0 and [I]0 are the initial concentrations of monomer and RAFT agent. 
c Determined by GPC. Polydispersity index (PDI) was calculated using the equation PDI = Mw / 
Mn. 
d Calculated from conversion. 
 
 
Similarly, PEG-b-PLLA block copolymers were prepared via DBU-catalyzed ROP of LLA, 
using a commercially available monofunctional PEG homopolymer as the initiator (see scheme 
B.1, Appendix B). Again, a DP of 200 was targeted for the PLLA block and the successful results 
are summarized in Table 4.3 (entries 3 and 4). Lastly, PLA-b-PPEGEEMA block copolymers were 
synthesized using PLA200-DATCOH homopolymers as the macro-RAFT agent, resulting in block 
copolymers with a number of ethylene glycol repeat units (and thus PEG amount) comparable to 
the corresponding PEG-b-PLLA analogs (Table 4.3, entries 5 and 6). The resulting PLLA, PEG-
b-PLLA, and PLLA-b-PPEGEEMA samples were then electrospun into fiber scaffolds using the 
parameters listed in Table 4.4 (entries 1, 4, and 6). Accounting for the difference in polymer type 
and architecture, only slight modifications in terms of solution concentration and applied voltage 
needed to be made in order to produce fiber scaffolds from the block copolymers as well as the 
homopolymers, which speaks to the versatility of the ES process. 
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1 PLLA (DATCOH) 15 20 0.302 ± 0.02 1.0 ± 0.2 
2 PLLA (DATCOH) 15 20 0.311 ± 0.02 1.1 ± 0.2 
3 PLLA (NPA) 15 20 0.299 ± 0.02 1.0 ± 0.2 
4 PEG-b-PLLA 20 15 0.290 ± 0.01 1.5 ± 0.4 
5 PEG-b-PLLA 20 15 0.313 ± 0.02 1.6 ± 0.4 
6 PLLA-b-PPEGEEMA 20 15 0.293 ± 0.02 1.3 ± 0.4 
7 PLLA-b-PPEGEEMA 20 15 0.296 ± 0.02 1.6 ± 0.4 
 
Constant conditions: All samples were spun from 9:1 CHCl3 : DMSO, using a 22 gauge needle 
and a 2 mL/h flow rate. The total spin time was 2 hours and the fiber mats were collected on 
aluminum foil mounted on top of a 10 x 10 cm lab jack. The distance from the needle to the 
collector was 20 cm. 
 
4.4.2 Properties, Degradation, and In Vitro Behavior of Fiber Scaffolds 
Once the fiber mats were prepared, their wetting, degradation, and in vitro behavior were 
investigated. First, the wetting behavior and contact angle of the PLA-based homopolymers and 
block copolymers was examined. A drop of water placed on top of each polymer fiber mat 
confirmed that the block copolymer scaffolds exhibit vastly improved hydrophilicity compared to 
the PLLA fiber mats. The PLLA sample showed strongly hydrophobic characteristics, whereas 




Figure 4.8 Wetting behavior of A) PLLA, B) PEG-b-PLLA, and C) PLLA-b-PPEGEEMA fiber mats. 
 
These results were quantified by measuring the contact angle of the samples. The water 
contact angle (Figure 4.9) for the PLLA mats was determined to be 126°, which is consistent with 
a hydrophobic material (whose contact angle is increased from about 76° in a cast film due to 
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increased surface roughness in the fiber mat).68,69 The contact angle for the block copolymer 
samples, on the other hand, was effectively zero as the mats wetted immediately after addition of 
a drop of water, indicating a completely hydrophilic fiber surface. Based on these results, it is 
hypothesized that during the ES process - as the fiber jet is traveling towards the collector - solvent 
evaporation and the difference in solubility parameters between PEG and PLLA, as well as 
PEGEEMA and PLLA, cause the two blocks to phase separate, thus driving the PEG-containing 
block to the surface. This results in the surface of the fiber mats demonstrating the wetting 
properties of the PEG-containing block and produces a hydrophilic surface. 
 
 
Figure 4.9 Water contact angle of A) PLLA, B) PLLA-b-PPEGEEMA, and C) PEG-b-PLLA. 
 
Next, the degradation of PLLA, PEG-b-PLLA, PLLA-b-PPEGEEMA samples under 
physiological conditions (pH = 7.4), as well as in basic (pH = 12.0) and acidic media (pH = 2.0) 
was studied. The degradation of biodegradable polymers such as polyesters is dependent on a 
variety of factors, including molecular weight, crystallinity, purity, temperature, pH, and water 
permeability. In simplistic terms, however, the degradation behavior can be described as chain 
scission, during which hydrolyzable bonds are cleaved to yield oligomers, and eventually 
monomers. Polyesters such as PLA have been known to degrade via a bulk degradation process, 
in which initially degradation occurs more readily at the surface due to the greater availability of 
water. Degradation products formed at the surface of the materials can be dissolved and removed 
whereas degradation products within the material may not diffuse out freely, thus accumulating 
and creating localized acidic environments (due to lactic acid accumulation), which can catalyze 
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and accelerate the degradation. This results in an overall non-linear degradation profile, 
characterized by almost no mass loss at first, followed by an eventual rapid mass loss due to 
autoacceleration. However, autoacceleration may be less prevalent in porous materials, which 
means that high-porosity materials tend to degrade slower than low-porosity materials due to 
increased diffusivity. In general, PLA exhibits low hydrolytic activity, which is caused by its 
hydrophobic nature affecting water uptake into the material, and by bond inaccessibility due to 
steric factors.18,24,70 
The degradation of the hydrophilic PEG-b-PLLA and PLLA-b-PPEGEEMA block 
copolymer scaffolds compared to the hydrophobic PLLA homopolymer scaffold was then 
investigated. Over the course of 2 weeks, the changes in mass, pH of the medium, wettability, 
and morphology were recorded. First, the PLLA homopolymer samples exhibited very little mass 
loss (3%) when incubated in PBS or in an acidic environment, but displayed more significant mass 
loss (47%) under basic conditions (Figure 4.10). 
 
 
Figure 4.10 Hydrolytic degradation: Percent mass loss over time in A) NaOH (pH = 12), B) PBS 
(pH = 7.4), and C) HCl (pH = 2). 
 
Photographs of the PLLA mats (Figure B.1, Appendix B) also showed no obvious macro-
scale defects, except for samples placed in aqueous NaOH, which started to display deterioration 
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after one day. These results can be explained by the limited wettability and steric consideration 
of PLLA, in addition to, the rate constants for the hydrolysis of esters. The uncatalyzed (neutral 
pH) hydrolysis reaction is slow (k = 3.16 x 10-10 s-1 for a small molecule ester) due to water being 
a weak nucleophile. Under acidic conditions, the protonation of the carbonyl oxygen activates the 
ester towards nucleophilic attack and the reaction proceeds at a much faster rate (k = 1.03 x 10-
4 M-1 s-1 for a small molecule ester). However, the steps in the hydrolysis reaction are reversible 
and the position of the equilibrium depends on the concentration of water and the alcohol formed. 
In base-catalyzed conditions, the hydrolysis is even faster (k = 1.52 x 10-1 M-1 s-1 for a small 
molecule ester) as the hydroxide ion represents a strong nucleophile, and once the ester is 
converted to the carboxylic acid and, subsequently, the carboxylate ion, the equilibrium shifts 




Figure 4.11 Hydrolytic degradation: Changes in solution pH A) NaOH, B) PBS, and C) HCl over 
time. 
 
Corresponding to the mass loss, the solution pH remained unchanged for physiological 
and acidic conditions, whereas the pH of the basic medium decreased by 1.5 pH units, 
corresponding to chain scission and the formation of carboxylate groups (Figure 4.11). The same 
108 
 
trend was seen for the PLLA-b-PPEGEEMA polymer. The samples exhibited little to no mass loss 
under physiological and acidic conditions, but experienced considerable mass loss in a basic 
medium (Figure 4.10). In fact, the PLLA-b-PPEGEEMA mats were the most affected by base-
catalyzed hydrolysis which was also reflected in a larger change in pH (Figure 4.11). Because the 
PLLA-b-PPEGEEMA block copolymer contains esters that can undergo hydrolysis in both the 
PLLA as well as the PPEGEEMA block, it makes sense that the samples experienced the most 
change under basic conditions. Again, photographs of the samples (Figure B.2, Appendix B) 
showed no large scale defects, except for the samples placed in aqueous NaOH, which degraded 
visibly. The PEG-b-PLLA mats behaved similarly, losing the most mass under basic conditions, 
but the samples also exhibited some mass loss in acidic and physiological media (Figure 4.10). 
As shown in Figure B.3 (Appendix B), the PEG-b-PLLA samples experienced physical 
degradation and broke into pieces. This could be caused by disruption and delamination of the 
different polymer phases in the fiber. Plasticization and delamination are induced by water uptake 
and result in increased chain mobility, which can in turn reduce the creep resistance of the 
material and lead to mechanical deformation and structural failure.18,73 
In addition, a sample of each polymer was placed in aqueous HCl (pH = 2) and kept at 60 
°C for 2 weeks. The elevated temperature resulted in increased mass loss (2-3 times more than 
at 37 °C) for each mat and photographs of the samples show physical degradation (Figures B.1, 
B.2, and B.3, Appendix B). As the applied temperature was close to the glass transition 
temperature (Tg) of PLA (55 – 65 °C)24, the increased polymer chain mobility may contribute to 
deformations and material fractures. 
As mentioned before, the water contact angle of the samples was measured and initial 
values confirmed the hydrophobic nature of PLLA and hydrophilic nature of the PEG-b-PLLLA 
and PLLA-b-PPEGEEMA block copolymers. After taking part in the degradation study, the contact 
angle of all samples that had remained intact was re-measured (Figures B.4 – B.9, Appendix B). 
The values varied somewhat for the individual PLLA samples (118 – 130°), which can be 
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attributed to differences in surface roughness. Yet overall, the PLLA samples showed no change 
in contact angle over time in either PBS or under acidic conditions and all samples remained 
hydrophobic. The samples placed in aqueous NaOH, however, displayed a 20-30° decrease after 
1 day and exhibited complete wetting after 7 days, indicating an increase in surface carboxylate 
groups. PLLA-b-PPEGEEMA mats in buffer and HCl also remained unchanged and displayed 
complete wetting throughout the study. PEG-b-PLLA samples initially wetted completely, but were 
not re-measured, because the samples did not remain intact, making it impossible to accurately 
measure the contact angle. 
 
  
Figure 4.12 Initial SEM micrographs of A) PLLA, B) PLLA-b-PPEGEEMA, and C) PEG-b-PLLA 
(scale bar = 50 μm). 
 
The morphology of the fiber mats was also examined via SEM. Initial SEM micrographs 
of the scaffolds (Figure 4.12) showed well-defined fibers for all three polymers (PLLA, for PEG-b-
PLLA, and PLLA-b-PPEGEEMA). The overall fiber diameters were measured to be 1.0 μm, 1.5 
μm, and 1.3 μm, respectively (Table 4.4, entries 1, 4, and 6). The diameters for the block 
copolymers are larger compared to the homopolymers, which could be a result of the larger 
molecular weight or the higher solution concentration that was used to produce the fiber mats. 
Micrographs of the samples incubated in PBS for 2 weeks showed no evidence of breakdown on 





Figure 4.13 SEM micrographs of A) PLLA, B) PLLA-b-PPEGEEMA, and C) PEG-b-PLLA after 14 




While the PEG-b-PLLA mats broke into larger pieces on the macro-scale, there were no 
micro-fractures visible (Figure 4.13). The same results were observed for samples placed in HCl, 
except a few micro-fractures were seen for PEG-b-PLLA. At elevated temperatures and 
incubation in HCl, all three polymer samples exhibited morphology changes and micro-fractures, 
consistent with the increased degradation. As previously discussed, using basic conditions had 
resulted in the most mass loss, which was mirrored in the SEM micrographs which showed 
extensive fiber breakdown after 2 weeks. 
Lastly, a preliminary cell study was conducted to investigate the ability of the different fiber 
mats to promote cell attachment. Two PLLA homopolymers, one prepared with our DATCOH 
inifer and one with NPA as the initiator, and two block copolymers, PEG-b-PLLA and PLLA-b-
PPEGEEMA, similar to the ones used in the degradation study were successfully spun into well-
defined porous fiber scaffolds (Table 4.4, entries 2, 3, 5, and 7), as confirmed by SEM (Figure 
B.10, Appendix B). The contact angle of the scaffolds was also measured and the results matched 
the previous wetting studies, confirming the hydrophobic nature of the PLLA and the hydrophilic 
nature of the block copolymers samples (Figure B.11, Appendix B). Green fluorescent protein-
labeled mouse head and neck cancer cells (GFP-Cu110) were seeded onto the four different 
scaffolds and cell adhesion was monitored using fluorescence microscopy. GFP-Cu110 cells 
were chosen, because they were easily cultured and the inherent fluorescence provided a 
convenient way to observe cell attachment. 
 
 
Figure 4.14 Bright field images showing GFP-Cu110 attachment on A) PLLA (DATCOH), B) PLLA 
(NPA), C) PEG-b-PLLA, and D) PLLA-b-PPEGEEMA. 
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After 1 week, no cell attachment was observed on either one of the homopolymer 
scaffolds, whereas PEG-b-PLLA showed some attachment and PLLA-b-PPEGEEMA showed 
significant cell adhesion (Figure 4.14). Despite containing almost the same number of PEG repeat 
units and nearly the same amount of overall PEG, the two block copolymer samples behaved 
differently. These preliminary results suggest that aside from overall hydrophilicity, the polymer 
architecture also comes into play. As amphiphilic block copolymers phase separate, it is possible 
that the long PEG chains in the linear PEG-b-PLLA polymer and the short PEG chains in the 
linear / bottlebrush PLLA-b-PPEGEEMA polymer arrange and present themselves differently 
within the fiber scaffold. This structural difference could possibly result in a more (PEG-b-PLLA) 
or less pronounced (PLLA-b-PPEGEEMA) anti-fouling behavior, thus affecting cell adhesion. In 
addition, SEM micrographs further confirmed the successful interaction of the PLLA-b-
PPEGEEMA scaffold with the cells (Figure 4.15). Finally, confocal fluorescence microscopy also 
indicated that cells were able to migrate into the porous material (Figure 4.15). 
 
 
Figure 4.15 Confocal fluorescence image and SEM micrograph of PLLA-b-PPEGEEMA and GFP-
Cu110. 
 
While further studies with mesenchymal stem cell are necessary, these preliminary in vitro 
results are encouraging, as they suggest that hydrophilic PLLA-b-PPEGEEMA scaffolds can be 




In conclusion, we successfully synthesized well-defined PLLA homopolymers, as well as 
PEG-b-PLLA and PLLA-b-PPEGEEMA block copolymers with similar PEG content via ROP and 
RAFT polymerization. Using ES techniques, we were able to spin these low molecular weight 
polymers into scaffolds with defect-free fibers. Contact angle measurements confirmed the overall 
improved hydrophilicity of the block copolymer samples compared to the homopolymer samples. 
PLLA-b-PPEGEEMA samples proved promising in a preliminary cell study using GFP-labeled 
cancer cells and showed successful cell attachment as well as cell migration into the fiber scaffold. 
While PEG-b-PLLA also exhibited improved hydrophilicity, the samples lacked structural integrity 
during degradation and did not prove promising in terms of cell attachment, most likely due to 
structural differences compared to PLLA-b-PPEGEEMA. The enhanced hydrophilicity of the block 
copolymer scaffolds did not alter the degradation behavior compared to the PLLA scaffolds under 
physiological conditions and significant breakdown was only observed under accelerated basic 
conditions. However, due to the controlled nature of ROP and RAFT polymerization, the 
amphiphilic PLLA-b-PPEGEEMA block copolymer could be readily tuned and further 
manipulated. 
4.6 References 
(1) O'Brien, F. J. Biomaterials and Scaffolds for Tissue Engineering. Mater. Today 2011, 14, 
88-95. 
 
(2) Niklason, L. E.; Langer, R. Prospects for Organ and Tissue Replacement. J. Am. Med. 
Assoc. 2001, 285, 573-576. 
 
(3) Bentley, T. S.; Phillips, S. J. 2017 U.S. Organ and Tissue Transplant Cost Estimates and 
Discussion. Milliman Research Report 2017, 1 - 17. 
 
(4) Langer, R.; Vacanti, J. Tissue Engineering. Science 1993, 260, 920-926. 
 
(5) Chen, Q.; Thouas, G. A. Metallic Implant Biomaterials. Mater. Sci. Eng., R 2015, 87, 1-57. 
 
(6) Baino, F.; Novajra, G.; Vitale-Brovarone, C. Bioceramics and Scaffolds: A Winning 




(7) Brauer, D. S. Bioactive Glasses - Structure and Properties. Angew. Chem. Int. Ed. 2015, 
54, 4160-4181. 
 
(8) Jafari, M.; Paknejad, Z.; Rad, M. R.; Motamedian, S. R.; Eghbal, M. J.; Nadjmi, N.; 
Khojasteh, A. Polymeric Scaffolds in Tissue Engineering: A Literature Review. J. Biomed. 
Mater. Res., Part B 2017, 105, 431-459. 
 
(9) Chen, Q.; Liang, S.; Thouas, G. A. Elastomeric Biomaterials for Tissue Engineering. Prog. 
Polym. Sci. 2013, 38, 584-671. 
 
(10) Holzapfel, B. M.; Reichert, J. C.; Schantz, J.-T.; Gbureck, U.; Rackwitz, L.; Nöth, U.; Jakob, 
F.; Rudert, M.; Groll, J.; Hutmacher, D. W. How Smart Do Biomaterials Need to Be? A 
Translational Science and Clinical Point of View. Adv. Drug Delivery Rev. 2013, 65, 581-
603. 
 
(11) Malafaya, P. B.; Silva, G. A.; Reis, R. L. Natural–Origin Polymers as Carriers and Scaffolds 
for Biomolecules and Cell Delivery in Tissue Engineering Applications. Adv. Drug Delivery 
Rev. 2007, 59, 207-233. 
 
(12) Nair, L. S.; Laurencin, C. T. Biodegradable Polymers As Biomaterials. Prog. Polym. Sci. 
2007, 32, 762-798. 
 
(13) Doppalapudi, S.; Jain, A.; Khan, W.; Domb, A. J. Biodegradable Polymers - An Overview. 
Polym. Adv. Technol. 2014, 25, 427-435. 
 
(14) Van Vlierberghe, S.; Dubruel, P.; Schacht, E. Biopolymer-Based Hydrogels As Scaffolds 
for Tissue Engineering Applications: A Review. Biomacromolecules 2011, 12, 1387-1408. 
 
(15) Sabir, M. I.; Xu, X.; Li, L. A Review on Biodegradable Polymeric Materials for Bone Tissue 
Engineering Applications. J. Mater. Sci. 2009, 44, 5713-5724. 
 
(16) Leijten, J.; Rouwkema, J.; Zhang, Y. S.; Nasajpour, A.; Dokmeci, M. R.; Khademhosseini, 
A. Advancing Tissue Engineering: A Tale of Nano-, Micro-, and Macroscale Integration. 
Small 2016, 12, 2130-2145. 
 
(17) Goonoo, N.; Bhaw-Luximon, A.; Bowlin, G. L.; Jhurry, D. An Assessment of Biopolymer 
and Synthetic Polymer-Based Scaffolds for Bone and Vascular Tissue Engineering. 
Polym. Int. 2013, 62, 523-533. 
 
(18) Brannigan, R. P.; Dove, A. P. Synthesis, Properties and Biomedical Applications of 
Hydrolytically Degradable Materials Based on Aliphatic Polyesters and Polycarbonates. 
Biomater. Sci. 2017, 5, 9-21. 
 
(19) Tian, H.; Tang, Z.; Zhuang, X.; Chen, X.; Jing, X. Biodegradable Synthetic Polymers: 
Preparation, Functionalization and Biomedical Application. Prog. Polym. Sci. 2012, 37, 
237-280. 
 
(20) Deshayes, S.; Kasko, A. M. Polymeric Biomaterials with Engineered Degradation. J. 




(21) Santoro, M.; Shah, S. R.; Walker, J. L.; Mikos, A. G. Poly(Lactic Acid) Nanofibrous 
Scaffolds for Tissue Engineering. Adv. Drug Delivery Rev. 2016, 107, 206-212. 
 
(22) Tyler, B.; Gullotti, D.; Mangraviti, A.; Utsuki, T.; Brem, H. Polylactic Acid (PLA) Controlled 
Delivery Carriers for Biomedical Applications. Adv. Drug Delivery Rev. 2016, 107, 163-
175. 
 
(23) Dong, Y.; Liao, S.; Ngiam, M.; Chan, C. K.; Ramakrishna, S. Degradation Behaviors of 
Electrospun Resorbable Polyester Nanofibers. Tissue Eng., Part B 2009, 15, 333-351. 
 
(24) Farah, S.; Anderson, D. G.; Langer, R. Physical and Mechanical Properties of PLA and 
Their Functions in Widespread Applications. Adv. Drug Delivery Rev. 2016, 107, 367-392. 
 
(25) Garlotta, D. A Literature Review of Poly(Lactic Acid). J. Polym. Environ. 2001, 9, 63-84. 
 
(26) Kutikov, A. B.; Song, J. Biodegradable PEG-Based Amphiphilic Block Copolymers for 
Tissue Engineering Applications. ACS Biomater. Sci. Eng. 2015, 1, 463-480. 
 
(27) Liang, D.; Hsiao, B. S.; Chu, B. Functional Electrospun Nanofibrous Scaffolds for 
Biomedical Applications. Adv. Drug Delivery Rev. 2007, 59, 1392-1412. 
 
(28) Cui, W.; Zhu, X.; Yang, Y.; Li, X.; Jin, Y. Evaluation of Electrospun Fibrous Scaffolds of 
Poly(DL-Lactide) and Poly(Ethylene Glycol) for Skin Tissue Engineering. Mater. Sci. Eng., 
C 2009, 29, 1869-1876. 
 
(29) Zhao, Y.; Zhu, J.; Zhang, J.; Chen, Z.; Li, W.; Deng, L.; Chen, K.; Wan, H.; Li, J.; Li, R. 
Optimization of Biodegradable PEG/PLGA Nanofiber Mats Electrospinning Process for 
Anti-Adhesion Application. J. Appl. Polym. Sci. 2018, 135, 46282. 
 
(30) Hu David, S.-G.; Liu, H.-J. Structural Analysis and Degradation Behavior in Polyethylene 
Glycol/Poly(L-Lactide) Copolymers. J. Appl. Polym. Sci. 1994, 51, 473-482. 
 
(31) Kim, K.; Yu, M.; Zong, X.; Chiu, J.; Fang, D.; Seo, Y.-S.; Hsiao, B. S.; Chu, B.; 
Hadjiargyrou, M. Control of Degradation Rate and Hydrophilicity in Electrospun Non-
Woven Poly(D,L-Lactide) Nanofiber Scaffolds for Biomedical Applications. Biomaterials 
2003, 24, 4977-4985. 
 
(32) Zoppi, R. A.; Duek, E. A. R.; Coraça, D. C.; Barros, P. P. Preparation and Characterization 
of Poly(L-Lactic Acid) and Poly(Ethylene Oxide) Blends. Mater. Res. 2001, 4, 117-125. 
 
(33) Peng, H.; Zhou, S.; Guo, T.; Li, Y.; Li, X.; Wang, J.; Weng, J. In Vitro Degradation and 
Release Profiles for Electrospun Polymeric Fibers Containing Paracetanol. Colloids Surf., 
B 2008, 66, 206-212. 
 
(34) Lins, L. C.; Wianny, F.; Livi, S.; Hidalgo, I. A.; Dehay, C.; Duchet-Rumeau, J.; Gérard, J.-
F. Development of Bioresorbable Hydrophilic–Hydrophobic Electrospun Scaffolds for 
Neural Tissue Engineering. Biomacromolecules 2016, 17, 3172-3187. 
 
(35) Buttaro, L. M.; Drufva, E.; Frey, M. W. Phase Separation to Create Hydrophilic Yet Non-




(36) Zhang, K.; Tang, X.; Zhang, J.; Lu, W.; Lin, X.; Zhang, Y.; Tian, B.; Yang, H.; He, H. PEG–
PLGA Copolymers: Their Structure and Structure-Influenced Drug Delivery Applications. 
J. Controlled Release 2014, 183, 77-86. 
 
(37) Harris, J. M.: Poly(Ethylene Glycol) Chemistry: Biotechnical and Biomedical Applications; 
Springer Science & Business Media, 2013. 
 
(38) Hucknall, A.; Rangarajan, S.; Chilkoti, A. In Pursuit of Zero: Polymer Brushes that Resist 
the Adsorption of Proteins. Adv. Mater. 2009, 21, 2441-2446. 
 
(39) Viswanathan, P.; Themistou, E.; Ngamkham, K.; Reilly, G. C.; Armes, S. P.; Battaglia, G. 
Controlling Surface Topology and Functionality of Electrospun Fibers on the Nanoscale 
Using Amphiphilic Block Copolymers to Direct Mesenchymal Progenitor Cell Adhesion. 
Biomacromolecules 2015, 16, 66-75. 
 
(40) Evrova, O.; Hosseini, V.; Milleret, V.; Palazzolo, G.; Zenobi-Wong, M.; Sulser, T.; 
Buschmann, J.; Eberli, D. Hybrid Randomly Electrospun Poly(Lactic-co-Glycolic 
Acid):Poly(Ethylene Oxide) (PLGA:PEO) Fibrous Scaffolds Enhancing Myoblast 
Differentiation and Alignment. ACS Appl. Mater. Interfaces 2016, 8, 31574-31586. 
 
(41) Huang, G.; Li, F.; Zhao, X.; Ma, Y.; Li, Y.; Lin, M.; Jin, G.; Lu, T. J.; Genin, G. M.; Xu, F. 
Functional and Biomimetic Materials for Engineering of the Three-Dimensional Cell 
Microenvironment. Chem. Rev. 2017, 117, 12764-12850. 
 
(42) Lutolf, M. P.; Hubbell, J. A. Synthetic Biomaterials as Instructive Extracellular 
Microenvironments for Morphogenesis in Tissue Engineering. Nat. Biotechnol. 2005, 23, 
47. 
 
(43) Abbott, A. Cell Culture: Biology's New Dimension. Nature 2003, 424, 870 - 872. 
 
(44) Holzwarth, J. M.; Ma, P. X. 3D Nanofibrous Scaffolds for Tissue Engineering. J. Mater. 
Chem. 2011, 21, 10243-10251. 
 
(45) Jiang, T.; Carbone, E. J.; Lo, K. W. H.; Laurencin, C. T. Electrospinning of Polymer 
Nanofibers for Tissue Regeneration. Prog. Polym. Sci. 2015, 46, 1-24. 
 
(46) Kishan, A. P.; Cosgriff-Hernandez, E. M. Recent Advancements in Electrospinning Design 
for Tissue Engineering Applications: A Review. J. Biomed. Mater. Res., Part A 2017, 105, 
2892-2905. 
 
(47) Lu, W.; Sun, J.; Jiang, X. Recent Advances in Electrospinning Technology and Biomedical 
Applications of Electrospun Fibers. J. Mater. Chem. B 2014, 2, 2369-2380. 
 
(48) Puppi, D.; Zhang, X.; Yang, L.; Chiellini, F.; Sun, X.; Chiellini, E. Nano/Microfibrous 
Polymeric Constructs Loaded with Bioactive Agents and Designed for Tissue Engineering 
Applications: A Review. J. Biomed. Mater. Res., Part B 2014, 102, 1562-1579. 
 
(49) Stocco, T. D.; Bassous, N. J.; Zhao, S.; Granato, A. E. C.; Webster, T. J.; Lobo, A. O. 




(50) Sun, B.; Long, Y. Z.; Zhang, H. D.; Li, M. M.; Duvail, J. L.; Jiang, X. Y.; Yin, H. L. Advances 
in Three-Dimensional Nanofibrous Macrostructures via Electrospinning. Prog. Polym. Sci. 
2014, 39, 862-890. 
 
(51) Xue, J.; Xie, J.; Liu, W.; Xia, Y. Electrospun Nanofibers: New Concepts, Materials, and 
Applications. Acc. Chem. Res. 2017, 50, 1976-1987. 
 
(52) Yang, G.; Li, X.; He, Y.; Ma, J.; Ni, G.; Zhou, S. From Nano to Micro to Macro: Electrospun 
Hierarchically Structured Polymeric Fibers for Biomedical Applications. Prog. Polym. Sci. 
2018, 81, 80-113. 
 
(53) Li, D.; Xia, Y. Electrospinning of Nanofibers: Reinventing the Wheel? Adv. Mater. 2004, 
16, 1151-1170. 
 
(54) Sill, T. J.; von Recum, H. A. Electrospinning: Applications in Drug Delivery and Tissue 
Engineering. Biomaterials 2008, 29, 1989-2006. 
 
(55) Pham, Q. P.; Sharma, U.; Mikos, D. A. G. Electrospinning of Polymeric Nanofibers for 
Tissue Engineering Applications: A Review. Tissue Eng. 2006, 12, 1197-1211. 
 
(56) Flory, P. J.: Principles of Polymer Chemistry; Cornell University Press, 1953. 
 
(57) Tomaszewski, W.; Duda, A.; Szadkowski, M.; Libiszowski, J.; Ciechanska, D. Poly(L-
lactide) Nano- and Microfibers by Electrospinning: Influence of Poly(L-lactide) Molecular 
Weight. Macromol. Symp. 2008, 272, 70-74. 
 
(58) Badami, A. S.; Kreke, M. R.; Thompson, M. S.; Riffle, J. S.; Goldstein, A. S. Effect of Fiber 
Diameter on Spreading, Proliferation, and Differentiation of Osteoblastic Cells on 
Electrospun Poly(lactic acid) Substrates. Biomaterials 2006, 27, 596-606. 
 
(59) Casasola, R.; Thomas, N. L.; Trybala, A.; Georgiadou, S. Electrospun Poly Lactic Acid 
(PLA) Fibres: Effect of Different Solvent Systems on Fibre Morphology and Diameter. 
Polymer 2014, 55, 4728-4737. 
 
(60) Casasola, R.; Thomas, N. L.; Georgiadou, S. Electrospinning of Poly(lactic acid): 
Theoretical Approach for the Solvent Selection to Produce Defect-Free Nanofibers. J. 
Polym. Sci., Part B: Polym. Phys. 2016, 54, 1483-1498. 
 
(61) Barton, A. F.: CRC Handbook of Solubility Parameters and Other Cohesion Parameters; 
Routledge, 2017. 
 
(62) Chanda, M.: Introduction to Polymer Science and Chemistry: A Problem-Solving 
Approach; CRC Press, 2006. 
 
(63) Agrawal, A.; Saran, A. D.; Rath, S. S.; Khanna, A. Constrained Nonlinear Optimization for 
Solubility Parameters of Poly(Lactic Acid) and Poly(Glycolic Acid) - Validation and 
Comparison. Polymer 2004, 45, 8603-8612. 
 
(64) Shenoy, S. L.; Bates, W. D.; Frisch, H. L.; Wnek, G. E. Role of Chain Entanglements on 
Fiber Formation During Electrospinning of Polymer Solutions: Good Solvent, Non-Specific 




(65) Zeng, J.; Haoqing, H.; Schaper, A.; Wendorff, J. H.; Greiner, A.: Poly-L-Lactide Nanofibers 
by Electrospinning – Influence of Solution Viscosity and Electrical Conductivity on Fiber 
Diameter and Fiber Morphology. e-Polymers 2003, 3, 1-9. 
 
(66) Saeed, A. O.; Dey, S.; Howdle, S. M.; Thurecht, K. J.; Alexander, C. One-Pot Controlled 
Synthesis of Biodegradable and Biocompatible Co-Polymer Micelles. J. Mater. Chem. 
2009, 19, 4529-4535. 
 
(67) Barz, M.; Armiñán, A.; Canal, F.; Wolf, F.; Koynov, K.; Frey, H.; Zentel, R.; Vicent, M. J. 
PHPMA-b-PLA Copolymers in Paclitaxel Formulations: Polylactide Stereochemistry 
Controls Micellization, Cellular Uptake Kinetics, Intracellular Localization and Drug 
Efficiency. J. Controlled Release 2012, 163, 63-74. 
 
(68) Li, D.; Frey, M. W.; Baeumner, A. J. Electrospun Polylactic Acid Nanofiber Membranes As 
Substrates for Biosensor Assemblies. J. Membr. Sci. 2006, 279, 354-363. 
 
(69) Ishaug-Riley, S. L.; Okun, L. E.; Prado, G.; Applegate, M. A.; Ratcliffe, A. Human Articular 
Chondrocyte Adhesion and Proliferation on Synthetic Biodegradable Polymer Films. 
Biomaterials 1999, 20, 2245-2256. 
 
(70) Woodard, L. N.; Grunlan, M. A. Hydrolytic Degradation and Erosion of Polyester 
Biomaterials. ACS Macro Lett. 2018, 976-982. 
 
(71) Guthrie, J. P. Hydration of Carboxylic Acids and Esters. Evaluation of the Free Energy 
Change for Addition of Water to Acetic and Formic Acids and Their Methyl Esters. J. Am. 
Chem. Soc. 1973, 95, 6999-7003. 
 
(72) Jung, J. H.; Ree, M.; Kim, H. Acid- and Base-Catalyzed Hydrolyses of Aliphatic 
Polycarbonates and Polyesters. Catal. Today 2006, 115, 283-287. 
 
(73) Lyu, S.; Untereker, D. Degradability of Polymers for Implantable Biomedical Devices. Int. 






HYDROTHERMAL SYNTHESIS OF HYDROXYAPATITE NANOPARTICLES AND 
SUBSEQUENT SURFACE MODIFICATION WITH POLY(LACTIDE) OR POLY(DOPAMINE) 
 
5.1 Abstract 
A hydrothermal synthesis approach was used to evaluate the synthesis of well-defined 
hydroxyapatite nanoparticles (HANPs). The effect of different parameters - such as the use of 
sodium citrate as an additive, the increase of overall reactant concentrations, reaction time as 
well as temperature - were investigated to provide a better understanding of the synthesis of 
biologically relevant  HANPs. The resulting HANPs were thoroughly characterized via Fourier 
transform infrared spectroscopy, transmission electron microscopy, and x-ray diffraction. 
Furthermore, experiments using surface grafting and surface coating techniques were conducted 
to gain valuable insights into the surface modification of HANPs with poly(lactide), as well as  
poly(dopamine). Again, characterization techniques, such as Fourier transform infrared 
spectroscopy, transmission electron microscopy, as well as 1H nuclear magnetic resonance 
spectroscopy, were employed to provide important details about the feasibility of these surface 
modification techniques. 
5.2 Introduction 
Bone defects and bone loss due to trauma, injuries, cancer, congenital anomalies and 
pathological diseases such as osteoporosis, osteoarthritis, and Paget’s disease have posed a 
significant challenge in the field of orthopedic and craniofacial surgery.1-3 Annually, over 2 million 
orthopedic procedures are performed using bone grafts and market predictions estimate the 
yearly revenue from the North American market alone to rise above $2 billion by 2023.4 Due to 
the high demand for bone grafts and bone substitutes, bone represents one of the most 
transplanted tissues, second only to blood.2 Currently, prevalent treatment options for bone 
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defects and bone loss include autografts (autologous tissue transfer) and allografts 
(transplantation of bone from donors or cadavers). Autografts have been the long-standing “gold 
standard” for bone repair, because they can be harvested from within the same patient (usually 
the iliac crest) and thus seldom elicit an immune response. However, there are significant 
drawbacks associated with autografts such as necrosis, infection and post-operative pain at the 
harvest site (donor site morbidity) and limited availability of suitable bone tissue, especially in 
pediatric and elderly patients. Allografts are a viable alternative, but concerns regarding the risk 
of disease transmission, potential immunological rejection, as well as the cost related to 
harvesting, processing, sterilizing, and storing donor bone material limit their application.5-7 
Because of the disadvantages associated with the traditional autograft and allograft treatment 
methods, alternative bone substitutes have been of considerable interest. 
A variety of substitutes based on allograft, polymer, cell, growth factor, and ceramic 
materials have been considered as suitable candidates for bone repair and bone tissue 
engineering applications.3,5,7,8 Especially hydroxyapatite (HA), a member of the calcium 
phosphate (CaP) ceramics family with the chemical formula Ca10(OH)2(PO4)6, has been widely 
researched due to its chemical and structural similarity to the inorganic component of native bone 
matrix.9-13 In general, HA exhibits good biocompatibility and bioactivity and HA-based bone 
substitute materials are slowly resorbed during bone healing and remodeling processes.6,10,14,15 
In order to function as a successful bone graft substitute, the material, however, should also be 
osteoconductive, osteoinductive, osteogenic, and possess mechanical properties that match or 
come close to those of the implant site.16 Osteoconductive materials are able to promote the 
attachment of osteoblasts or osteoprogenitor cells on the surface and within the bone substitute 
or scaffold. Osteoinduction, on the other hand, refers to the ability of a material to promote the 
differentiation of mesenchymal stem cells to osteoblasts. In addition, osteogenic materials exhibit 
the ability to induce de novo bone formation. HA-based bone graft substitutes are largely 
considered osteoconductive and have shown to potentially be osteoinductive, although 
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experimental evidence over the past years has suggested that the osteoinductive behavior of HA 
and other CaP-based biomaterials is not an inherent property, but related to the underlying 
microstructure of the scaffold.15,17,18 HA biomaterials are not considered osteogenic, but can show 
osteogenic behavior if seeded with cells prior to being introduced to an implant site. Furthermore, 
HA-based bone graft substitutes can provide initial structural support, but they are brittle which 
limits their processability and applications and especially porous HA ceramics often do not closely 
match the mechanical properties of natural trabecular or cortical bone.1,14,19 
Considering the above mentioned desirable characteristics of ideal bone graft substitutes, 
one of the most promising strategies in the field of bone tissue engineering has been the use of 
composite materials, which help combine the benefits of different materials to better mimic the 
biological and structural properties of bone.3,15,20 Notably, nanocomposites based on synthetic or 
natural polymers and CaP ceramics have been of considerable interest, due to bone itself being 
an organic-inorganic composite, consisting of type I collagen nanofibers and HA nanocrystals. 
Natural polymers such as collagen, chitosan, and alginate may be a logical choice as they share 
similarities with the extracellular matrix, but synthetic polymers have also been widely researched 
due to their ability to be tailored to different properties (molecular weight, biofunctionality, 
degradation profile et cetera).19,21-25 Examples of nanocomposites containing electrospun 
poly(lactide) (PLA) homopolymer and block copolymer fibers and HA nanoparticles (HANPs) have 
successfully combined desirable scaffolds properties such as biocompatibility, biodegradability, 
osteoconductivity, osteoinductivity, and improved mechanical properties.26-30  
Despite the benefits, one of the main challenges associated with nanocomposite scaffolds 
stems from the incompatibility of the nanoparticles with the polymer matrix. Hydrophilic HANPs 
exhibit a low affinity with hydrophobic polymers such as PLA as well as the organic solvents used 
during scaffold preparation, which results in poor mixing of the components and uneven 
distributions of the inorganic component within the polymer.26,27,30 In order to avoid agglomeration 
and improve incorporation of the HANPs into the PLA matrix, different approaches using fillers or 
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surfactants, amphiphilic block copolymers as well as surface modified nanoparticles have been 
employed.9,26-28,31,32 Grafting PLA from the surface of HANPs has been a particularly popular 
approach as it results in improved interfacial adhesion between the nanoparticles and the polymer 
matrix.33-39 For example, Hong et al.33,34 reported the surface modification of HA nanocrystals with 
PLA via ring opening polymerization (ROP) of lactide from the hydroxyl groups present on the 
surface. While the authors report that the PLA grafted HANPs (PLA-g-HANPs) dispersed more 
easily in chloroform and composites of PLA and PLA-g-HANPs exhibited slightly improved 
mechanical behavior in terms of elongation at break, the surface characterization methods 
employed don’t conclusively prove the successful covalent attachment of PLA to the surface of 
the particles. Thermogravimetric analysis (TGA) and FTIR spectroscopy provide proof that PLA 
is present in the sample, but don’t confirm surface attachment. Furthermore, transmission electron 
microscopy (TEM) micrographs show no apparent surface coating and solid state 31P nuclear 
magnetic resonance (NMR) spectroscopy offers inconclusive results. With this in mind, we herein 
seek to prepare well-defined nanoscale HA using a hydrothermal synthesis approach and further 
investigate the surface modification of HANPs with PLA via the grafting-from method. 
5.3 Experimental 
The following sections lists the materials used in this chapter and describe the relevant 
synthesis and characterization methods. 
5.3.1 Materials 
Calcium nitrate tetrahydrate (99%) and sodium citrate tribasic (anhydrous, 99%) were 
purchased from Alfa Aesar. Sodium phosphate tribasic dodecahydrate (certified ACS, 99.4%), 
chloroform (CHCl3, Certified ACS Grade) and toluene (Certified ACS Grade) were purchased from 
Fisher Scientific. Phosphorus pentoxide (P2O5, with moisture indicator), dimethyl sulfoxide 
(DMSO, anhydrous, ≥99.9%), tin(II) 2-ethylhexanoate (95%), Trizma Base (≥99.9%), dopamine 
hydrochloride (Sigma Grade), and 4-(dimethylaminopyridine) (DMAP, ≥99%, Reagent Plus) were 
purchased from Sigma-Aldrich. Sodium hydroxide (NaOH, ACS Grade, pellets) was Macron Fine 
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Chemicals brand and was purchased from VWR. Hydrochloric acid (HCl, ACS Grade) was 
purchased from EMD Millipore. Ethanol (anhydrous, 200 proof, ACS Grade) and methanol (ACS 
Grade) were purchased from Pharmco-Aaper. Nanopure water was obtained from a Barnstead 
Nanopure water purification system. L-lactide (LLA, Purasorb L) was purchased from Purac 
Corbion and was recrystallized three times from toluene, dried in a vacuum oven for 24 h, and 
then stored in a vacuum desiccator over P2O5 prior to use. Dry toluene for all ROP experiments 
was obtained from a commercial solvent purification system (Innovative Technology, Inc.). For 
the ROP experiments, all glassware, stir bars, ground-glass syringes and needles were oven-
dried for at least 24 h and glassware was further flame-dried upon assembly. 
5.3.2 Instrumentation and Characterization 
TEM was performed on a Philips CM200, with an accelerating voltage of 120 kV. Dilute 
solutions of unmodified HANPs or polymer-modified HANPs suspended in ethanol were placed 
on lacey Formvar / carbon-coated copper TEM grids and allowed to air-dry. A Keen View Soft 
Imaging System coupled to iTEM software was used to acquire the images. ImageJ software was 
employed to measure the length and width of the HANPs (200 particles per sample). Attenuated 
total reflectance Fourier transform infrared spectroscopy (ATR-FTIR) was performed using a 
Thermo Scientific Nicolet iS50 spectrometer and processed using OMNIC software. The zeta 
potential of the HANPs dispersed in nanopure water was measured on a Malvern Zetasizer Nano 
ZS at a scattering angle of 173° and analyzed via Malvern Zetasizer software. Powder x-ray 
diffraction (XRD) intensity data was collected on a PANalytical X’Pert Pro MRD using Cu Kα 
radiation. 1H NMR spectra were recorded using CDCl3 at room temperature on a JEOL ECA 500 
(500 MHz) spectrometer and data obtained was processed using MestReNova software. pH 
measurements were taken on a Fisher Scientific Accumet AE150 pH meter.  All HANP samples 
were collected using a Thermo Scientific Sorvall Legend 14 microcentrifuge or a Fisherbrand 




5.3.3 General Hydrothermal Synthesis of HANPs (with Sodium Citrate) 
The procedure was adapted from the literature.40 An aqueous sodium citrate solution was 
added over the course of 10 min to an aqueous calcium nitrate solution, while stirring 
continuously. An aqueous sodium phosphate solution was then added over the course of 15 min, 
again while stirring continuously. The resulting reaction mixture was transferred to a 200 mL 
Teflon-lined stainless steel autoclave reactor, which was placed in a pre-heated oven. After a 
specified time, the reactor was allowed to cool to room temperature and the nanoparticles were 
collected via centrifugation (14 600 rpm, 15 min). The nanoparticles were then washed by re-
dispersion in nanopure water and collected by centrifugation (3 cycles), followed by re-dispersion 
in ethanol and collected by centrifugation (3 cycles). Lastly, the nanoparticles were freeze-dried 
for 2 d. Typical conditions for the experiments carried out using different concentrations were as 
follows: aqueous sodium citrate solution (40 mL, 0.0067 M), aqueous calcium nitrate solution (60 
mL, 0.01 M), aqueous sodium phosphate solution (60 mL, 0.006 M), 24 h, 180 °C (1x HANPs); 
aqueous sodium citrate solution (40 mL, 0.034 M), aqueous calcium nitrate solution (60 mL, 0.05 
M), aqueous sodium phosphate solution (60 mL, 0.03 M), 24 h, 180 °C (5x HANPs); aqueous 
sodium citrate solution (40 mL, 0.067 M), aqueous calcium nitrate solution (60 mL, 0.1 M), 
aqueous sodium phosphate solution (60 mL, 0.06 M), 24 h, 180 °C (10x HANPs); aqueous sodium 
citrate solution (40 mL, 0.17 M), aqueous calcium nitrate solution (60 mL, 0.25 M), aqueous 
sodium phosphate solution (60 mL, 0.15 M), 24 h, 180 °C (25x HANPs); aqueous sodium citrate 
solution (40 mL, 0.34 M), aqueous calcium nitrate solution (60 mL, 0.5 M), aqueous sodium 
phosphate solution (60 mL, 0.3 M), 24 h, 180 °C (50x HANPs). Typical conditions for the 
experiments carried out at different temperatures were as follows: aqueous sodium citrate solution 
(40 mL, 0.067 M), aqueous calcium nitrate solution (60 mL, 0.1 M), aqueous sodium phosphate 
solution (60 mL, 0.06 M), 24 h, and the different temperatures ranged from no hydrothermal 
treatment (the reaction mixture was not transferred to the autoclave reactor and was worked up 
immediately), 120 °C, 150 °C, 180 °C, to 210 °C. Typical conditions for the experiments carried 
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out for different reaction times were as follows: aqueous sodium citrate solution (40 mL, 0.067 M), 
aqueous calcium nitrate solution (60 mL, 0.1 M), aqueous sodium phosphate solution (60 mL, 
0.06 M), 180 °C, and the different reaction times ranged from 0 h (no hydrothermal treatment), 3 
h, 6 h, 12 h, 24 h, to 48 h. 
5.3.4 General Hydrothermal Synthesis of HANPs (without Sodium Citrate) 
An aqueous sodium phosphate solution was added to an aqueous calcium nitrate solution 
over the course of 15 min, while stirring continuously. The resulting reaction mixture was 
transferred to a 200 mL Teflon-lined stainless steel autoclave reactor, which was placed in a pre-
heated oven. After a specified time, the reactor was allowed to cool to room temperature and the 
nanoparticles were collected via centrifugation (14 600 rpm, 15 min). The nanoparticles were then 
washed by re-dispersion in nanopure water and collected by centrifugation (3 cycles), followed 
by re-dispersion in ethanol and collected by centrifugation (3 cycles). Lastly, the nanoparticles 
were freeze-dried for 2 d. Typical conditions for the experiments carried out using different 
concentrations were as follows: aqueous calcium nitrate solution (60 mL, 0.01 M), aqueous 
sodium phosphate solution (60 mL, 0.006 M), 24 h, 180 °C (1x HANPs); aqueous calcium nitrate 
solution (60 mL, 0.05 M), aqueous sodium phosphate solution (60 mL, 0.03 M), 24 h, 180 °C (5x 
HANPs); aqueous calcium nitrate solution (60 mL, 0.1 M), aqueous sodium phosphate solution 
(60 mL, 0.06 M), 24 h, 180 °C (10x HANPs); aqueous calcium nitrate solution (60 mL, 0.25 M), 
aqueous sodium phosphate solution (60 mL, 0.15 M), 24 h, 180 °C (25x HANPs); aqueous 
calcium nitrate solution (60 mL, 0.5 M), aqueous sodium phosphate solution (60 mL, 0.3 M), 24 
h, 180 °C (50x HANPs). 
5.3.5 Stability of HANPs 
HANPs (50 mg) were dispersed in 10 mL of one of each of the following solutions: HCl (1 
M), NaOH (1 M), nanopure water, and CHCl3 / DMSO (9:1). After 24 h, the supernatant was 
removed and the particles were washed by re-dispersion in water (3 cycles), followed by ethanol 
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(1 cycle) and collected by centrifugation (14 600 rpm, 15 min). The nanoparticle samples were 
then freeze-dried for 1 d. 
5.3.6 Surface Modification of HANPs with Poly(Dopamine) 
HANPs (100 mg) were dispersed in Trizma buffer (50 mL, 0.01 M, pH = 8.5). Dopamine 
hydrochloride (2 mg / mL) was then added and the reaction was allowed to stir at room 
temperature for 24 h. The nanoparticles were collected by centrifugation (4 300 rpm, 15 min) and 
further washed by re-dispersion in water (3 cycles) as well as methanol (3 cycles) and again 
collected by centrifugation. The nanoparticles were then freeze-dried for 1 d. 
5.3.7 Surface Modification with PLA (Using DMAP or Tin Catalyst) 
The procedure was adapted from the literature.41 LLA (1.44 g, 10 mmol) was dissolved in 
anhydrous toluene (25 mL) prior to the addition of HANPs (0.250 g). The mixture was refluxed 
using a Dean-Stark apparatus for 4 h. DMAP (0.975 g, 8 mmol) or tin(II) 2-ethylhexanoate (8 mg, 
0.02 mmol) was then added and the reaction was refluxed using a Dean-Stark apparatus for an 
additional 16 h. After cooling, the nanoparticles were collected by centrifugation (4 300 rpm, 15 
min) and further purified by re-dispersion in chloroform and again collected by centrifugation (3 
cycles). Lastly, the nanoparticles were freeze-dried for 2 d.  
5.3.8 Further Purification of PLA Surface Modified HANPs 
HANPs (100 mg) were re-dispersed 30 mL of chloroform and stirred for 2 d (the chloroform 
was replaced after 24 h). The particles were collected by centrifugation (4 300 rpm, 15 min) and 
washed once more by re-dispersion in chloroform and collected again by centrifugation. Lastly, 
the nanoparticles were freeze-dried for 1 d. 
5.4 Results and Discussion 
5.4.1 Synthesis of Well-Defined HANPs 
Owing to its potential applications in the field of bone repair and bone tissue engineering, 
the synthesis of nanoscale HA has been of considerable interest. Various synthesis techniques, 
ranging from precipitation, sol-gel, emulsion, solid state, electrospraying, microwave irradiation to 
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hydrothermal methods have been explored.9,40,42-53 Among these approaches, precipitation, sol-
gel, and hydrothermal synthesis techniques have been the most commonly employed. In order to 
prepare HA suitable as a bone graft substitute, the stoichiometry, size, and morphology of the 
particles must be considered. Native bone typically contains small HA nanocrystals that are 40 - 
60 nm long, 20 nm wide, and have a stoichiometric ratio of Ca/P = 1.50 - 1.67.54 Precipitation 
methods offer control over the stoichiometry of the nanoparticles by adjusting the calcium and 
phosphate reagent concentrations, but the resulting HANPs often exhibit varying phase purity and 
size distribution, non-uniform morphologies, and low crystallinity.9 In order to better regulate 
nucleation and crystal growth, additives such as cetyl ammonium bromide need to be employed, 
which can be difficult to remove.55 Sol gel techniques have also been of interest as they generally 
result in homogenous molecular mixing and generate particles with more narrow size 
distributions. However, the phase purity, crystallinity, and morphologies still vary.9 Another 
approach utilizes hydrothermal methods, which have proven advantageous due to their ability to 
produce HANPs with high phase purity and crystallinity.9 Furthermore, the size and morphology 
of the HANPs can be tailored by using additives such as surfactants and small molecules. The 
use of sodium citrate has been particularly popular, as it is biocompatible and forms calcium citrate 
complexes, thus allowing for a way to slow down nucleation and crystal growth by reducing the 
binding rate between calcium and phosphate ions.40,45,49 
For example, Jin et al. employed a hydrothermal method using sodium citrate as an 
additive and demonstrated the synthesis of HA nanorods (HANRs) of different sizes. The authors 
investigated the effect of the molar ratio of citrate to calcium and found that the aspect ratio of the 
HANRs as well as the colloidal stability increased as the ratio was increased.49 Jin et al. also 
examined the effect of temperature and found that increase in hydrothermal temperature resulted 
in larger particle sizes and higher crystallinity.40 However, the HANRs synthesized in these studies 
did not fall in the size range mimicking biological HA and the experiments yielded only small 
amounts of HANRs (tenths of milligrams). Based on theses results, we sought to expand on 
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existing work and reproducibly synthesize well-defined HANPs with the appropriate stoichiometry, 
good phase purity and crystallinity, and particle sizes in a biologically useful size range. 
 
 
Figure 5.1 Hydrothermal synthesis of HANPs using calcium nitrate, sodium phosphate, and 
trisodium citrate. 
 
5.4.2 Effect of Reagent Concentration, Temperature, and Time on the Synthesis of HANPs 
First, the amounts used by Jin et al.40 were scaled up four times to accommodate for our 
200 mL autoclave reactor (as opposed to the authors’ 50 mL reactor). Calcium nitrate and sodium 
phosphate at a ratio of 1.67 were used as the calcium and phosphate precursors for the HANPs. 
Trisodium citrate was added as a small molecule additive to slow down nucleation and provide 
control over crystal growth. An overall synthesis route listing the reagents and showing the 
autoclave reactor as well as the final HANP product can be seen in Figure 5.1. This initial 
experiment (referred to as concentration 1x) produced well-defined HANRs (TEM Figure 5.2 A) 
with an average length of 168 nm and an average width of 31 nm (Figure 5.3 A). These results 
were similar to the particles obtained by Jin et al., although the authors mainly utilized DLS 
(Dynamic Light Scattering) as a means to determine the size of the HANRs (182 nm) and only 






Figure 5.2 TEM micrographs of HANRs synthesized using increasing overall concentrations of 
calcium nitrate, sodium phosphate, and sodium citrate: A) 1x, B) 5x, C) 10x, D) 25x, and E) 50x. 
 
DLS is a powerful technique to ascertain nanoparticle sizes, yet only spherical shapes can 
be clearly described by a single value hydrodynamic diameter. For non-spherical particles, DLS 
can only provide the diameter of a sphere with the same translational diffusion coefficient as the 
particle in question. Surfactants, stabilizers, or additives such as sodium citrate present on the 
surface of the particles can also further skew the hydrodynamic size calculated, as surface 
structure affects the diffusion speed of the particles, and thus changes the apparent size. While 
DLS results can still highlight a trend or change in nanoparticle size, we focused on using TEM 
as a means to determine the morphology and size parameters of the HANRs in our study. 
The amounts produced by the 1x concentration synthetic procedure still yielded only about 
50 mg of HANRs, so a series of experiments were conducted in which the overall concentrations 
of all of the reactants (referred to as concentrations 5x, 10x, 25x, and 50x) was increased. The 
yields increased as the concentrations were increased and approximately 0.25 g, 0.50 g, 1.5 g, 




Figure 5.3 Changes in HANR length and width as a function of A) concentration (using citrate), 
B) concentration (not using citrate), C) temperature, and D) time. 
 
In terms of particle morphology and size, Figure 5.2 shows that well-defined HANRs were 
synthesized in all cases and Figure 5.3 A shows that the particle size decreases for the 1x, 5x, 
and 10x concentrations (average lengths: 168 nm, 106 nm, 79 nm; average widths: 31 nm, 29 
nm, 26 nm, respectively), but then levels off and remains essentially the same for the 25x and 
50x concentrations (average lengths: 76 nm, 79 nm; average widths: 23 nm, 23 nm, respectively). 
This trend can be explained by examining the nucleation and growth processes involved. In 
general, nucleation only occurs if the concentration of solute reaches a minimum concentration 
above equilibrium solubility, where supersaturation is achieved. A higher initial concentration can 
be translated into the formation of a larger number of smaller nuclei.56-58 This would account for 
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the decrease in particle size as the reagent concentrations increases. The plateau in particle size 
can be attributed to a maximum nucleation concentration, at which an upper limit in terms of 
number of nuclei formed is reached. 
 
 
Figure 5.4 TEM micrographs of HANRs synthesized using increasing overall concentrations of 
calcium nitrate and sodium phosphate: A) 1x, B) 5x, C) 10x, D) 25x, and E) 50x. 
 
The same series of experiments was also conducted without the addition of sodium citrate. 
The TEM micrographs again show well-defined HANRs (Figure 5.4), but the average lengths (71 
nm, 73 nm, 73 nm, 72 nm, 71 nm) and widths (24 nm, 23 nm, 24 nm, 24 nm, 24 nm) of the 
nanoparticles remained the same for all concentrations (Figure 5.3 B). This can be attributed to 
the difference in growth processes. For the experiments using sodium citrate, citrate forms 
complexes with calcium which are weakened during the hydrothermal treatment, and calcium is 
slowly released to bind with phosphate and hydroxide ions. In addition, citrate tends to adsorb on 
crystal facets perpendicular to the anisotropic growth direction, thus favoring the nanoparticles to 
grow longer and not wider, which also explains why the HANRs prepared with citrate do not 
change as much in width as they do in length.45,59,60 Without citrate present, the nanoparticles are 




Figure 5.5 TEM micrographs of HANRs synthesized using different temperatures: A) no 
hydrothermal treatment, B) 120 °C, C) 150 °C, D) 180 °C, and E) 210 °C. 
 
Next, we investigated the effect of temperature and time on particle growth. All 
experiments were conducted using sodium citrate as an additive and an overall concentration of 
10x was used, as it had previously reliably provided well-defined nanorods and higher 
concentrations of 25x and 50x had had no effect on the particle size other than yield. Figure 5.5 
shows the changes in particle size, indicating that without hydrothermal treatment or temperatures 
below 150 °C, no well-defined shapes or sizes could be achieved. At temperatures of 150 °C and 
above, clear nanorod morphologies were again synthesized. Figure 5.5 shows that the increase 
in temperature results in larger particles. This is because the concentration required for 
supersaturation and, thus nucleation, is decreased at higher temperatures, as solute solubilities 
change with temperature. Furthermore, the dissociation constants of the calcium citrate 
complexes decreases with increasing temperature, thus releasing calcium more readily than at 
lower temperatures.59,61 The change in particle length and width is quantified in Figure 5.3 C. No 
sizes were determined for the particles that were synthesized using either no hydrothermal 
treatment or 120 °C, because no clear shapes and boundaries between particles could be 
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discerned. For the HANRs prepared at 150 °C or above, the lengths increased from 61 nm, to 79 
nm and 94 nm, whereas the widths increased from 16 nm, to 23 nm and 25 nm, as the 
temperatures were changed from 150 °C, 180 °C, to 210 °C, respectively. No experiments above 
210 °C were conducted, because it represented the maximum operational temperature for the 
Teflon insert of the autoclave. Furthermore, particles sizes were moving away from biologically 
relevant HA nanocrystal sizes. 
 
 
Figure 5.6 TEM micrographs of HANRs synthesized using different reaction times: A) 0 h, B) 3 h, 
C) 6 h, D) 12 h, E) 24 h, and F) 48 h. 
 
Figures 5.6 and 5.3 D show the change in particle size with a change in reaction times of 
0 to 48 hours. As expected, the HANRs increase in length from 28 nm to 52 nm, 70 nm, 79 nm, 
and 96 nm over time as the nanoparticles continue to grow. The average width of the HANRs also 
changed from 10 nm to 13 nm, 17 nm 23 nm, and 25 nm, but again did not increase as much as 
the length scale due citrate adsorption on the surface, resulting in the HANRs to preferentially 
grow anisotropically. 
Lastly, the stability of the HANRs in a few different solvents was investigated. In each 
case, 50 mg of HANRs were placed in either nanopure water, 1 M NaOH, 1 M HCl, or 9:1 
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CHCl3/DMSO (as this was the solvent mixture used in the electrospinning experiments in Chapter 
4) for 24 hours. The TEM micrographs in Figure 5.7 indicate that the nanorods are stable in water, 
base, and the organic solvent mixture, but dissolve in acidic media. This is in agreement with the 
literature and also the reason why tooth decay occurs when enamel is demineralized or dissolved 
due to a decreased pH in the mouth.62 
 
 
Figure 5.7 HANR stability in A) water, B) 9:1 CHCl3/DMSO, C) 1 M NaOH, and D) 1 M HCl. 
 
The HANRs prepared with or without sodium citrate were also characterized via FTIR 
spectroscopy and XRD. FTIR spectroscopy has been widely utilized to confirm the successful 
synthesis of HA.9,63,64 A representative FTIR spectrum of the HANRs synthesized with sodium 





Figure 5.8 FTIR spectra of HANRs prepared A) with sodium citrate and B) without sodium citrate. 
 
The bands at 3574 cm-1 and 630 cm-1 are associated with the stretching and librational 
mode of the hydroxyl group. Absorption bands at 1090 cm-1, 1023 cm-1, 962 cm-1, 601 cm-1, and 
561 correlate with vibrations of the phosphate group. The first three peaks emanate from the 
stretching mode vibrations, whereas the last two stem from the bending mode of the phosphate 
group. More bands at 1573 cm-1, 1454 cm-1, 1404 cm-1, and 875 cm-1 could possibly arise from 
carbonate substitution. These peaks are associated with stretching and bending modes of the 
carbonate group and could indicate that the HANRs underwent A and B type substitution, in which 
carbonate substitutes for hydroxide or phosphate.63,64 This substitution is not uncommon and can 
arise from dissolved CO2 in solution. In addition, however, these bands are associated with the 
carboxylate stretch of sodium citrate adsorbed to the surface of the HANRs, making it unclear 
whether or not carbonate substitution had occurred. HA in the body is calcium deficient and 
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exhibits carbonate substitution, thus making carbonate-substituted HANRs biologically relevant 
and interesting.65 Furthermore, some recent studies suggest that carbonate substitution may lead 
to enhanced osteoconduction.66,67 
The HANRs synthesized in the absence of sodium citrate exhibit the same bands 
corresponding to the hydroxyl and phosphate vibrational modes, but show no evidence of 
carbonate substitution or citrate adsorption since no sodium citrate was used as an additive. The 
band at 875 cm-1 is still present and aside from being associated with the bending mode of the 
carbonate group, it can also be attributed to the presence of hydrogen phosphate. Additional 
evidence is challenging to find as other bands associated with hydrogen phosphate are difficult 
to discern from the stretching mode of the phosphate group of HA. 
 
 




In addition to the FTIR results, representative XRD profiles of both the HANRs synthesized 
with and without sodium citrate (Figure 5.9) show the characteristic diffraction peaks of the 
hexagonal HA unit cell. No other CaP phases such as tricalcium phosphate were observed.9,63 
Lastly, we also measured the zeta potential of the HANRs in nanopure water. The representative 
values were determined to be – 26 mV for the HANRs synthesized with sodium citrate and – 5 
mV for the HANRs prepared without sodium citrate. The difference in the zeta potential value is 
representative of the synthesis conditions used. When sodium citrate is used as an additive, 
citrate stabilized HANRs are produced (HANRs with physisorbed citrate ions on the surface), 
which results in an overall more negative surface charge density. 
5.4.3 Surface Modification of HANPs 
Following the synthesis of well-defined HANRs with different sizes and good phase purity, 
attempts to modify the nanoparticles with PLA were investigated. Using a grafting-from approach, 
tin(II) 2-ethylhexanoate-catalyzed ROP of lactide, as reported in the literature examples by Hong 
et al,33,34 was used. The HANRs were freeze-dried and subjected to azeotropic distillation before 
polymerization to ensure the removal of any residual water, which can act as a nucleophile, thus 
initiating the polymerization and forming free PLA in solution. The resulting polymer-inorganic 
hybrid particles were characterized by TEM but did not show any visible polymer on the surface 
(Figure 5.10 A). Next, the same grafting-from approach but employing the organocatalyst DMAP, 
as reported by Mrowczynski et al.,41 was used instead of the traditional tin catalyst. Figure 5.10 B 
shows that there is evidence of PLA synthesized in solution, but again no surface coating of the 
HANRs was observed. In order to rule out carbonate substitution having an effect on the surface 
modification, we also conducted the same set of experiments with HANRs that hadn’t been 
synthesized using sodium citrate. However, despite more evidence of PLA produced in solution, 




Figure 5.10 Surface modification of HANRs (prepared using sodium citrate) with PLA using A) tin 
octoate or B) DMAP. Surface modification of HANRs (prepared without sodium citrate) with PLA 
using C) tin octoate or D) DMAP. 
 
The samples were also further characterized using NMR and FTIR spectroscopy. 1H NMR 
spectra (Figures C1-4, Appendix C) collected of the individual polymerization mixtures show that 
in each case small amounts of polymer had been formed, as indicated by the appearance of new 
peaks in the range of 5.15 – 5.25 ppm that are associated with the methine protons of PLA. FTIR 
analysis also illustrated the presence of an ester in the HANR samples, as evidenced by a 
carbonyl stretch in the range of 1735 – 1750 cm-1. The band is, however, very small and even 
more diminished after the particle samples were stirred in chloroform for two days, thus 
demonstrating that the ester present could be removed by extensive washing of the samples 
(Figures C5-8, Appendix C). This leads to the conclusion that overall the surface modification of 
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HANRs with PLA was not successful. Evidence from TEM, NMR and FTIR spectroscopy suggests 
that small amounts of polymer were formed in solution, but that the ester present (polymer or 
monomer) could be removed from the sample via simple washing and was thus not covalently 
attached to the nanoparticles.  
As previously mentioned, Hong et al.33,34 reported that the ROP of lactide could be initiated 
by hydroxyl groups available on the surface of the nanoparticles. However, recent research has 
demonstrated that within the hexagonal structure of HA, the hydroxyl ions are located in the 
columns parallel to the c-axis of the hexagonal unit cell and are surrounded by columnar calcium 
ions and not on the surface.9 Thus, hat these hydroxyl ions are not surface accessible and unable 
to initiate the polymerization on the exterior of the HANRs. It is possible that the Hong et al. were 
referring to P-OH groups on the surface rather than Ca-OH groups. These groups are, however, 
only formed via protonation of the surface phosphate groups and are associated with the 
formation of a new band in the FTIR spectrum (3660 - 3680 cm-1).32 Neither the FTIR spectra 
recorded in our studies nor the spectra reported by Hong et al. show a peak in that range. Hong 
et al. also reported TGA and 31P NMR characterization. However, while a mass loss indicates the 
presence of PLA in the sample, it does not provide proof of covalent attachment. In addition, the 
solid state NMR results reported were vague and state that a small change in a “distinctive 
resonance peak” indicated that the chemical surrounding of the phosphorus atom had been 
altered, but no detailed explanation was presented.  With this in mind, it appears the results by 
Hong et al. may have been misinterpreted and it seems unlikely that the ROP of lactide can simply 
be initiated from the surface of HANPs. 
Another approach to modify the HANRs involves the use of poly(dopamine) (PDA). PDA 
has recently received considerable interest as a surface modification agent for drug delivery and 
other biomedical applications as well as battery, catalysis, and water treatment related 
applications.68-70 PDA can be easily synthesized via the oxidative polymerization of dopamine and 
has previously been used by Mrowczynski et al.41 to modify magnetic nanoparticles in order to 
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provide an anchor for the ROP of lactide from the surface. As such, this approach was attempted 
to prepare PDA-coated HANRs, which can be seen in Figure 5.11. TEM micrographs show that 
surface modification was achieved on the small scale (100 mg) (Figure 5.11 A), but attempts to 
scale up the synthesis to 500 mg produced variable results, in which only part of the sample was 
coated (Figure 5.11 B). 
 
 
Figure 5.11 PDA-coated HANRs: A) small-scale experiment and B) scaled-up experiment. 
 
Despite the uneven coating and considering recent literature reporting a better 
understanding of PDA structure and surface chemistry as well as improved ways to control the 
surface modification of nanoparticles with PDA, this approach may still offer a way to 




We herein report the successful synthesis of well-defined HANRs of varying sizes, ranging 
from 28 nm to 168 nm, using hydrothermal methods. FTIR analysis showed that the HA produced 
may be carbonate-substituted, which may prove beneficial as it mimics biological HA and could 
potentially exhibit improved osteoconduction. The HANRs synthesized also exhibited good phase 
purity and stability. The modification of HANRs using a grafting-from approach, involving the ROP 
of lactide from the surface of the nanoparticles, was also investigated in detail. While 1H NMR 
spectroscopy and TEM micrographs showed that PLA was produced in solution, no evidence of 
covalent surface attachment was found. Furthermore, an ester stretch was observed via FTIR 
analysis, but extended washing of the nanoparticles diminished the peak, indicating that the PLA 
present in the sample could be removed via washing, thus further negating a covalent surface 
attachment. Alternatively, the surface modification of HANPs with PDA was investigated and 
found to potentially provide a means for grafting PLA from the surface of HANPs in the future. 
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CONCLUSIONS AND FUTURE WORK 
 
6.1 Conclusions 
Due to the drawbacks associated with autografts and allografts, the search for suitable 
bone graft alternatives has been an active area of research in the field of tissue engineering, 
regenerative medicine and biomaterials science. One of the most promising substitutes involves 
the use of organic-inorganic hybrid materials, such as bionanocomposites prepared from 
polymers like poly(lactide) PLA and calcium phosphate ceramics like hydroxyapatite (HA). 
Despite new insights into the mechanism of the ring opening polymerization (ROP) of lactide using 
organocatalysts, such as 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU), most recent publications on 
the synthesis of PLA-based homopolymers and block copolymers lack detailed kinetics and 
information on the effects of monomer concentrations, reaction time, and initiator-to-catalyst 
ratios. The synthesis of biomimetic nanosized HA also still presents a challenge, because only 
few synthesis methods available result in the preparation of HA with the right stoichiometry, 
controllable size and morphology, as well as phase purity. In addition, the preparation of scaffolds 
for bone tissue engineering applications using techniques like electrospinning (ES) have proven 
to be powerful, yet many studies involving electrospun fiber scaffolds do not include details on 
why certain processing parameters were chosen and no universal protocol to fabricate defect-
free fibers exists. Lastly, the biodegradation behavior of fiber scaffolds is affected by a myriad of 
factors, and new or improved testing standards and evaluation methods would be beneficial. With 
this in mind, the work presented in this dissertation focused on the synthesis of well-controlled 
PLA-based homopolymers and amphiphilic block copolymers, as well as the preparation of well-
defined biomimetic hydroxyapatite nanoparticles (HANPs). Furthermore, relatively simple 
conditions to produce electrospun fiber scaffolds from PLA homopolymers and block copolymers 
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were presented along with details regarding the degradation behavior of said scaffolds under 
physiological and accelerated conditions. 
Firstly, a new heterofunctional initiator/chain transfer agent (inifer), containing a hydroxyl 
group and a thiocarbonylthio moiety, was synthesized and shown to successfully initiate the ROP 
of L-lactide as well as mediate the reversible addition-fragmentation chain transfer (RAFT) 
polymerization of poly(ethylene glycol) ethyl ether methacrylate (PEGEEMA). The inifer 
performed well compared to a generic small molecule initiator and detailed kinetics experiments 
demonstrated that the ROP followed first order kinetics for the majority of the polymerization and 
that transesterification side reactions only occurred at conversions above 90 percent when using 
concentrated reaction conditions. The use of dilute conditions resulted in less transesterification, 
yet the overall results varied more due to the use of an extended workup procedure, which may 
have caused more divergence in terms of when the polymerization reactions were quenched. In 
addition, using different ratios of inifer-to-catalyst highlighted that this molar ratio can be 
successfully used to steer the ROP towards the activated-alcohol pathway (by using excess inifer) 
or the nucleophilic-attack pathway (by using excess catalyst). This is important, because only the 
activated-alcohol pathway produces linear PLA chains that can further participate in the RAFT 
polymerization of PEGEEMA. Furthermore, the molar ratio of monomer-to-inifer could be used to 
synthesize PLA homopolymers of different molecular weights. Lastly, amphiphilic block 
copolymers were successfully prepared using the previously synthesized PLA homopolymers, 
which contained a thiocarbonylthio end group, as macro-chain transfer agents. Kinetic studies 
showed that the higher molecular weight PLA homopolymers were able to better mediate the 
RAFT polymerization, due to steric considerations affecting the addition-fragmentation equilibria 
involved in the RAFT process. Overall, these results are significant, because they provide an 
improved understanding of the synthesis of well-defined PLA-based homopolymers and 
amphiphilic block copolymers. 
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Secondly, several PLA homopolymers as well as PPEGEEMA or poly(ethylene glycol) 
(PEG)-containing amphiphilic block copolymers were synthesized and successfully converted into 
uniform fiber scaffolds using ES techniques. The effect of the different solution and processing 
parameters governing fiber formation and morphology were discussed, and simple conditions 
suitable for both homopolymer and block copolymer samples were presented. Contact angle 
measurements of the resulting fiber scaffolds also confirmed that the block copolymer samples 
exhibited improved hydrophilicity compared to the hydrophobic PLA homopolymers. In addition, 
degradation studies carried out under physiological conditions or acidic conditions showed little 
to no breakdown for any of the fiber scaffolds over the course of two weeks. However, 
experiments carried out under basic conditions resulted in pronounced degradation, which can 
be attributed to the differences in the rate constant associated with uncatalyzed, acid-catalyzed, 
and base-catalyzed ester hydrolysis. Next, a preliminary cell study showed very promising results 
for the PLA and PPEGEEMA-containing block copolymer scaffolds, which was made manifest in 
successful cell attachment and cell migration into the scaffold. These results are of great interest 
as PEG-based scaffolds are believed to predominantly exhibit anti-fouling behavior, but our 
results suggest that with alternative architectures (such as PPEGEEMA-containing polymers) and 
tunable hydrophilic behavior, enhanced interaction with cells can be achieved. 
Finally, well-defined HANPs were successfully prepared using a hydrothermal synthesis 
approach. Particle sizes ranging from 168 nm to 28 nm were achieved, showing that parameters 
such as reagent concentration, temperature, and reaction time can be used to tune the size to 
yield biomimetic HA. The surface modification of HANPs using a grafting-from approach 
previously reported in the literature was not found successful, due to a lack of suitable surface 
chemistry to promote the ROP of lactide from the surface of the HANPs. However, preliminary 
work using poly(dopamine) as a surface coating for HANPs may present surface functionalities 
that can subsequently initiate the ROP of lactide. These results are valuable as they demonstrate 
the ability to produce HANPs with tunable sizes that are promising as substitutes for biological 
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HA. In addition, the investigation of the surface modification presented in this work is the first to 
raise questions about the feasibility of altering the surface of HANPs via surface grafting. 
6.2 Future Work 
Despite the promising work that has already been done in the development of bone graft 
substitutes based on nanocomposites or hybrid materials, there is much research to be conducted 
before suitable scaffolds and constructs will reach clinical application. This work has 
demonstrated that a combination of ROP and RAFT polymerization could be used to synthesize 
well-defined block copolymers. These amphiphilic block copolymers have exhibited an overall 
improved hydrophilicity and enhanced ability for cell attachment compared to recent literature, yet 
the optimal ratio of the hydrophobic-to-hydrophilic block has not yet been determined. Since 
PPEGEEMA-based materials have been shown to have anti-fouling properties, additional work 
needs to be done to determine the preferred degree of hydrophilicity for cell attachment. 
Fortunately, both ROP and RAFT polymerization are deemed to be controlled polymerization 
techniques, that are defined by a linear increase of molecular weight with conversion and, thus a 
predeterminable degree of polymerization. This allows for the properties of the amphiphilic block 
copolymer to be tailored by varying the degree of polymerization of each individual block. 
Furthermore, the RAFT polymerization process can be applied to a wide range of vinyl monomers, 
which allows for further functionalization of the existing amphiphilic PLA-b-PPEGEEMA block 
copolymer. For example, the following block copolymer could be synthesized (Figure 6.1). The 
biodegradable yet hydrophobic PLA block would again be prepared via the ROP of lactide and a 
second bioblock could be synthesized via the RAFT copolymerization of PEGEEMA and N-
(methacryloxy)succinimide (mNAOS). This would impart enhanced hydrophilicity, but also allow 
for further biofunctionalization (attachment of bioactive agents, such as proteins containing the 





Figure 6.1 Structure of a PLA-b-PPEGEEMA-co-PmNAOS block copolymer. 
 
Despite the promising results obtained in a preliminary cell study, the amphiphilic block 
copolymer scaffolds prepared in this dissertation still need to be further evaluated using 
mesenchymal stem cells. In addition, the scaffolds exhibited no significant degradation under 
physiological conditions over the course of two weeks. Since PLA is known to degrade slowly, a 
longer study would be needed to fully investigate the degradation behavior of the PLA-based 
homopolymers and amphiphilic block copolymers. Most bone fractures are known to heal over 
the course of six to twelve weeks, therefore a successful scaffold would have to be designed to 
degrade in that timeframe. Because of the long degradation times associated with PLA-based 
polymers, the properties of the amphiphilic block copolymer could be further tuned and improved 
by copolymerizing lactide with glycolide to produce a biodegradable PLGA block, which is 
expected to speed up the degradation due to the more readily hydrolyzed ester linkages in 
poly(glycolide). Lastly, there is still a need to design and implement updated or new testing 
standards and evaluation protocols for biomaterials scaffolds. Especially protocols regarding the 
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degradation of more complex constructs, such as amphiphilic block copolymer or nanocomposite 
materials, would be beneficial, so that researchers can readily compare new results to existing 
literature data and draw more meaningful conclusions. The need for improved and more universal 
standards and protocols can also be extended to studies involving cell testing and mechanical 
testing. 
Finally, the surface modification of HA still needs to be addressed. With results presented 
in this work, highlighting that the ROP of lactide directly from the surface of HANPs may not be 
attainable, an alternative way to functionalize HANPs needs to be investigated. As previously 
mentioned, poly(dopamine) could offer a means to grow PLA off of the surface of HANPs. Recent 
literature examples, demonstrating improved control over the uniformity and thickness of 
poly(dopamine) on silver and gold nanoparticles, could provide insights into producing more well-
defined poly(dopamine) coatings on HANPs. However, surface modifications using 
poly(dopamine) do not present a covalent attachment to the HANPs and could thus be removed 
via extensive washing or purification methods involving sonication. Alternatively, the hydrophilic-
hydrophobic properties of amphiphilic block copolymers could be used to improve the interfacial 
adhesion between the polymer and the nanoparticles. Due to the hydrophilic nature of 
PPEGEEMA as well as HA, the ability of HANPs to mix and bind with the polymer matrix could 
be enhanced, thus resulting in scaffolds with improved mechanical properties as well as in vitro 
behavior. 
Future work could also involve the use of PPEGEEMA and other hydrophilic polymers 
based on oligo(ethylene glycol methacrylate) (OEGMA) for stimuli-responsive applications. By 
varying the number of PEG repeat units present in the side chain, the thermoresponsive behavior 
of the polymer could be tuned. These polymer materials could find applications in 
thermoresponsive hydrogel-type scaffolds or wound dressings and drug-eluting scaffolds. 
Furthermore, emerging fabrication techniques, such as 3D printing, have been of considerable 
interest due to their ability to fabricate structures with hierarchically complex architectures. As the 
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field of tissue engineering is trying to address increasingly complex medical needs, the formation 
of scaffolds and medical devices with unique and even patient-specific geometric forms, sizes, 
and shapes would have a tremendous impact. However, the lack of printable biomaterials that 
also exhibit sufficient chemical and mechanical properties for constructing regenerative scaffolds 
has been a barrier. Thus, there is also a need for the development of new polymeric biomaterial 
inks and composite inks that can be employed using 3D printing methods. 
In summary, the field of tissue engineering, regnerative medicine and biomaterials science 
represents an exciting, yet complex research paradigm that is an ongoing endeavor to develop 
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Figure A.2 Slope of the linear portion of the semilogarithmic plots of the ROP of LLA (1.7 M) using 
DATCOH or NPA in the presence of DBU. 
− 𝑑[𝐿𝐿𝐴]𝑑𝑡 = 𝑘𝑝 [𝐿𝐿𝐴] [𝐼] [𝐷𝐵𝑈] = 𝑘𝑎𝑝𝑝 [𝐿𝐿𝐴] 𝑙𝑛 ( 11 − 𝑝) =  𝑘𝑎𝑝𝑝 ∗ 𝑡 
𝑝 = [𝐿𝐿𝐴]0  − [𝐿𝐿𝐴][𝐿𝐿𝐴]0  𝑘𝑎𝑝𝑝 = 𝑘𝑝 [𝐷𝐵𝑈]0[𝐼]0 
kapp (apparent rate constant) equals the slope and was determined to be 0.009185 s-1 for 
DATCOH and 0.008143 s-1 for NPA. 
[I] equals the initial concentration of inifer or initiator (which represents the concentration of the 
propagating species) and was 0.01652 M for DATCOH as well as NPA. 
[DBU] equals the initial concentration of catalyst and was also 0.01652 M. 
kp (propagation rate constant) was thus determined to be 33.66 s-1M-1 for DATCOH and 29.84 s-




Figure A.3 Representative 1H NMR spectrum of a PLLA homopolymer synthesized via the ROP 
of LLA using NPA and DBU. 
 
 
Figure A.4 Representative 1H NMR spectrum of a PLLA homopolymer synthesized via the ROP 




Table A.1 Experimental results for the ROP of LLA (0.7 M) using DATCOH or NPA and DBU. 














DATCOH        
R1 5 36 5 600 5 740 5 270 5 660 1.07 
R2 10 62 9 350 9 350 7 670 8 350 1.09 
R3 15 71 10 640 10 640 8 710 9 480 1.09 
R4 30 83 12 370 13 090 9 720 10 650 1.10 
R5 60 84 12 520 13 090 10 260 11 290 1.10 
NPA        
R1 5 52 7 580 8 020 5 310 5 950 1.12 
R2 10 71 10 320 11 330 7 610 8 290 1.10 
R3 15 80 11 620 12 630 8 600 9 400 1.09 
R4 30 88 12 770 13 640 8 190 9 690 1.20 
R5 60 89 12 920 14 360 9 700 10 680 1.10 
 
a Polymerization conditions: [LLA]0 : [ROH]0 : [DBU]0 = 100:1:1, [LLA]0 = 0.7 M, RT, CHCl3. 
b Conversion was calculated using gravimetric methods. 
c Theoretical molecular weight was calculated based on the determined conversion, using the 
following equation: Mn (theoret.) = [LLA]0 / [ROH]0 x Conversion x MLLA + MROH, where MLLA and 
MROH are the molecular weights of LLA monomer and alcohol inifer or initiator, and [LLA]0 and 
[ROH]0 are the initial concentrations of LLA and inifer or initiator. 
d Calculated by end group analysis using 1H NMR. 






Figure A.5 Semilogarithmic plots (left) for the ROP of LLA (0.7 M) using A) DATCOH or B) NPA 
in the presence of DBU, as well as the evolution of number average molecular weight (Mn) and 




Figure A.6 Slope of the linear portion of the semilogarithmic plots of the ROP of LLA (0.7 M) using 
A) DATCOH or B) NPA in the presence of DBU. 
 
kapp (apparent rate constant) equals the slope and was determined to be 0.001312 s-1 for 
DATCOH and 0.001446 s-1 for NPA. 
[I] equals the initial concentration of inifer or initiator (which represents the concentration of the 
propagating species) and was 0.006802 M for DATCOH as well as NPA. 
[DBU] equals the initial concentration of catalyst and was also 0.006802 M. 





Figure A.7 GPC chromatograms for the kinetic study of the ROP of LLA (0.7 M) using A) DATCOH 
and B) NPA in the presence of DBU. 
 
 





SUPPLEMENTARY INFORMATION TO 
PREPARATION OF BIODEGRABLE FIBER SCAFFOLDS BASED ON AMPHIPHILIC BLOCK 
COPOLYMERS USING ELECTROSPINNING – PROPERTIES, DEGRADATION, AND IN 
VITRO BEHAVIOR 
 
Employing the additive method by Small1, the solubility parameter of PLLA was calculated 
using the following equation, 
 δ = ρM  ∑ F B.1 
where δ is the solubility parameter, ρ is the density, M is the molecular weight of the repeat unit, 
and F are the molar attraction constants. 
 






(cal cm3)1/2 / mol 
F >CH 
(cal cm3)1/2 / mol 
F -COO- 
(cal cm3)1/2 / mol 













χ PLLA - solvent 
Acetone 20.3 58.079 0.7845 0.35 
Chloroform 19.0 119.38 1.4788 0.36 
DMF 24.8 73.09 0.9445 1.20 




Using values in Table B.1, δ PLLA was calculated to be 9.63 cal1/2 cm-3/2 or 19.7 MPa1/2. 
Next, the values listed in Table B.2 were substituted into equation 4.1 to calculate χ for PLLA and 
acetone, chloroform, DMF, and DMSO, respectively and the results are also summarized in Table 
B.2. 
 













Figure B.1 PLLA scaffolds in A) PBS buffer, B) HCl, and C) NaOH over time (1 day, 3 days, 7 











Figure B.2 PLLA-b-PPEGEEMA scaffolds in A) PBS buffer, B) HCl, and C) NaOH over time (1 





Figure B.3 PEG-b-PLLA scaffolds in A) PBS buffer, B) HCl, and C) NaOH over time (1 day, 3 












Figure B.6 Water contact angle of PLLA-b-PPEGEEMA scaffolds in buffer and HCl over time. 
 
 
Figure B.7 Water contact angle of PLLA-b-PPEGEEMA in NaOH (no t = 14 d contact angle was 




Figure B.8 Water contact angle of all three polymer mats in HCl at elevated temperature (no t = 
14 d contact angle was obtained, because samples were not intact). 
 
 
Figure B.9 Water contact angle of PEG-b-PLLA in buffer, HCl, and NaOH (no t = 14 d contact 





Figure B.10 SEM micrographs of A) PLLA (DATCOH), B) PLLA (NPA), C) PEG-b-PLLA, and D) 
PLLA-b-PPEGEEMA scaffolds (scale bar = 100 μm). 
 
 
Figure B.11 Water contact angles of the PLLA homopolymer and block copolymer scaffolds. 
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Figure C.1 1H NMR spectrum of the reaction mixture used in the tin(II) 2-ethylhexanoate-catalyzed 














Figure C.2 1H NMR spectrum of the reaction mixture used in the DMAP-catalyzed ROP of lactide 

















Figure C.3 1H NMR spectrum of the reaction mixture used in the tin(II) 2-ethylhexanoate-catalyzed 
















Figure C.4 1H NMR spectrum of the reaction mixture used in the DMAP-catalyzed ROP of lactide 











Figure C.5 FTIR spectra of PLA-g-HANRs (synthesized with sodium citrate; tin(II) 2-




Figure C.6 FTIR spectra of PLA-g-HANRs (synthesized with sodium citrate; DMAP-catalyzed 




Figure C.7 FTIR spectra of PLA-g-HANRs (synthesized without sodium citrate; tin(II) 2-




Figure C.8 FTIR spectra of PLA-g-HANRs (synthesized with sodium citrate; DMAP-catalyzed 
ROP) A) before and B) after washing. 
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